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Summary 
 
 I have analysed the regulation and function of the Him gene to gain new 
insights into Drosophila heart development and its controlling factors. My results 
show that Him is important during the early specification of pericardial cells and 
cardioblasts. Loss of Him leads to a reduced number in both of these cell types by the 
end of embryogenesis. Over-expression of Him throughout the heart results in 
supernumerary pericardial cells. 
 Him is expressed in all embryonic pericardial cells from embryonic stage 12 to 
approximately stage 15. I have identified an enhancer fragment that reproduces this 
expression pattern. Phylogenetic footprinting revealed three highly conserved regions 
within this sequence. I undertook an extensive mutational analysis of this enhancer to 
identify regulatory elements within it. I identified Tinman as a direct activator of Him 
expression. My data indicate that Him is activated in a widespread area of the dorsal 
mesoderm and the amnioserosa and is actively limited to the pericardial cells. A 5 bp 
mutation within the enhancer sequence allows for expression within the cardioblasts. 
 Both heart cell types develop from the dorsal mesoderm and some share 
immediate progenitors. By stage 13, Him is pericardial cell specific and Mef2 is 
cardioblast specific. This is essential for normal heart development. If Him is not 
excluded from the cardioblasts, expression of the muscle-cell specific differentiation 
gene myosin is disrupted, similar to what has been described for Mef2 null mutants. If 
Mef2 is expressed in pericardial cells, the larval development of the pericardial cells is 
severely disturbed. 
 A possible explanation for these data is that Him is part of a genetic program 
that prevents the premature differentiation of heart cells and its down-regulation 
permits the pericardial cells to undergo their correct development. "
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Chapter 1  Introduction 1 
1.  Introduction 
 
The fruit fly, Drosophila melanogaster, has become a widely studied model 
organism in many scientific areas. Drosophila offers many advantages such as small 
size, easy cultivation, short generation time and this model system is suitable to both 
well-developed classic and modern genetic approaches. In Drosophila, a functional 
heart is only necessary after completed embryogenesis. 
The early patterning mechanisms that establish the basic body plan and its 
further subdivision are well studied. It is now known that many of these steps and 
processes are well conserved throughout the animal kingdom. This amazing 
conservation of patterning and the corresponding transcription networks has also been 
shown to be true especially for early heart development (Bodmer, 1995; Harvey, 1996; 
Olson and Srivastava, 1996, Zaffran and Frasch, 2002).  
In Drosophila, a functional heart is only necessary after completed 
embryogenesis. The Drosophila heart derives, as all hearts do, from the mesodermal 
germ layer. After the specification of the mesoderm this germ layer is subdivided into 
the fat-body and the somatic, visceral and heart mesoderm, each of which then 
differentiates further (Azpiazu and Frasch, 1993; Riechman et al., 1997). 
 
 
1.1 Drosophila development 
 
1.1.1 Life cycle 
 
The Drosophila life cycle takes about 11 days (at 25°C). The female flies deposit a 
fertilized egg on the surface of the food. This egg develops externally and is thus easily 
accessible for experiments. The embryonic development is completed within 24 hours 
and the first instar larva hatches by this time. The first larval instar lasts 24 hours. It 
takes another 48 hours (i.e. 96 hours AEL = after egg laying) for the third instar larva to 
develop from the second larval instar larva. This larva then continues to eat and grow to 
eventually pupate to begin metamorphosis into the adult fly (ca. 120 hours AEL). 
During pupation most of the larval tissues are histolysed and the adult fly develops. It 
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ecloses approximately ten to eleven days after egg laying. One of the few tissues that is 
not completely histolysed during metamorphosis is the heart. 
 
 
1.1.2 Embryonic development 
 
The complete process of embryonic development has been divided into 17 
distinct stages (Campos-Ortega and Hartenstein, 1985) to aid in its study. After the first 
nuclear divisions the embryo cellularizes (between two and three hours AEL, 
embryonic stage 5) which is followed by gastrulation. During gastrulation the three 
germlayers (endoderm, ectoderm and mesoderm) are formed. The endoderm will 
develop into the fore- and hindgut. The ectoderm will develop into the nervous system 
and epidermis, which secretes the cuticle of the developing fly. The mesoderm 
differentiates into the visceral muscle, muscles and heart and as such is of particular 
importance to this thesis, and will be explored further.  
 
 
1.1.3 Formation of the mesodermal germlayer and its subdivision 
 
The mesodermal germlayer is established on the ventral side of the Drosophila 
embryo. The mesodermal cells are internalized through the process of gastrulation. The 
maternally deposited factor Dorsal becomes active in the nuclei of the ventral most cells 
(Chasen and Anderson, 1993) and thus activates the zygotic genes twist (twi) and snail 
(sna) (Ip et al., 1992; Jiang et al., 1991; Pan et al., 1991; Thisse et al., 1988; Boulay et 
al., 1987). Both Twist and Snail are transcription factors necessary for the development 
of the mesoderm. Twist activates later mesodermal genes and Snail represses non-
mesodermal genes in the developing germlayer. The Twist protein is a helix-loop-helix 
protein and is necessary to activate the homeobox gene tinman (tin) and the MADS 
domain transcription factor Mef2 (Myocyte enhancer factor 2) (Taylor et al., 1995; Yin 
et al., 1997). The early mesoderm is characterised by the uniform expression of Twist, 
Tinman and Mef2. 
During gastrulation, the mesodermal cells divide twice and migrate along the 
inner surface of the ectoderm towards the dorsal side of the embryo subsequently 
forming a monolayer of cells underneath the ectoderm (this corresponds to embryonic 
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stage 8; Leptin and Grunewald, 1990; Dunin Borkowski et al., 1995). The outer 
ectodermal layer now influences the subdivision of the mesoderm through signals such 
as Decapentaplegic (Dpp) along the dorso-ventral axis and Wingless (Wg) and 
Hedgehog (Hh) along the anterior-posterior axis (during embryonic stage 9; Staehling-
Hampton et al., 1994; Dunin Borkowski et al, 1995; Frasch, 1995; Baylies et al., 1998). 
The mesoderm is also subdivided along the anterior-posterior axis by the 
expression domains of the pair-rule genes even-skipped (eve) and sloppy-paired (slp). 
While mesodermal areas under the influence of Even-skipped will form the visceral 
musculature and the fat body, the areas under the influence of Sloppy-paired will form 
the somatic musculature and the heart (Riechmann et al., 1997). 
The developing dorsal mesoderm in its early stages is characterised through 
uniform tinman expression, which becomes restricted to this part of the mesoderm at 
this stage, and will give rise to the visceral musculature and the heart. tinman mutants 
do not form either heart or visceral mesoderm (Bodmer, 1993). The expression of 
Sloppy-paired and Wingless (in the ectoderm) induces the differentiation of the heart 
mesoderm in the mesodermal cells that are in close contact with the ectoderm (Azpiazu 
and Frasch, 1993; Riechmann et al., 1997). In the cells further away from the ectoderm, 
Tinman activates bagpipe (bap) and thus promotes the formation of the visceral 
mesoderm (Azpiazu and Frasch, 1993). The generation of the visceral and the heart 
domain within the mesoderm are mutually exclusive since the expression of the Sloppy-
paired protein represses bagpipe expression. 
During these specification processes, the mesodermal cells divide a third time 
and form two layers of cells. As stated above, the inner layer gives rise to the fat body 
and the visceral muscles, while the outer mesodermal layer remains under the control of 
high levels of Twist and also remains in physical contact with the overlaying ectoderm. 
This outer layer will form the somatic muscles and the heart (Dunin Borkowski et al., 
1995; Riechmann et al., 1997).  
 
 
1.2  The dorsal vessel 
 
By late embryonic stage 12, the dorsal mesoderm extends as a continuous band 
along the sides of the embryo. Following germband retraction and dorsal closure of the 
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embryo these cells migrate towards the dorsal midline of the embryo and will form the 
dorsal vessel or heart along the dorsal midline shortly after dorsal closure (Frasch, 
1999). During the process of dorsal migration and closure the presumptive heart cells 
are patterned further under the control of a network of various genes (Cripps and Olson, 
2002). 
As a result of the inwards movement of the progenitors of the fat body and the 
visceral muscles, the mesoderm forms a “crest and trough” pattern along the anterior-
posterior axis by early embryonic stage 10; the peak of each crest forms under the part 
of the ectodermal stripe with highest levels of Wingless (Dunin Borkowski et al., 1995). 
The heart progenitors start to be specified at this stage as well. During embryonic stage 
10 a transient cluster of cells expressing Lethal of scute (L’sc) appears in the peak area 
of the dorsal mesoderm that was exposed to the highest levels of Decapentaplegic (Dpp) 
expression. The process of lateral inhibition singles out precursors for the heart in this 
cluster of cells and the first specific heart progenitors that are detectable are one or two 
Eve-positive cells within this peak area in late stage 10/early stage 11 embryos (Dunin 
Borkowski et al., 1995; Park et al., 1998; Carmena et al., 1998). The crest cells that 
contain the heart precursors begin to spread out to the sides during embryonic stage 11 
and by the end of this stage the division of the progenitor into the two Eve-positive 
pericardial cells has occurred (Park et al., 1998; Carmena et al., 1998). Two different 
models for the generation of the Eve-positive pericardial cells have been proposed; they 
disagree in the exact lineage of the Eve-positive pericardial cells (Park et al., 1998; 
Carmena et al., 1998). The analysis of Park et al. (1998), based on the analysis of 
induced clones and the expression pattern of marker genes, argues that two precursors 
asymmetrically divide to each yield one Eve-positive pericardial cell and a cell that 
contributes to the DA1 muscle of the somatic mesoderm. Contrary to this, the study of 
Carmena et al. (1998) used immuno-histochemical and over-expression techniques 
together with rescue experiments to argue that the asymmetric division occurs one step 
earlier and that the immediate progenitor of the Eve-positive pericardial cells divides 
symmetrically to produce these two daughter cells. This latter model is the model 
depicted in Figure 1.2.1 F and is the more widely referenced model. 
During early stage 12, together with the beginning of the germband retraction, 
the first precursors for the Odd-positive cells appear underneath the ectodermal Odd-
skipped stripe (Ward and Skeath, 2000). The four Odd-positive pericardial cells of the 
mature embryonic heart are generated from three different precursors. Two of these 
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precursors divide asymmetrically during the early part of stage 12 and generate one 
Odd- and Svp-positive pericardial cell and one Svp-positive cardioblast each; the third 
precursor appears slightly later during late stage 12/early stage 13 and divides 
symmetrically into two Odd-positive pericardial cells (Ward and Skeath, 2000). By 
stage 14, four Odd-positive pericardial cells are arranged in a row along the anterior-
posterior axis of each hemisegment (see Figure 1.2.1 B for a schematic of the Odd-
positive pericardial cell lineage). 
While the lineage of the remaining heart cells is also known, the timing of their 
division is less well studied. It is, however, generally accepted that these cells are also 
generated during late stage 11/early stage 12 (Ward and Skeath, 2000). In their study 
from 2000, Ward and Skeath used immuno-histochemical techniques in combination 
with clonal analysis and assays in numb and sanpodo mutants to show that the four 
Tinman-positive cardioblasts share one common superprogenitor (TSP in Figure 1.2.1 
C), which divides into two progenitors, one of which gains Ladybird early expression 
and divides into the two Tinman- and Ladybird-expressing cardioblasts, while the other 
progenitor generates the two Tinman-expressing cardioblasts (Ward and Skeath, 2000). 
The remaining two cardioblasts of each hemisegment are generated from a Seven-up-
superprogenitor (SSP in Figure 1.2.1 B). This superprogenitor divides into two 
equivalent progenitor cells, which then continue to divide asymmetrically each into a 
Seven-up-positive cardioblast and pericardial cell (see above; Ward and Skeath, 2000). 
The Seven-up pericardial cells are also two of the four Odd-positive pericardial cells. 
The two Tinman- and Ladybird-positive pericardial cells and the two Tinman-
positive pericardial cells are all generated through the symmetric division of a precursor 
cells (Ward and Skeath, 2000); these make up the four Tinman-positive pericardial 
cells. It is currently unknown if these two progenitors for the four Tinman-positive 
pericardial cells share a superprogenitor as do the Tinman-positive cardioblasts. 
 
 
1.2.1 The embryonic heart 
 
The segmentally organised Drosophila heart stretches from the third thoracic 
segment to the eighth abdominal segment. It pumps haemolymph towards the anterior 
of the animal. As is typical of insects, all other parts of the circulatory system are open;  
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Figure 1.2.1: The cells of the Drosophila heart and their lineage (adapted after 
Ward & Skeath, 2000; Alvarez et al., 2003; Han & Bodmer, 2003). 
A Schematic representation of the organisation of a hemisegment of the embryonic 
heart. B lineage of the Svp-positive cardioblasts and the Svp/Odd-positive and Odd-
positive pericardial cells. C lineage of the Tin- and Tin/Lbe-positive cardioblasts. D 
lineage of the Tin- and Tin/Lbe-positive pericardial cells. E lineage of the Eve-positive 
pericardial cells. F key to colours, symbols and abbreviations used throughout the 
figure. 
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the haemolymph re-enters the dorsal vessel through openings, termed ostia, in the 
posterior part of the heart. 
The embryonic Drosophila heart is subdivided into two morphologically 
different parts along the anterior-posterior axis of the animal: the heart proper in the 
posterior four segments and the aorta in the anterior segments. A pair of cardiovascular 
valves separates these two regions. The aorta appears thinner than the heart proper and 
also has a smaller lumen. Situated around the anterior-most region of the aorta are the 
lymph-gland and the endocrine ring-gland. The lymph-gland is responsible for the 
generation of the haemocytes that start circulating through the animal with the start of 
metamorphosis (Holz et al., 2003; for a review of the hematopoietic function of the 
lymph gland see Evans et al., 2003). The ring gland is part of the endocrine system of 
the fruit fly and is responsible for the production of ecdysone (Harvie et al., 1989; 
DeValesco et al., 2004). 
The dorsal vessel consists of a closed, contractile tube of myocardial cells or 
cardioblasts, and an outer layer of loosely associated pericardial cells (Rizki, 1978). The 
pericardial cells are non-contractile and have a function in the filtration of the 
haemolymph (Rizki, 1987; Das et al. 2008; Weavers et al., 2009, Zhuang et al., 2009). 
The pericardial cells are one of two types of nephrocytes found in Drosophila and 
together with the Malphighian tubules make up the excretory system of the fruit fly. The 
second types of nephrocytes found in Drosophila are the garland cells, which are 
located around the oesophagus of the animal. Both types of nephrocytes take up waste 
particles smaller than 10-12nm through filtration and endocytosis (Crossley, 1972; 
Weavers et al., 2009) and are able to metabolize, store and exocytose these waste 
materials (for a recent review see: Denholm and Skaer, 2009). 
 
As previously described the heart is organised in a segmentally repeating 
pattern. Exceptions to this are the anterior-most and the posterior-most segments, T3 
and A8, respectively. In these two segments cells express different genes and are also 
present in different numbers. The lymph gland lies posterior to the ring gland and 
encompasses the segments T3 and A1. The remaining heart containing segments (A2-
A7) all contain the same number of cells; each of these segments contains twelve 
cardioblasts and twenty pericardial cells (Ward and Skeath, 2000; Han et al., 2002). 
Unless otherwise stated, I will further describe the arrangement of the embryonic heart 
per hemisegment, i.e. a segment split in half along midline and the anterior-posterior 
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axis.  Each hemisegment has an identical arrangement of sub-groups of heart cells. 
These sub-groups of heart cells are defined by the different expression of known 
transcription factors and marker genes (see Figure 1.2.1 for reference). 
The cardioblasts can be distinguished from the pericardial cells by the 
expression of Mef2 (Taylor et al., 1995; Yin et al., 1997; Bour et al., 1995; Lilly et al., 
1995). Four of the six cardioblasts of each hemisegment express tinman (Bodmer, 1993; 
Azpiazu and Frasch,1993). The remaining two cardioblasts do not express tinman, but 
instead express seven-up (svp; Bodmer and Frasch, 1999) and dorsocross (doc; Lo and 
Frasch, 2001). Two of the four Tinman-positive cardioblasts express the ladybird genes, 
ladybird-early (lbe) and ladybird-late (lbl) (Jagla et al., 1997). These four cardioblasts 
also express the T-box genes midline (mid) and H15 (Miskolczi-McCallum et al., 2005; 
Qian et al., 2005, Reim et al., 2005). 
The pericardial cells are characterised by the uniform expression of zfh-1 (zinc 
finger homeodomain 1) and pericardin (prc; Lai et al., 1991; Zaffran et al., 1995; 
Chartier et al., 2002). As with the cardioblasts there are also sub-groups within the 
pericardial cells. tinman is also expressed in the pericardial cells; the four pericardial 
cells ventral to the cardioblasts are called Tinman-positive pericardial cells (see Figure 
1.2.1 A). The posterior two of these four Tinman-expressing cells also express ladybird. 
The group of four pericardial cells positioned lateral and slightly ventral to the 
cardioblasts are named Odd-pericardial cells after their expression of odd-skipped (odd; 
Ward and Coulter, 2000; Ward and Skeath, 2000). The anterior two of these four cells 
express seven-up as well as odd-skipped and are termed Odd/svp-lacZ pericardial cells. 
In the late embryonic heart the Eve-pericardial cells, which also express tinman, are 
located dorsally to the rest of the heart (Frasch and Levine, 1987). 
The early heart mesoderm is characterised by the uniform expression of tinman. 
Within the cluster of tinman expressing cells there are two mutually exclusive clusters 
of cells expressing ladybird and even-skipped. These two genes repress each other and 
form two distinct groups of precursors (Han et al., 2002). The T-box gene cluster 
dorsocross1, dorsocross2 and dorsocross3 (all three are usually grouped together and 
referred by one single abbreviation: doc) is also expressed in these early heart 
progenitors (Reim and Frasch, 2005). The doc genes are activated by Dpp and Wingless 
and are independent of Tinman in the early stages of heart development. The doc genes 
are necessary for the correct specification of the heart cells. 
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 The GATA-factor Pannier starts to be expressed around stage 11 and its 
expression is dependent on both Tinman and Doc, which are, in turn, also positively 
regulated by Pannier (Gajewski et al., 2001; Reim and Frasch, 2005). Doc expression is 
initiated in all heart precursors, but is then limited to the two anterior-most cardioblasts 
per hemisegment expressing seven-up during stage 12 to 13. Pannier and Doc activate 
two further T-box genes, midline/neuromancer2 (mid or nmr2) and H15/neuromancer1 
(H15 or nmr1). These two genes are expressed in the cardioblasts only; their expression 
has not been detected in the pericardial cells. midline expression starts in early stage 12, 
while the expression of H15 starts slightly later during mid stage 12. Midline has been 
shown to be necessary for tinman expression from late stage 12 to stage 14 and to 
negatively influence doc expression in the cardioblasts. However, both of these 
interactions might be indirect (Miskolczi-McCallum et al., 2005; Qian et al., 2005, 
Reim et al., 2005). 
 Another direct Tinman target, which is expressed in all heart cells, is the bHLH 
factor Hand (Heart, Autonomic Nervous system, neural crest-Derived cell types). Both 
Tinman and Pannier are necessary to activate expression of hand during stage mid 12 
(Han and Olsen, 2005). So far, the function of the Hand protein in the embryonic 
Drosophila heart development is unknown, but it has been shown to be necessary for 
the formation of the adult heart from the larval heart during metamorphosis (Lo et al., 
2007) and to be a direct target of the transcription factor Biniou in the visceral 
mesoderm (Popichenko et al., 2007). 
 Further direct Tinman targets are the ß3-tubulin and Mef2 genes (Gajewski et 
al., 1998; Gajewski et al., 1999; Kremser et al., 1999). Mef2 is initially expressed in all 
of the mesoderm, but becomes restricted to the cardioblasts within the heart mesoderm 
(Gajewski et al., 1998; Gajewski et al., 1999). Expression of ß3-tubulin in the heart is 
restricted to the four Tinman expressing cardioblasts and not observed in the two 
anterior Seven-up-positive cardioblasts. 
 The gene zinc finger homeodomain 1 (zfh-1) is initially expressed in the 
developing mesoderm and is then restricted to the pericardial cells with the Drosophila 
heart (Lai et al., 1991). Zfh-1 is the most commonly used marker for the pericardial 
cells. Towards the end of embryonic development, zfh-1 expression becomes further 
restricted to a sub-set of pericardial cells as the Eve-positive pericardial cells lose zfh-1 
expression (Su et al., 1999; Johnson et al., 2003). 
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1.2.2 The larval heart 
  
 The development of the Drosophila heart continues during the larval life of the 
animal. By the end of embryogenesis the heart is capable of pumping the haemolymph 
through the body. During the larval development, the heart grows in size in parallel with 
the whole animal. Generally there is still little that is known about the expression of 
genes in the heart during larval development. This is in part due to the fact that the larva 
secretes a cuticle, which makes immuno-histochemical methods more difficult as 
antibodies are unable to diffuse through this layer. 
The transcription factor hand remains expressed in all heart cells (cardioblast 
and pericardial cell) throughout larval life and into the adult fly (Sellin et al., 2006). 
tinman expression has also been described in the heart tube (Qian et al., 2008) and Mef2 
expression has been described for the cardioblasts of third instar larvae (Molina and 
Cripps, 2001). Sellin et al. (2006) have described the organisation of the larval heart 
using a hand-GFP reporter construct. Their study showed that the number of hand-GFP-
positive pericardial cells is reduced dramatically from the first instar larvae to the 
second instar larvae. There is evidence that the majority of pericardial cells are lost from 
the anterior part of the larval dorsal vessel and that these cells most likely degenerate 
(Sellin et al., 2006; Das et al., 2008). However, Sellin et al. (2006) state that they could 
not obtain reproducible results with propidium iodide and acridine orange, two 
commonly used stains for apoptosis; leaving the fate of this set of pericardial cells 
unclear. It is currently also not known if this loss of pericardial cells affects a specific 
sub-set of the pericardial cells. Das et al. (2008) have shown that in third instar larvae, 
all larval pericardial cells express odd-skipped and even-skipped but not tinman or 
seven-up and that the pericardial cells have the same identity with regard to the markers 
they tested for. They also observe pericardin expression throughout larval development 
(Das et al., 2008). Serpent, a GATA factor, is also expressed in third instar larvae 
(Brodu et al., 1999). In a recent paper, Lehmacher et al. (2012) mention that the 
embryonic Odd-positive pericardial cells are maintained into larval life. 
During the first larval instar the cardioblasts begin to grow and extend 
themselves along the anterior-posterior axis and the pericardial cells lose their close 
association with the cardiac tube (Sellin et al., 2006). Towards the end of the first instar 
the remaining pericardial cells also begin to grow in diameter and their nucleus enlarges 
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considerably as well. This nucleus enlargement is most likely due to the polytenization 
of the chromosomes (Kambysellis and Wheeler, 1972; Rizki, 1978). 
The continuous arrangement of the pericardial cells along the heart tube as seen 
in the embryo is interrupted in the early second instar larvae. The remaining pericardial 
cells are all arranged in one plane, but they do not resemble “pearls-on-a-string” 
anymore; especially in the anterior region there are large gaps between the pairs of 
pericardial cells. So far, no connective structures between the pericardial cells have 
been described. Along the heart proper the spacing of the pericardial cells is, however, 
quite close. 
 
 
1.2.3 The adult heart 
 
 The heart is one of the organs of the fly that is not completely histolysed and re-
built during the metamorphosis of the larva to the adult fly. The adult heart remains at 
the dorsal midline of the animal. It does however undergo several morphologic changes. 
The transcription factor Hand appears to have a crucial role for the correct formation of 
the adult heart as its loss leads to a number of defects associated with the development 
of the adult heart, i.e. the myofibrillar structure is disorganized and the systolic and 
diastolic diameter is reduced leading to a premature death of the adult flies (Lo et al., 
2007). The adult heart is shortened to what was the embryonic “aorta” when compared 
to the larval and embryonic heart, it now only extends from the brain in the dorsal 
anterior region as far as the segment A5 and also gains a curved structure following the 
general shape of the abdomen (Ritzki, 1978; Curtis et al., 1999; Molina and Cripps, 
2001; Sellin et al., 2006). The cardiac cells of the posterior most segments undergo 
programmed cell death (Jensen, 1973; Molina and Cripps, 2001; Zeitouni et al., 2007).  
This shorter adult heart is formed in response to the last peak of ecdysone 
expression during morphogenesis, which in turn controls the expression of the Hox 
genes ultrabithorax (Ubx) and abdominalA (abdA; Monier et al., 2005). The anterior 
segments A1 to A4 express Ubx and the posterior three segments A5 to A7 express 
abdA. The cardiac cells of the last segment (A5) “transdifferentiate” from regular 
myocardial cells in the middle of the larval heart into the specialized cells of the 
terminal chamber of the heart; this chamber is innervated but lacks automatic contractile 
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activity (Zeitouni et al., 2007). This change is dependent on the expression of abdA and 
the inhibition of the Wnt signalling cascade (Zeitouni et al., 2007). The Wnt signalling 
cascade is also necessary for the de novo formation of the inflow tract in the abdominal 
segments A2 and A3 and the differentiation of the cardiac cells (Curtis et al., 1999; 
Sellin et al., 2006; Zeitouni et al., 2007). During the remodelling of the larval to adult 
heart no new cardiomyocytes are formed, instead the already present and functional 
cells differentiate and grow in size and in the number of myofibrils they contain 
(Monier et al., 2005; Zeitouni et al., 2007). The adult heart possesses five ostia/inflow 
tracts that develop from the Seven-up positive cardioblasts of the embryo (Curtis et al., 
1999; Wasserthal, 2007; Shah et al., 2011). The PDGF-VEGF pathway is necessary for 
this valve formation and is, similarly to the already mentioned pathways, triggered by 
the ecdysone cascade during pupation (Zeitouni et al., 2007). 
Recently it has been shown that two separate populations of pericardial cells 
contribute to tissues outside the heart proper. During pupation a ventral layer of 
longitudinal muscle develops beneath the adult heart (Curtis et al., 1999; Zeitouni et al., 
2007; Shah et al., 2011). This layer of ventral longitudinal fibres is thought to originate 
from the secondary lymph gland cells, which are located posterior to the actual lymph 
glands of the animal (Shah et al., 2011). This muscle layer is syncytial and its formation 
is dependent on the activation of the FGF pathway (Zeitouni et al., 2007). The same 
study also shows the necessity of Notch signalling for the correct differentiation of the 
ventral heart muscle. 
Tögel et al. (2008) described the Drosophila wing hearts (pulsatile organs under 
the scutellum of the adult flies) as organs necessary to remove the epithelial cells from 
the wings upon eclosion of the adult fly. They have identified the origins of these 
organs as the anterior-most Eve-positive pericardial cells (Tögel et al., 2008). These 
anterior-most Eve-positive pericardial cells are located anterior to the lymph gland and 
are a sub-set of the Eve-positive pericardial cells described earlier. However, contrary to 
the already described Eve-positive pericardial cells these cells exclude tinman 
expression by embryonic stage 13 (Tögel et al., 2008). The origin of the wing hearts 
adds a further example that pericardial cells can indeed contribute to myogenic tissue in 
the adult fly. 
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1.3 Bioinformatic analysis of non-coding sequences 
 
 One of the big advantages of Drosophila as a model system is the immense 
effort that has been put into sequencing other Drosophila species. The genome of 
twelve Drosophila species has been sequenced, assembled and has been made publicly 
available (Drosophila 12 Genomes Consortium, 2007). This project has been unique in 
its scope and in the number of different species of one genus that have been sequenced. 
With the help of this project it is possible to analyse the degree of conservation of non-
coding and coding sequences between the different species. The lessons learnt from 
these analyses will also facilitate bioinformatic approaches for other species enabling 
predictions of protein function, potential regulators and transcription factor binding sites 
to become more accurate. 
The data of the sequenced genomes for D. simulans, D. sechellia, D. yakuba, D. 
erecta, D. ananassae, D. persimilis, D. willisoni, D. virilis, D. mojavensis and D. 
grimshawi are publicly available (Drosophila 12 genome consortium, 2007). Together 
with the previously released sequence data for D. melanogaster and D. pseudoobscura 
these species cover different evolutionary distances from D. melanogaster. Their 
relation to each other is shown in Figure 1.3.1 (Russo et al., 1995; Powell, 1997). D. 
virilis, D. mojavensis and D. grimshawi are the species that are farthest removed from 
D. melanogaster; the evolutionary distance between D. melanogaster and D. virilis is 
equivalent to the distance between mice and humans (Hartl and Lozovskaya, 1994). 
Approximately 22 to 26 % of non-coding sequence between these species is conserved 
(Bergman et al., 2001). All other Drosophila species, for which sequence data are 
available, are within the Sophophora sub-group of the Drosophila genus and are thus 
more closely related. The two species closest related to D. melanogaster are D. 
simulans and D. sechellia. D. simulans was separated approximately ten millions years 
ago from D. melanogaster, while D. yakuba was separated from D. melanogaster about 
eight million years ago. The Melanogaster subgroup of the Sophophora also includes D. 
erecta and the complete Melanogaster group also includes D. ananassae. This group 
diverged around ten million years ago and split from the Obscura group about 22 
million years ago. Two sequenced members of the Obscura group, D. pseudoobscura 
and D. persimilis, have been included in the sequencing project to allow for the study 
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Figure 1.3.1: Phylogenetic relationships between the twelve Drosophila 
species used in this study (image taken from Flybase 
(http://flybase.org/static_pages/species/sequenced_species.html)). 
This diagram only shows the relevant branching points of the different 
species and is simplified (this is especially true for the virilis-repleta 
radiation).   
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of an evolutionary outgroup to the Melanogaster subgroup. There are differences in the 
estimates for the evolutionary distance between D. pseudoobscura and D. melanogaster. 
They range from 40 to 50 millions years (Russo et al., 1995; Powell, 1997; Tamura et 
al., 2004; Drosophila 12 Genomes Consortium et al., 2007; Obbard et al., 2012). 
For my project the sequence data have helped me to define the regions that are 
most likely to be involved in the transcriptional regulation of Him. This so-called 
“Phylogenetic footprinting” of the non-coding sequence, i.e. the alignment of sequence 
data for the same region of different species, reveals those regions that have been 
conserved through the course of time. As for coding sequence, the degree of 
conservation of non-coding sequence is seen as an indicator of essential functions e.g. 
transcription factor binding sites. It has also been shown that the cis-regulatory 
sequences of Drosophila are highly constraint (Bird et al., 2006; Wittkopp, 2006; 
Drosophila 12 Genome Consortium, 2007; Ozdemir et al., 2011). This approach will 
facilitate the search for transcriptional regulators of Him. 
Based on the availability of the Drosophila genome sequence and on the 
development of new high-throughput techniques established in the ENCODE 
(Encyclopedia of DNA Elements) project, the modENCODE (model organism 
ENCODE) project for Drosophila melanogaster and Caenorhabditis elegans (worm) 
was established (Celniker et al., 2009; The modENCODE Consortium et al., 2010). The 
aim of the modENCODE project is to generate and link the various different but 
comparable data sets about gene expression and regulation, known target genes and 
chromatin structure etc. Thus, the modENCODE project will facilitate and help 
integrative studies of the function of particular genes in relation to its position in the 
genome and the role it has during the animals’ life cycle. The modENCODE project has 
also vastly improved the annotation of the genomes. One area of interest for the project 
has been to build and establish tools to reliably predict transcription factor binding sites 
and their binding factors (Flynet; Tian et al., 2009). This in turn, has allowed for the 
development of the first cis-regulatory maps of Drosophila, which has identified many 
candidate regulatory elements in combination with chromatin activity and accessibility 
and new transcription factor co-binding relationships. The transcriptional network 
described in this map currently includes about 800 different regulatory relationships 
(Nègre et al., 2011). Ozdemir et al., 2011 show some of the possibilities and power this 
approach has by analysing the binding characteristics, function and evolutionary 
development of the transcription factor Twist at various stages during the embryonic 
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development of Drosophila. This genome-wide, computational approach generates a lot 
of data that looks promising. It is however, essential to prove and connect these data to 
its functional relevance as transcription factor binding sites can be assigned in error as 
pointed out by Halfon et al., 2011. 
 
 
1.4 Conservation of heart development between vertebrates and 
Drosophila 
 
Even though the adult Drosophila and vertebrate heart appear very different, the 
early development of both heart types has been shown to be conserved and comparable 
(Bodmer, 1995; Harvey, 1996; Olson and Srivastava, 1996, Zaffran and Frasch, 2002). 
In both vertebrates and Drosophila, the presumptive heart cells are generated from the 
area of the mesoderm that moved furthest from the invagination point during 
gastrulation. These cells form two symmetric cell bands, which then move towards each 
other in order to form a linear heart “tube”. The embryonic Drosophila heart remains in 
this tube-like shape, while the vertebrate heart undergoes many morphological and 
structural changes, i.e. the looping and formation of compartments within the heart 
(Christoffels et al., 2000; Harvey, 1998). According to Hartenstein and Mandal (2006), 
all parts of the Drosophila cardiovascular system (contractile cardioblasts, the 
pericardial cells (nephrocytes) and the lymph gland that produces the haemolymph) are 
equally related to all the cell types of the vertebrate vascular system. Both 
cardiovascular systems are of mesothelial origin and contain cells and tissues that are 
responsible for the formation of blood cells, the excretory system, the circulatory 
system and the contractile heart (Mandal et al., 2004; Hartenstein and Mandal, 2006; 
Medioni et al., 2009). Evidence for this can also be found on a genetic level as the 
Drosophila rudhira (rudh) gene is exclusively expressed in the pericardial and garland 
cells from the third larval instar onwards and into adult life. The Rudhira protein 
belongs to the WD40 class and regulates macropinocytic uptake in the post-embryonic 
pericardial cells (Das et al., 2008b). Its ortholog in mouse, Rhudhira (Rudh), is 
expressed in endothelial precursors during vasculogenesis and angiogenesis (Siva and 
Inamdar, 2006; Das et al., 2008). 
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As indicated by this example, not only the morphological and structural steps of 
the early heart development are conserved between the Drosophila and vertebrate heart, 
but also many transcription factors have been conserved in their role and function 
(Bodmer and Venkatesh, 1998; Zaffran and Frasch, 2002). For example, the vertebrate 
orthologs for the Drosophila tinman gene (Nkx2.5 in mouse) are also the earliest known 
genes expressed in the presumptive heart cells (Lints et al., 1993; Harvey, 1996; Tanaka 
et al., 1998). Both Drosophila Tinman and murine Nkx2.5 have been shown to interact 
with GATA factors and regulate the transcription of downstream genes (Durocher et al, 
1997; Gajewski et al., 1998; Gajewski et al, 1999; Bruneau et al., 2001; Gajewski et al, 
2001). In a ChIP-on-chip study, Liu et al. (2009) showed that Drosophila Tinman 
activates eyes absent, a member of the Eya-Six family of transcription factors that are 
involved in muscle development in both flies and vertebrates, and that Drosophila 
Tinman regulates stat92E, a component of the JAK/STAT signalling pathway, which is 
also necessary for the somatic muscle development in Drosophila and myotome 
morphogenesis in zebrafish; showing that Tinman also influences the development of at 
least two further mesoderm derivatives (Liu et al., 2009). Drosophila Tinman is 
essential for heart development; tinman null mutants do not form a heart (Azpiazu and 
Frasch, 1993; Bodmer, 1993). In mice Nkx2.5 is not essential for the formation of the 
heart; the null mutant mice begin the process of heart formation but then the “heart” 
fails to continue to develop past the linear stage (Lyons et al., 1995; Harvey, 1996). In 
vertebrates the function of Nkx2-5 is not to initiate heart development but to ensure the 
activation of down-stream genes and the proper continuous development of the heart 
past the first few initial steps (Bartlett et al., 2010; Behrens et al., 2013; Guner-Ataman 
et al., 2013). In humans Nkx2-5 is implicated in congenital heart disease (for a recent 
review see Reamon-Buettner and Borlak, 2010). 
The transcription factors of the MEF-2 (myocyte enhancer factor 2) MADS-Box 
family have important roles during the differentiation of the mesoderm in vertebrates 
and Drosophila (Bour et al., 1995; Lilly et al., 1995; Olson et al., 1995; Lin et al., 
1997). Vertebrates have four members of the Mef2 family of transcription factors, 
Mef2-A, -B, -C and –D. The heart of mice lacking Mef2C fail to undergo heart looping 
and also lack the right ventricle chamber due to the down-regulation of the hand2 
transcript (Lin et al., 1997). In both, vertebrates and Drosophila, Mef2 is known to be a 
central node for the regulation of gene expression in conjunction with various co-factors 
(for a review see: Potthoff and Olson, 2007).  Drosophila has only one Mef2 gene (Bour 
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et al., 1995; Lilly et al., 1995; Taylor et al., 1995) and its loss leads to a nearly complete 
loss of Myosin-expressing cells within the somatic mesoderm and a complete loss of 
myosin expression in the heart while the cardioblasts are still present (Bour et al., 1995; 
Lilly et al., 1995; Ranganayakulu et al., 1995; Gunthorpe et al., 1999; D. Liotta, PhD 
thesis). 
Another example of conservation of the molecular mechanisms is the group of 
GATA transcription factors. The Drosophila GATA factor Pannier is required for the 
specification of both myocardial and pericardial cells (Gajewski et al., 2001; Alvarez et 
al., 2003; Klinedinst and Bodmer; 2003). The corresponding vertebrate factors GATA-4, 
GATA-5 and GATA-6 are also expressed in the developing heart and regulate the 
expression of cardiac specific genes (Molkentin, 2000; Latinkic et al., 2003; Sorrentino 
et al., 2005). GATA-4 is also necessary for the migration of the heart primordial 
towards the midline (Molkentin et al., 1997; Kuo et al., 1997). The murine GATA-4 
protein is able to function as a cardiogenic factor in Drosophila (Gajewski et al., 1999). 
T-box genes are also conserved between Drosophila and vertebrates. Similarly 
to tinman, these genes are also implicated in congenital heart disease. Tbx20 is 
expressed in the cardiac crescent in mouse development and its Drosophila orthologs, 
H15/Neuromancer2/midline are expressed in the cardioblasts (Ryan and Chin, 2003; 
Miskolczi-McCallum et al, 2005; Qian et al., 2005; Reim et al., 2005). The three 
dorsocross genes (doc1, doc2 and doc3) are expressed in the Seven-up-positive 
cardioblasts. The dorsocross genes are most closely related to the vertebrate Tbx6 genes 
that are expressed in the paraxial mesoderm of vertebrate embryos (Reim et al., 2003; 
Reim and Frasch, 2005). Both Drosophila and vertebrate T-box genes are involved in 
the development, specification and differentiation of the heart (Hoogaars et al., 2007; 
Reim et al., 2003; Reim and Frasch, 2005; Reim et al., 2005). 
This remarkable level of evolutionary conservation stretches as far as to the 
physiology of the heart and thus the Drosophila heart is becoming a well-established 
model system for the study of heart disease (for recent reviews see: Piazza and 
Wessells, 2011; Medioni et al., 2009; Cammarato et al., 2011; Nishimura et al., 2011; 
Maruyama and Andrew, 2012; Qian and Bodmer, 2012). 
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1.5 Him (Holes in muscle)  
 
Him was discovered in a subtractive hybridisation screen, which was aimed at 
identifying genes specifically expressed in the progenitors of developing mesoderm 
(Taylor, 2000). Within the heart, Him is only expressed in the pericardial cells but prior 
to the work contained in this thesis, this had not been confirmed by evaluating the co-
localisation of Him with known pericardial cell markers. This localisation would make 
it one of the few known genes that are expressed in all pericardial cells, but not 
expressed in the cardioblasts. The two other examples of proteins expressed in the 
pericardial cells but not in the cardioblasts include Zfh-1, which is expressed in all 
pericardial cells up to embryonic stage 15 and Pericardin. Zfh-1 expression is lost from 
the two Eve-positive pericardial cells per hemisegment by stage 15 (Su et al., 1999; 
Johnson et al., 2003) and Pericardin is secreted from the cells into the intercellular space 
and becomes a component of the extracellular matrix, making it unsuitable to detailed 
studies of cell numbers. Thus, Him and Zfh-1 are the only two known embryonic 
markers for the complete pericardial cell population. 
 
Him is a novel inhibitor of myogenesis and interacts with Groucho (Liotta et al., 
2007). In the somatic mesoderm of the embryo, Him is necessary to prevent premature 
activity of Mef2 and for the specification of the adult muscle precursors (Liotta et al., 
2007). Our lab has further shown that Him plays a similar role in the development of the 
dorso-longitudinal muscles of the indirect flight musculature of the adult fly (Soler and 
Taylor, 2009). 
Him is a relatively small gene located at 17A2 on the X chromosome of 
Drosophila melanogaster. It consists of only two exons and its cDNA has a length of 
1324 nucleotides. The Him protein is located in the nucleus and contains a WRPW-
domain in its C-terminus. This WRPW-domain is necessary for its interaction with 
Groucho (Liotta et al., 2007; D. Liotta, PhD thesis). 
The expression pattern of Him is similar to that of zfh-1 (zn finger homeodomain-
1). The transcription factor zfh-1 is expressed in all pericardial cells and has been shown 
to be necessary for the formation of the Eve-expressing pericardial cells (Lai et al., 
1991; Lai et al., 1993; Su et al., 1999). Prior to my work, the function of Him during 
heart development was not known. It is also unknown if and from which developmental 
Chapter 1  Introduction 20 
stage onwards the expression patterns of Him and Mef2 in the heart are separate or even 
mutually exclusive. We assume their expression patterns to be mutually exclusive from 
an early stage onwards and have shown that at least from embryonic stage 13 onwards 
this is indeed the case (see chapter 3). Thus, it is possible that Him has a similar 
function in the Drosophila heart to its function described in the embryonic somatic 
musculature and the indirect flight muscles of the adult fly. We speculate that during the 
later stages of the development of the embryonic somatic musculature, Him is necessary 
to keep the adult muscle progenitors (AMPs) in a specified but undifferentiated state by 
preventing premature Mef2 activity in these cells. The adult muscle progenitors are 
some of the few mesodermal cells that maintain Him expression until the end of 
embryogenesis. It is currently not known how the adult muscle progenitors and the heart 
cells react to a loss of Him. While the expression pattern of Him in the embryonic 
somatic musculature has been described (Liotta et al., 2007), its expression pattern in 
the embryonic heart has not been studied in detail and we know little about Him 
expression in the developing larvae, generating further questions that need answering. 
 
The best-studied example of transcriptional regulation during heart development 
is the even-skipped enhancer and it has been shown that this enhancer is an important 
integrating point for various regulatory pathways activated in pericardial cells (Knirr 
and Frasch, 2001; Han, Z. et al., 2002; Jagla, 2002). The Even-skipped protein, 
however, is only expressed in two of the ten pericardial cells per hemisegment. This 
sub-population of pericardial cells appears to separate itself from the rest of the 
developing pericardial cells at an early stage during heart development. The Eve-
positive pericardial cells are also the only pericardial cells that share a close lineage 
with dorsal muscle cells as described previously (see section 1.2.1). Very little is known 
about the regulation of any other genes in the pericardial cells. While nothing is known 
about the regulation of Odd in the pericardial cells, it has been shown that the 
expression of Tin in the pericardial cells requires a separate enhancer fragment than the 
expression in the cardioblasts (Venkatesh et al., 2000). Furthermore it is only known 
that Dpp represses zfh-1 expression in a subset of pericardial cells (Johnson et al., 
2003). Thus, the analysis of the transcriptional regulation of Him, a gene that is 
expressed in all pericardial cells, will greatly contribute to the understanding of cell-
type specific gene expression within the complete set of pericardial cells and not just a 
sub-set like the Eve-positive pericardial cells. This in turn, will enable us to further 
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understand the basic underlying principles of the development of the main two cell 
types in the Drosophila heart and will possibly allow us to make predictions about 
similar processes in vertebrates.  
 
 
1.6 Aims of the project 
 
The first aims of my research were to establish and describe the expression pattern 
of the Him transcript in the development of the Drosophila heart and to determine 
whether Him was a valuable marker for pericardial cells. Subsequent aims were to 
analyse the cardiac phenotype caused by the loss or gain of Him and to analyse the 
transcriptional regulation of Him. Together this would be the first study of role of Him 
in the pericardial cells and would give us an insight into the underlying mechanisms that 
distinguish the myogenic and non-myogenic cardiac cell types and their close 
developmental relationship. Knowledge and understanding of these mechanisms is of 
importance for the development of treatments for congenital and acquired heart disease 
as changes in the regulation of heart development lead to congenital heart disease which 
affect nearly 1 % of live births and is considered the number one cause of neonatal 
death (Bruneau, 2008; Narlikar et al., 2010). 
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2. Materials and Methods 
 
 
2.1 Drosophila melanogaster 
 
2.1.1 Maintenance of Fly Stocks 
 
The fly stocks were maintained in plastic tubes or bottles on standard culture 
medium (for recipe see Appendix) at 18 °C or 25 °C. The stocks were changed 
approximately every two weeks (if kept at 25 °C) or every four weeks (if kept at 18 °C). 
Tables 2.1.1, 2.1.2 and 2.1.3 list all fly stocks that were used or newly generated for this 
work. 
 
 
2.1.2 Embryo collection and fixation for non-fluorescent immuno-histochemical 
analysis 
 
The embryos were collected on apple juice agar plates (for recipe see Appendix) 
for the times and temperature calculated to produce embryos of the desired stage; most 
experiments were done on over-night embryo collections (25 °C) to allow for a range of 
developmental stages. The embryos were collected into a wire-mesh basket with a 
paintbrush and washed with water. In order to remove the chorion, the embryos were 
placed in a water-bleach (1:1) mix for approximately two minutes (Nationwide; bleach 
purchased from New Hall Janitorial). This process was monitored under a dissecting 
microscope. De-chorionated embryos become shiny and float towards the surface. The 
embryos were then rinsed with water, transferred to a 2 ml tube containing a 1:1 mix (1 
ml each) of heptane and 4 % paraformaldehyde (in PBS) and fixed for 20 minutes on a 
Lukeham shaker (setting 6-7). The paraformaldehyde was removed and 1 ml of 
methanol added. Vigorous shaking of the embryos in this mixture for 30 seconds 
removed the vitelline membrane of the embryos. The embryos were then rinsed in 1 ml 
fresh 100 % methanol several times and stored in methanol at -20 °C until required. 
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Table 2.1.1: List of fly stocks used in this work. The Gal4 and UAS-lines used for this 
work are listed separately in tables 2.1.2 and 2.1.3, respectively. 

 
 
Chapter 2  Materials and Methods 24 
 
 
 
 
Table 2.1.2: List of the various Gal4–driver lines used in this study. 
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Table 2.1.3: List of the various UAS expression lines used in this study. 

 
Chapter 2  Materials and Methods 26 
 
2.1.3 Embryo collection and fixation for FISH (Fluorescent In Situ Hybridisation) 
 
The embryos were collected as in 2.1.2 with the following changes: the embryos 
were collected into a wire-mesh basket submersed in TXN  (0.7% NaCl, 0.04% 
TritonX-100) and rinsed in TXN and then in water. The chorion was removed as 
described in 2.1.2. The embryos were then again washed in TXN and water, transferred 
to a 2 ml tube containing a 1:1 mix (1 ml of each solution) of heptane and “ribofix 
solution” (containing 4 % formaldehyde; for 1ml: 25!l 20xPBS, 50!l 0.5M EGTA, pH 
8.0, 896!l 10% methanol-free Formaldehyde (Polysciences)) and fixed for 25 minutes 
on a Lukeham shaker (setting 6-7). The ribofix solution was then removed and replaced 
with the same volume (1 ml) of methanol. Vigorous shaking of the embryos in this 
mixture for 30 seconds removed the vitelline membrane of the embryos. The embryos 
were then rinsed in 1 ml 100 % methanol, which was then removed and replaced by 1 
ml 100% ethanol. The embryos were washed several times in 100% ethanol and stored 
at -20 °C in ethanol until required. 
 
 
2.1.4 Counting pericardial cells in larvae 
 
The number of pericardial cells in larvae was counted using a handCGFP 
reporter fragment which is expressed in all heart cells at all stages of the development of 
the fly (Sellin et al., 2006). The size and shape differences between the pericardial cells 
and the cardioblasts allow for an easy distinction of the two cell types in the larvae. In 
order to ensure that only larvae of the same developmental stage were compared, I 
collected embryos for each experiment on apple juice agar plates for a two hour 
window. These plates were then incubated at 25°C until the larvae had reached the 
desired point in their development. The pericardial cells were assayed in young first 
instar larvae (28-30 h AEL = after egg laying), young second instar larvae (52-54 h 
AEL) and mid-stage third instar larvae (100-102 h AEL). 
At the correct time-point the larvae were picked off the apple juice plates, rinsed 
in distilled water, dried and mounted on a coverslide in a drop of immersion oil (Zeiss 
Immersol 518 N) and covered with a coverslip. As spacers I used the following: 2 layers 
of Scotch® Magic tape (3M, 19 x 25 mm) for the first instar larvae and a window cut 
into one layer of white insulation tape for second instar larvae and a window cut into 
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two layers of white insulation tape for third instar larvae. Slides with second and third 
instar larvae were then placed on an ice block that had been stored at -20°C to further 
slow down movement of the larvae. First instar larvae are not robust enough for this 
treatment, but their movement slowed down after approximately 3 to 5 min of exposure 
to the immersion oil. Despite this treatment the larvae remained alive for at least the 2 
hour time window used to score them. 
The pericardial cells of live larvae were then imaged under fluorescence on a 
Zeiss Axioscope (using the Zeiss 15 GreenH 546 filterset) using 10x, 20x and 40x 
magnification. Images were taken with an AxioCam HRc camera (Zeiss) and the 4.0 
version of the Axiovision software (Zeiss) and then processed minimally in Photoshop 
CS2 or CS6 (Adobe).  
 
 
2.1.5 Statistical analysis 
 
For each cell counting experiment I aimed to count 20 different animals, for a 
few experiments I was not able to count the full 20 animals for a particular genotype 
and developmental stage. When this was the case this information is supplied in the 
appropriate graph. All graphs show the mean cell number and standard error for each 
experiment as calculated in Excel (Microsoft). All further statistical analysis was 
performed in Minitab (Minitab, Ltd.). 
For the embryonic experiments I used three different controls (OR, 
handCGFP2.3 and handCGFP3.1; insertions of the handCGFP reporter fragment on the 
second and third chromosome, respectively). The results obtained for these controls in 
the embryonic experiments passed the three assumptions of ANOVA (Analysis of 
Variance; they are on an interval scale, normally distributed and have a similar degree 
of variance). Thus I proceeded using a 1-way ANOVA to verify my hypothesis that 
there is no significant difference between the three controls. This was indeed the case, 
thus all three controls have similar pericardial cell numbers during the embryonic 
stages. 
As my analysis of the larval pericardial cells is dependent on the presence of the 
handCGFP reporter construct, the two different handCGFP lines served as controls for 
these stages. As with the embryonic analysis, the results obtained for these tests were 
suitable for an ANOVA at each time point. For the second and third instar larvae my 
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hypothesis that there is no significant difference between the controls was correct and I 
proceeded as with the embryonic cell counts. However, the controls at the first instar 
time-point did show a significant difference in the pericardial cell number obtained for 
the two controls. This most likely highlights a problem in the counting of the pericardial 
cells as they are still very similar in size to the cardioblasts and arranged partly on top of 
each other and in a three dimensional structure around the cardioblasts. In consequence 
of these results I have discounted the result for my cell counts in the first instar larvae as 
not reliable. 
All experimental (non-control data) were grouped together (e.g. all Him null 
mutants and appropriate controls for one developmental point and type of cells). A large 
proportion of the data did not meet one assumption of ANOVA, they were not normally 
distributed, and so all data were thus analysed with non-parametric test methods. 
Kruskal-Wallis tests were used to detect significant differences between data sets, 
followed by pairwise Mann-Whitney tests to determine which experiments differed 
significantly when compared directly with the appropriate control. The p-value for each 
tested pairwise combination was noted. As the chance of a significant result becomes 
more likely with the large number of pairwise combinations tested, I applied the 
Bonferroni method (post-hoc test) to the results of the Mann-Whitney test. This test 
takes the number of pairwise comparisons that were tested into consideration and as a 
result lowers the p-value required for a statistically significant result correspondingly. 
All instances where a cell count is given as significantly different to the control in the 
results section have thus passed the Mann-Whitney test and the post-hoc test, which 
requires p-values of at least under 0.00625 for the chosen interval of 95 %. 
 
 
2.1.6 Wing analysis 
 
The analysis of the degree of wing translucence was performed as described in 
Tögel et al., 2008 and as described in personal communications with M. Tögel and A. 
Paululat. 
In order to test for the correct “clearing” of the wings after eclosing from the 
pupae, the wings were removed from 6 hour old adult flies. The wings were then 
mounted on a dry slide and covered with a cover-slip (no mounting medium was used). 
The cover-slip was then sealed to the microscope slide with nail varnish. The 
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translucency of the wings was then evaluated under a Zeiss Axioscope using 5x, 10x 
and 20x magnification. Images were taken with a AxioCam HRc camera (Zeiss) and the 
4.0 version of the Axiovision software (Zeiss) and then minimally processed in 
Photoshop CS2 or CS6 (Adobe).  
 
 
2.1.7 Generation of transgenic lines of Drosophila melanogaster 
 
New transgenic lines of Drosophila were generated by microinjection of the 
construct into the posterior of a pre-cellularised yw embryo, the area where the pole 
cells and thus the future gonads of the animal are formed. Microinjections were 
performed by Jun Han. The construct integrates into the fly genome from the plasmid 
with the help of a separately supplied transposase; insertion of the construct into the 
germline established a stable transgenic line.  Each construct also carried the mini-white 
selection marker, which, if integrated into the genome, restores the red eye colour to the 
previously w- adult flies. This allowed for an easy selection of transgenic flies. 
The DNA mix for microinjection consisted of a final concentration of 1!g/!l 
construct DNA and 0.25!g/!l helper DNA (plasmid p"25.1; Rubin and Spradling, 
1982; source of the !3-4 transposase) in 1x Spradling buffer (1mM Sodium Phosphate 
buffer pH 6.8, 0.5mM KCl). Before injection the mix was centrifuged at maximum 
speed for 10 minutes to remove any salt percipiate and 0.5 to 1!l of the mix were 
loaded into the injection needles. 
For microinjection, embryos of yw flies were collected in intervals of 30 minutes 
and then de-chorionated with a 1:1 mix of water:bleach (sodium hydrochloride, Sigma). 
The de-chorionated embryos were aligned in a row and transferred to a cover-slip edge 
that had previously been treated with glue (the glue solution is obtained by placing 
double-sided Scotch® tape (3M) in 50 to 100ml of heptane). The posterior of each 
embryo was oriented just at the edge of the cover-slip. The aligned embryos were then 
desiccated for approximately 10 minutes in a sealed desiccator chamber (Simax GL36) 
with Silica-gel 6-16 (mesh self-indicating, Fisher) and then covered in a thin layer of 
halocarbon oil (Voltalef, H10S) to prevent further drying out of the embryos. The 
microinjections needles used were purchased from Eppendorf (Femtotips II). A 
micromanipulator connected to a pump was then used to inject the construct and helper 
DNA into the embryo under a microscope (Nikon). 
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The injected embryos on the cover-slip were then placed on an apple-juice plate, 
which contained some yeast paste (dried bakers yeast mixed in dH2O) and a wet filter 
paper (Whatman) to provide food and prevent drying out of the larvae, respectively. 
Hatched first instar larvae were transferred into a vial containing fly food and kept at 
25°C until the adult (termed F0) eclosed. 
The eclosed F0 flies were individually crossed with yw virgins. The offspring of 
these flies (F1) had red eyes if the injected construct integrated into the fly genome. 
These were selected and by successive crossing of these flies to balancer stock (flies 
that carry a marker on each chromosome) the chromosome carrying each insertion was 
established. Where possible the transgenic lines were brought to homozygosity to 
establish a stock. A list of all generated transgenic fly strains and the lines tested for 
each strain can be found in Table 2.1.4 and Figure 3.5.1. 
 
 
2.1.11 The Gal4/UAS system 
 
The Gal4/UAS system allows over-expression of genes in specific tissues and 
subsets of cells (Brand and Perrimon, 1993). One line carries the coding sequence of the 
Gal4 protein under the control of a characterised promoter or enhancer element and a 
second fly line carries the gene, which is to be over-expressed, under the control of the 
UAS element. If females of the first line are crossed with males of the second line, the 
offspring expresses the gene under the control of the characterised promoter or enhancer 
element used to drive Gal4 expression. 
 
Example of the fly crosses: 
 
Da-Gal4 UAS-tinman 
Da-Gal4 UAS-tinman 
 
                                                              Da-Gal4 
                                                            UAS-tinman 
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Table 2.1.4: List of established transgenic lines for this study, their expression pattern 
and primers used to clone each enhancer fragment. 
Lines: tested independent lines; PC: expression in pericardial cells; Cb: expression in 
cardioblasts; Origin: all constructs and lines were cloned and established in this lab, 
none are currently published; Fwd: forward primer; Rev: reverse primer 
Name Lines PC Cb Origin Fwd Rev 
PCE 6; 34; 41 ! " S. McConnell 1C6SET3 
FOR 
1C6SET3 
REV 
PCE S4 L1-1; L1-2 ! " S. McConnell Set3_S4 
_fwd 
1C6SET3 
REV 
PCE 
!extreg1 
L1-1; L7-1; L9-1 ! ! this study Setextreg1 
_Fd-EcoRI 
1C6SET3 
REV 
PCE 
!reg1 
L3-1; L5-2; L7-1; L13-1 ! ! this study 1C6_reg1 
_Fwd-EcoRI 
1C6SET3 
REV 
PCE 
LSA 
L5-1; L7-2; L11-1 ! ! this study Set3_LSA 
_reg1_Fwd 
Set3_LSA 
_reg1_Rev 
PCE 
LSA1-5 
L1-2; L6-2; L6-3; L8-1 ! ! this study Set3_LSA 
_1-5_Fwd 
Set3_LSA 
_1-5_Rev 
PCE 
Oct1 
L2-1; L3-2 ! " this study Set3*oct 
-1.1_Fwd 
Set3*oct 
-1.1_Rev 
PCE* 
S5/S6 
L1-1; L2-2; L3-1; L4-1 ! " S. McConnell 1C6Set3 
S5-FOR 
+ 
1C6Set3 
S6-FOR 
1C6Set3 
S5-REV 
+ 
1C6Set3 
S6-REV 
PCE* 
S6 
L1-1; L1-3; L3-1; L4-1 L4-3; L8-
3) 
! " S. McConnell 1C6Set3 
S6-FOR 
1C6Set3 
S6-REV 
PCE* 
S6new 
L2-2; L3-2; L5-1; L5-2; L6-2 ! " this study Set3*S6 
new_fwd 
Set3*S6 
new_rev 
PCE 
!tin1 
L7-1; L9-1; L10-1 " " this study 1C6_reg1 
/-tin_Fwd 
-EcoRI 
1C6SET3 
REV 
PCE 
!Med 
L1-1; L2-1; L6-1; L7-1; L8-1 ! " this study Set3med_ 
EcoRI_Fwd 
1C6SET3 
REV 
PCE 
!Ebox 
L3-2; L4-1; L5-1; L6-2 ! " this study Set3EBox 
_EcoRI_Fwd 
1C6SET3 
REV 
PCE 
S1 
L6-6 " " S. McConnell Set3_S1 
_fwd 
1C6SET3 
REV 
PCE 
!tin2 
L10-2 " " this study 1C6SET3 
FOR 
1C6-reg3/4 
_Rev-XhoI 
PCE 
S2 
L10-1; “no line” ! " S. McConnell 1C6SET3 
FOR 
Set3_S2 
_rev 
PCE 
!reg1 
!tin2 
L2-2; L4-3 " " this study 1C6_reg1 
_Fwd-EcoRI 
1C6-reg3/4 
_Rev-XhoI 
PCE* 
S5 
L1-1; L4-1 " " S. McConnell 1C6Set3S5 
-FOR 
1C6Set3S5 
-REV 
PCE* 
S5C-T 
L2; L8 ! " this study Set3*S5 
C-T_fwd 
Set3*S5 
C-T_rev 
PCE* 
S5T-A 
L8; L12 ! " this study Set3*S5 
T-A_fwd 
Set3*S5 
T-A_rev 
PCE 
LSD4-9 
L2-1; L3-1; L5-2; L6-2 ! " this study Set3_LSD 
_4-9_Fwd 
Set3_LSD 
_4-9_Rev 
PCE 
LSE 
L2-1; L5-1; L5-3 ! " this study 
study 
Set3_LSE 
_reg2_Fwd 
Set3_LSE 
_reg2_Rev 
PCE 
LSF 
L1-2; L2-4; L3-2; L4-4s ! " this study Set3_LSF 
_reg2_Fwd 
Set3_LSF 
_reg3_Rev 
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2.2 Cell biology 
 
2.2.1 Immunohistochemistry (detection of individual proteins in Drosophila 
embryos) 
 
 The antibody stains were performed essentially as described in Rushton et al. 
(1995). The fixed embryos were blocked for 3 x 10 minutes on a Lukeham shaker 
(setting 2) at room temperature in 1 ml PBS-Triton (0.1 % (v/v) Triton in 1 x PBS (140 
mM NaCl, 6.5 mM KCl, 2.5 mM Na2HPO4, 1.5 mM KH2PO4; pH 7.5)) with 0.5 %  
(w/v) bovine serum albumin (PBS-Triton-BSA; BSA, Sigma), rinsed three times in 1 ml 
PBS and then incubated at 4 °C overnight on an A600 rocker (Denley) with the 
appropriate primary antibody (see table 2.2.1 for all antibodies used in this study). The 
embryos were rinsed in 1 ml PBS-Triton and washed 3 x 10 minutes on a Lukeham 
shaker (setting 2) in 1 ml PBS-Triton and incubated with biotinylated secondary 
antibody (1:200 dilution in 1 x PBS) for one hour at room temperature without any 
shaking. After rinsing for 3 times in 1 ml PBS-Triton and then 3 washes for 10 min at 
room temperature in 1 ml PBS-Triton, the embryos were incubated with the AB-
complex of the Vectastain Elite ABC kit (Vector Laboratories) to amplify the signal. 
For each antibody reaction 2 !l of solution A and 2 !l of solution B were gently mixed 
in 200 !l 1 x PBS and the AB (Avidin-Biotin) complex was allowed to form by 
incubating the AB mixture for 30 minutes without shaking at room temperature. The 
pre-incubated AB-solution was then added to the embryos and incubated for a further 
30 min at room temperature without shaking to allow the AB-complex to bind to the 
Biotin molecules on the secondary antibody. This was followed by three rinses in 1 ml 
PBS-Triton and three 10 minutes washes in 1 ml PBS-Triton on a Lukeham shaker 
(setting 2). The colour of the stain was then developed with 0.5 mg/ml 3,3’-
diaminobenzadine-tetrahydrochloride (DAB; Sigma D9015) and 0.06 % (v/v) hydrogen 
peroxide in dH20 (a 1/100 dilution of a commercially available 6% Hydrogen Peroxide 
Solution, 20 vols (Care +, L.C.M. Ltd). The staining reaction was stopped by rinsing the 
embryos three times in 1 ml of PBS-Triton, followed by three 10 minutes washes in 1 
ml PBS-Triton. 
The embryos were mounted in 80 % glycerol and analysed with a Zeiss 
Axioscope using 10x, 20x and 40x magnification. Images were taken with an AxioCam  
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Table 2.2.1: List of antibodies used in this study
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 HRc camera (Zeiss) and the 4.0 version of the Axiovision software (Zeiss) and then 
processed minimally in Photoshop CS2 or CS6 (Adobe). 
 
 
2.2.2 Immunohistochemistry (detection of multiple proteins in Drosophila 
embryos) 
 
Multiple labelling of proteins in whole-mount Drosophila embryos essentially 
followed the same protocol described in 2.2.1. If the two primary antibodies were raised 
in different species, they were applied at the same time and then developed 
successively. For this the embryos were treated as described in section 2.2.1 but only 
one of the biotinylated secondary antibodies was added. After developing the first 
antibody in the presence of NiCl2 to give a black precipitate, the embryos were rinsed 
three times in 1 ml PBS-Triton and then washed three times for 10 minutes on a 
Lukeham shaker (setting 2) in 1 ml PBS-Triton-BSA. Then the second biotinylated 
secondary antibody was added and developed as described in section 2.2.1. The less 
widely expressed protein and/or weaker antibody was usually developed first to ensure 
the stain is clearly visible. The first antibody was developed in the presence of NiCl2 
and thus the formed precipitate has a black colour. The second antibody is developed 
without any salts and the precipitate is brown allowing for a distinction between the two 
antibodies. 
If both antibodies were raised in the same animal, the protocol described in 2.2.1 
was followed for the first antibody. After developing this antibody (again in the 
presence of NiCl2 to give a black colour) the embryos were rinsed three times in 1 ml of 
PBS-Triton and then washed three times for 10 minutes on a Lukeham shaker (setting 
2) in 1 ml PBS-Triton each. The embryos were then blocked in 1 ml PBS-Triton-BSA 
on a Lukeham shaker (setting 2) for 30 minutes. Then, the second primary antibody was 
added to the embryos and the embryos were again incubated on an A600 rocker at 4°C 
over-night. The remainder of the stain was carried out as described in section 2.2.1 and 
the second colour reaction was again performed in the absence of salts to give a brown 
precipitate. 
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2.2.3 Single fluorescent labelling of proteins in whole-mount Drosophila embryos 
 
The fluorescent antibody stains followed the same protocol as the 
immunohistochemical procedure with the following alterations I made after optimizing 
the protocol described in 2.2.1 for fluorescence.  The fixed embryos were washed three 
times for 10 minutes in 1 ml PBS-Triton and 2 % (v/v) normal goat serum (Sigma) 
before the primary antibody was added. After the incubation with the primary antibody 
the embryos were rinsed three times and then washed four times for 10 min in PBS-
Triton and 2 % normal goat serum. If the used antibody was known to generate high 
levels of background, before the last wash the embryos were incubated in Vectastain 
SignalEnhancer (Molecular Probes, Invitrogen) for 30 min on a Lukeham shaker 
(setting 2) to reduce background as much as possible. The secondary antibodies (see 
Table 2.2.1, Molecular Probes, Invitrogen) were added in a 1/200 dilution in PBS-
Triton with 2 % (v/v) normal goat serum (total volume 200 !l per reaction) and 
incubated for approximately two hours at room temperature without shaking. The 
embryos were then rinsed three times in 1 ml PBS-Triton and washed six times for 10 
min in 1 ml PBS-Triton on a Lukeham shaker (setting 2) before mounting in 
“Fluorescent Mounting Medium" (90% glycerol, pH 8.6, 25mg/ml DABCO (Sigma; 
Wood, W. pers. communication). The embryos were imaged with a Zeiss Axioscope 
using 10x, 20x and 40x magnification. Images were taken with an AxioCam HRc 
camera (Zeiss; using the Zeiss 15 GreenH 546 and the Zeiss 10 Blue 450-490 SB 
filtersets) and the 4.0 version of the Axiovision software (Zeiss) and processed 
minimally in Photoshop CS2 or CS6 (Adobe). Alternatively, the embryos were analysed 
with a Leica DM6000 microscope and the Leica TCS SP2 AOBS spectral confocal 
system. Single image slices were selected or merges of image stacks created and further 
image processing was then done in the accompanying Leica Confocal Software. 
 
 
2.2.4 Multiple fluorescent labelling of proteins in whole-mount Drosophila embryos 
 
Multiple labelling of proteins in whole-mount Drosophila embryos with 
fluorescent secondary antibodies essentially followed the same protocol described in 
2.2.2 and 2.2.3. If the two primary antibodies were raised in different species, they were 
Chapter 2  Materials and Methods 36 
 
applied at the same time and the secondary fluorescent-labelled antibodies were also 
applied in one step during the secondary antibody incubation. 
If both primary antibodies were raised in the same animal, double-labelling was 
achieved by completing the protocol for single fluorescent labelling for the first 
antibody (see section 2.2.3). Then the embryos were rinsed three times in 1 ml PBS-
Triton and washed four times for 10 minutes in PBS-Triton + 2 % (v/v) normal goat 
serum to make sure to block the embryos well between the incubation between the first 
secondary and the second primary antibodies. The second first antibody was then added 
to the embryos and the staining was finished as described in section 2.2.3. 
 
 
2.2.5 RNA In situ Hybridisation 
 
The distribution of a specific transcript in whole-mount embryos is visualized 
using the method described by Taylor (2000) and uses Digoxigenin-labelled RNA 
probes (for the generation and quantification of the DIG labelled RNA probes please see 
2.3.11 and 2.3.12, respectively). The fixed embryos were transferred to a 1.5 ml tube 
and slowly re-hydrated in 3 steps (rinse in 1.5 ml 100 % methanol, then in 1.5 ml of 3:2 
MeOH/4 % paraformaldehyde in PBS solution, then let stand for 5 min in 1:2 MeOH/4 
% paraformaldehyde in PBS solution). Following this, a 10 minutes post-fixation step in 
1.5 ml of 4 % paraformaldehyde in PBS on the Lukeham shaker (setting 1.5) was 
performed. The embryos were rinsed and washed in 1.5 ml PBT (1x PBS + 0.1% 
Tween20) and pre-hybridised for 1 hour at 55°C in hybridsation buffer (50% formamide 
(Fluka), 4 x SSC (Sigma), 1 x Denhardt’s solution (Sigma), 250 !g/ml yeast tRNA 
(BRL), 250 !g/ml salmon testis DNA (Sigma), 50 !g/ml heparin (Sigma) and 0.1 % 
Tween-20). The embryos were then incubated on the rocking platform of the 
hybridisation oven (Techne Hybridizer HB-1D) for a minimum of 14 hours at 55°C in 
the presence of a final concentration of 0.125!g of DIG-labelled RNA probe in a total 
of 500 !l hybridisation buffer in a 1.5 ml tube. 
After the hybrdisiation the embryos were washed in 1 ml washing solution (50 
% formamide, 2 x SSC, 0.1% Tween-20) for 4 times spaced evenly throughout the day 
at the hybridisation temperature (e.g. 10 am, 12.30 pm, 2.30 pm and 5 pm), with the last 
wash being overnight. The embryos were then rinsed in 1 ml PBT and washed in 1 ml 
PBT for 30 minutes at room temperature and then incubated for 90 minutes in anti-DIG-
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AP antibody (Roche, 1:2000 dilution) in 200 !l total volume of PBT + 5 % (v/v) normal 
goat serum. The embryos were rinsed again in 1 ml PBT and washed 4 x 20 minutes in 
1 ml PBT and then rinsed twice and washed once for 5 minutes in AP buffer (100 mM 
Tris pH 9.5, 100 mM NaCl, 50 mM MgCl2, 0.1% Tween). The colour reaction was then 
allowed to proceed in the dark by the addition of 0.3 ml of AP buffer and 2.7 !l NBT 
(4-NitroBlue Tetrazolium Chloride Solution; Roche) and 2.1 !l BCIP (5-Bromo-4-
chloro-3-indolyl-phosphate, 4-toluidine salt; Roche) to the embryos and the progress 
monitored under a dissecting microscope. The reaction was stopped by rinsing the 
embryos in 1 ml PBT three times and washing the embryos in 1 ml PBT for 10 minutes 
for another three times. The embryos were then left to equilibrate in 80 % glycerol 
overnight before being analysed using a Zeiss Axioscope using 10 x, 20 x and 40 x 
magnification. Images were taken with a AxioCam HRc camera (Zeiss) and the 4.0 
version of the Axiovision software (Zeiss) and then processed minimally in Photoshop 
CS2 or CS6 (Adobe).  
 
 
2.2.6 RNA In Situ and immunohistochemical double labelling of RNA transcripts 
and proteins 
 
The protocol for the first two days is the same as the one described in 2.2.4. The 
protocols differ from the antibody incubation onwards. Here, the primary antibody at 
the appropriate dilution and the anti-DIG-AP antibody (Roche, 1:2000) were added 
together in a total volume of 200 !l of PBT and incubated for 2 hours at room 
temperature without shaking, the tubes were placed on their sides. The embryos were 
then washed 4 x 15 minutes in 1 ml PBT and incubated in the biotinylated secondary 
antibody (1:200) and the anti-DIG-AP antibody (1:2000) in a total volume of 200 !l of 
PBT for 1 hour without any shaking. Following this, the embryos were again washed 4 
x 15 minutes in 1 ml PBT and then incubated in the Vectastain Elite ABC (Molecular 
Probes) reagent for 30 minutes (leave the Avidin-Biotin complex to form for 30 minutes 
before applying to the embryos, see section 2.2.1 for details). The embryos were washed 
three times 10 minutes in 1 ml PBT. The antibody stain is developed first (according to 
the protocol described in 2.2.1, 600 !l PBT + 30 !l DAB (0.5 mg/ml), catalyst are 20 !l 
0.06 % (v/v) H2O2 in dH2O, no salts). This reaction mix was removed and the embryos 
washed three times in 1 ml PBT for 15 minutes before being transferred into AP buffer 
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(100 mM Tris pH9.5, 100 mM NaCl, 50 mM MgCl2, 0.1% Tween-20) and washed 3 x 5 
minutes in 1 ml of this buffer. The labelled RNA probe was visualised according to the 
protocol described in 2.2.4 (600 !l AP buffer + 2.7 !l NBT + 2.1 !l BCIP). The 
embryos were then washed in PBT and were, before analysis under the Zeiss Axioskop 
(see above), left to equilibrate in 80 % glycerol overnight. 
 
 
2.2.7 Fluorescent In situ Hybridisation (FISH) 
 
M. Drechsler and A. Paululat (University of Osnabrück, Germany) kindly gave 
the FISH protocol to us. The embryos were washed on a Lukeham shaker (setting 2) for 
five times 10 minutes in 1 ml PBT (1 x PBS, 0.1 % Tween-20) and then post-fixed in 1 
ml 10 % methanol-free formaldehyde (Polysciences, Germany) for 20 min and washed 
again five times 10 minutes in 1 ml PBT on a Lukeham shaker (setting 2). This was 
followed by a wash in 1:1 PBT:hybridisation buffer (for 100 ml: 50 ml Formamide, 25 
ml 20 x SSC, 0.1 ml 50 mg/ml heparin, 1 ml 10% TritonX-100) and then two 10 minute 
washes in 1 ml hybridisation buffer on the Lukeham shaker (setting 2). The embryos 
were then incubated in 1 ml of hybridisation buffer on the rocker platform of the 
hybridisation oven (Techne Hybridizer HB-1D) for at least an hour at 55°C. 
The DIG-labelled RNA probe was diluted to 1:500 (for both Him and lacZ) in 
hybridisation buffer (500 !l total volume per reaction) and denatured at 80°C for a 
minimum of 15 minutes and then stored on ice for 1 minute immediately before use. 
The probe was transferred onto the embryos and incubated for at least 40 hours at the 
hybridisation temperature (55°C) on the rocker platform of the hybridisation oven. 
After hybridisation the embryos were washed three times 60 minutes in 1 ml of 
hybridization buffer on the rocker platform of the hybridisation oven and then twice for 
30 minutes in a 1:1 mixture of PBT:hybridisation buffer (1 ml final volume). All these 
wash steps were carried out at the hybridisation temperature of 55°C. After the last 
wash in PBT:hybridisation buffer the embryos were washed 5 x 20 min at room 
temperature in 1 ml PBT and incubated with pre-absorbed (to reduce unspecific binding 
of the antibody) anti-DIG antibody (1:1000, made in sheep) at 4°C overnight. On the 
next day the embryos were washed four times 30 minutes in 1 ml PBT at room 
temperature on the Lukeham shaker (setting 2) and incubated in biotinylated anti-sheep 
antibody (1:200) in a total volum of 200 !l PBT at 4°C overnight on a rocker. 
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The next day the embryos were washed four times 30 minutes in 1 ml PBT and 
incubated in the Vectastain AB Complex (Molecular Probes, 200 !l final volume per 
reaction, see section 2.2.1 for details) for 1 hour at room temperature (the Avidin-Biotin 
complex was left to form for 30 minutes before incubation). The embryos were washed 
five times 10 minutes in 1 ml PBT and incubated 45 to 60 minutes in TSA Cy3 or TSA 
Cy5 (diluted 1:50 in amplifier solution which was supplied with the Vectastain TSA 
Cy3 or Cy5 Kits, Perkin Elmer). From this point onwards the embryos need to be kept 
in the dark under aluminium foil. The embryos were then washed again for five times 
10 minutes in 1 ml PBT, followed by heating the embryos to 70°C for 15 minutes while 
suspended in PBT, followed by 3 more 10 minute washes in 1 ml PBT. 
If no further antibody stain was necessary, the embryos were then transferred 
into approximately 500 !l Fluorescence Mounting Medium (90% glycerol in PBS, pH 
8.6, 25mg/ml DABCO; W. Wood, pers. communication) and left to equilibrate 
overnight at 4°C before analysis. The embryos were imaged with a Zeiss Axioscope 
using 10x, 20x and 40x magnification. Images were taken with an AxioCam HRc 
camera (Zeiss; using the Zeiss 15 GreenH 546 and the Zeiss 10 Blue 450-490 SB 
filtersets) and the 4.0 version of the Axiovision software (Zeiss) and then processed 
minimally in Photoshop CS2 or CS6 (Adobe). Alternatively, the embryos were analysed 
with a Leica DM6000 microscope and the Leica TCS SP2 AOBS spectral confocal 
system. Single image slices were selected or merges of image stacks created and further 
image processing was performed in the accompanying Leica Confocal Software. 
 
 
2.2.8 Antibody stain after FISH 
 
This slightly altered protocol (M. Drechsler, S. Albrecht, A. Paululat, pers. 
communication) for fluorescent antibody staining was followed after the completion of 
the FISH protocol. It is based on the protocol described in sections 2.2.3 and 2.2.4. 
Following the last wash of the FISH protocol the embryos were incubated for 30 
minutes in 1 ml freshly made blocking solution (PBT + 2% normal goat serum) at room 
temperature on the Lukeham shaker (setting 2) and then the appropriate primary 
antibody (diluted in blocking solution, 200 !l final volume, see table 2.2.1) was added 
and the embryos were incubated on a slow rocker at 4°C overnight. 
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The next day the primary antibody was removed and the embryos rinsed three 
times in 1 ml blocking solution, washed four times 10 minutes in 1 ml blocking solution 
on the Lukeham shaker (setting 2) and blocked for 1 hour at room temperature in 1 ml 
blocking solution on the Lukeham shaker (setting 2). During this time the fluorescent 
secondary antibody was pre-absorbed to reduce background fluorescence. For the pre-
absorption the secondary antibody was incubated (1:200 dilution) without shaking on 
embryos not expressing the antigen for approximately 1 hour at room temperature. 
These embryos were treated as described in section 2.2.1 until the first antibody 
incubation. The diluted fluorescent secondary antibody was then removed from the 
blank embryos and transferred to the tube with the experimental embryos and incubated 
for 2 hours at room temperature on a Lukeham shaker (setting 1). The embryos were 
then rinsed three times in 1 ml PBT and washed six times for 10 minutes in 1 ml PBT. 
After the final wash the embryos were transferred into Fluorescent Mounting medium 
(90% glycerol in PBS, pH 8.6, 25mg/ml DABCO; W. Wood, pers. communication) and 
left to equilibrate overnight at 4°C before analysis. The imaging was done as described 
in section 2.2.6. 
 
 
2.3 Molecular Biology 
 
2.3.1 Bacteria 
 
The bacterial strain used was Escherichia coli DH5!. The E. coli bacteria were 
grown in LB-medium in a shaking incubator (250 rpm) or on LB-Agar plates 
(containing ampicillin at a concentration of 100 µg/ml) at 37°C. 
 
 
2.3.2 Preparation of Plasmid DNA 
a) Boiling Mini Prep 
This preparation was used to analyse 1.5 to 5 ml of culture. The bacteria were 
grown overnight and spun down for 15 min at maximum speed in a benchtop centrifuge 
(13 000 rpm; Biofuge pico, Heraeus Instruments). The supernatant was decanted and 
the bacterial pellet was air-dried for approximately 5 minutes. The pellet was then 
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resuspended in 150 µl STET-buffer  (10 mM Tris (pH 8.0), 25 mM EDTA, 100 mM 
NaCL, 0.1 % Triton X-100, 8 % sucrose) with Lysozyme (1 mg/ml final concentration; 
Sigma) and boiled for exactly 45 seconds. This step lysed the cells. The genomic DNA, 
proteins and cell debris were spun down for 15 min at maximum speed (13 000 rpm) in 
a benchtop centrifuge. The supernatant was transferred to new 1.5 ml tube and the same 
volume of isopropanol (150 µl) at room temperature was added to precipitate the DNA. 
The samples were carefully mixed by inverting the tubes and the DNA was pelleted in 
1.5 ml tubes by centrifugation for 15 min at maximum speed. The supernatant was 
decanted and the pellets washed with 1 ml 70 % ethanol and then dried. The dried pellet 
was resuspended in 30 µl dH2O and further analysed as described below. 
 
b) Midi Preps 
For the preparation of plasmid DNA in larger quantities the Qiaquick Filter 
Plasmid Midi Kit (Qiagen) was used. The preparation was done according to the 
manufacturer's manual; the DNA was then resuspended in 100 µl dH2O. 
 
2.3.3 Analysis of DNA with restriction enzymes 
 
All restriction enzymes were supplied by NEB and used according to their 
guidelines. Digests were in a total volume of 50 µl, in the presence of BSA (final 
concentration of 100 !g/ml) using 5 units of enzyme. Double digests were done in the 
buffer specified by the NEB buffer compatibility table. 
 
2.3.4 Phenol-Chloroform extraction 
 
Phenol-Chloroform extraction was used to produce clean DNA preparations for 
cloning after restriction digests. The volume of the sample to be extracted was adjusted 
with ddH20, e.g. to 100 µl if necessary. Then the same volume of phenol-chloroform-
isoamylalcohol (25:24:1) was added and the sample was mixed well by inversion of the 
tube. Following centrifugation at maximum speed for 5 min in a centrifuge (13 000 
rpm, Biofuge pico, Heraeus Instruments), the upper phase was removed and the 
supernatant was ethanol precipitated (Section 2.3.5) before further analysis. 
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2.3.5 Ethanol precipitation 
 
The volume of the sample to be precipitated was brought up to a volume that is 
easy to handle, e.g. 100 µl. A tenth of the sample volume (e.g. 10 µl) of NaOAc (3 M, 
pH 5.2; Sigma) was added and the sample was mixed well by inversion. Then twice the 
sample volume (e.g. 220 µl) of ice-cold 100 % ethanol were added and mixed again by 
inverting the sample tube. The sample was kept on ice or in the freezer (-20°C) for at 
least 30 min. After this, the sample was centrifuged at maximum speed for 20 min. The 
pellet was washed in 70 % ethanol, air-dried and resuspended in the desired volume 
dH20 (e.g. 100 !l). 
 
 
2.3.6 Dephosphorylation of DNA 
 
In order to reduce the self-ligation of vectors during ligation, digested vectors 
were dephosphorylated. The digested vector was extracted with phenol-chloroform 
(Section 2.3.4) and ethanol precipitated (Section 2.3.5). The precipitated vector was 
resuspended in 27 µl ddH2O. Then 3 µl of the 10 x CIP-buffer (NEB) and 2 µl of CIP 
(calf intestinal phosphatase, NEB) were added. The mix was incubated at 37°C for 20 
min. After this time, 1 µl of CIP was added and the mix was incubated at 37°C for a 
further 10 min. After the dephosphorylation of the DNA the alkaline phosphatase was 
inactivated by incubating the mix for 10 min at 65°C. 
 
 
2.3.7 Ligation of DNA fragments 
 
Ligations were done in a total volume of 10 or 20 µl using 5 or 10 units of T4 
Ligase (Roche), respectively. The 2 x T4 Rapid Ligation Buffer was used according to 
the manufacturer's specifications. The amounts of DNA used for the ligations was 
calculated according to the following formula: 
ng of vector x kb size of insert/kb size of vector x molar ratio of insert/vector = ng of insert 
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 (obtained from the Promega manual for pGEM-T, the molar ratio used was 1:1). Since 
all ligations for this study involved an EcoRI restriction site, the ligations were done at 
12°C overnight. Table 2.3.1 lists all plasmids used in this study. 
 
 
2.3.8 pGEM-T cloning 
 
DNA fragments generated by PCR were immediately sub-cloned into the 
pGEM-T vector (Promega). The pGEM-T Kit was used according to the manufacturers 
(Promega) instructions. The amount of insert needed was calculated according to the 
formula given in Section 2.3.7, the pGEM-T vector was supplied at 50 ng/!l and has an 
approximate size of 3 kb. 
 
 
2.3.9 Generation of competent E. coli DH5!  cells 
 
DH5! E. coli cells were grown overnight at 37°C at approximately 250 rpm in 5 
ml of SOB medium (for 1l SOB medium: 20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 
dissolve in 950 ml dH2O and add 10 ml 250 mM KCl, adjust to pH 7.0 and to a volume 
of 1 L, autoclave. Before use add 5 ml of a sterile 2 M MgCl2 solution.) in a 14 ml 
round-bottomed sterile plastic tube. This culture was added to 500 ml of SOB medium 
in a sterile 2 L culture flask. The bacteria were then grown in the described conditions 
until they reach an OD650 of 0.5. It is important to not overgrow the bacteria. Once this 
OD has been reached the cells were kept on ice as much as possible. The culture was 
transferred into sterile 250 ml centrifuge containers and spun for 5 minutes at 4 000 rpm 
in a pre-cooled rotor (Sorval centrifuge, GSA rotor). The supernatant was discarded 
while keeping the cells on ice and the cell pellet was gently resuspended in 150 ml cold 
(4°C) TFB1 (100 mM RbCl2, 50 mM MnCl2.4H2O, 30 mM KAc, 10 mM CaCl2.2H2O, 
15 % (v/v) glycerol, pH adjusted to 5.8 with 0.2 M glacial acetic acid, filter sterilized 
and store at 4°C in a sterile bottle). The cells were pelleted by  
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Table 2.3.1: List of all plasmids used in this study. 
Name Notes Origin 
Him cDNA In pBluescript 
Used to generate Him 
RNA probe 
Our lab 
lacZ construct In pBluescript 
Used to generate LacZ 
RNA probe 
Richard Cripps 
Sd construct Generated from cDNA 
clone RE23308 
DGRC 
Hand construct Used to generate Hand 
RNA probe 
Achim Paululat 
Tin cDNA Suitable for in vitro 
transcription/translation 
Manfred Frasch 
pGEM-T® Cloning vector Promega 
pBluescript II KS+ Cloning vector Stratagene 
pCaSpeR hs43 
!Gal 
Vector containing the 
hs43 promoter to test 
for enhancer activity, 
Fly injection vector 
Carl Thummel,  
Hanh Nughyen 
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centrifuging the suspension at 4 000 rpm for 5 minutes. The supernatant was removed 
again and the cell pellet resuspended in 20 ml TFB2 (10 mM MOPS, 10 mM RbCl2, 75 
mM CaCl2.2H20, 15 % (v/v) glycerol, pH adjusted to between 6.8 and 7.0, filter sterilize 
and stored at 4°C in an autoclaved bottle). The cell suspension was aliquoted into 200 
!l amounts in 1.5 ml tubes on ice and at a room temperature of 4°C. The aliquots were 
then snap frozen in liquid nitrogen, and the competent cells stored at -70°C. 
 
 
2.3.10 Transformation of competent E. coli cells 
 
The E. coli strain DH5! was used for transformations. The competent cells were 
generated as described in Section 2.3.9. The cells were removed from storage at -70°C 
and thawed on ice. 3 µl of the ligation mix was pre-chilled in a round-bottom Falcon 
tube and then 50 µl of the thawed competent cells were added to the ligation mix. The 
cells and the ligation mix were incubated on ice for 30 min and then heat-shocked at 
42°C for 30 seconds. After the heat-shock, the cells were immediately returned to ice 
for 2 min. Then 450 µl of pre-warmed SOC medium (for 1l SOC medium: 20 g 
tryptone, 5 g yeast extract, 0.5 g NaCl, dissolved in 950 ml dH2O and add 10 ml 250 
mM KCl, adjust to pH 7.0 and to a volume of 1 l, autoclave. Before use add 5 ml of a 
sterile 2 M MgCl2 solution and 20 ml sterile 1 M glucose solution) were added to the 
cells, and the cells incubated for 30 min at 37°C to enable establishment of Amp-
resistance. After this incubation, the cells were plated on pre-warmed LB-Amp-Agar 
plates and incubated overnight at 37°C. 
 
 
2.3.11 PCR (Polymerase-Chain-Reaction) 
 
The primers for the enhancer fragments created in this study were ordered from 
MWG and resuspended in Molecular Biology Reagent grade water (Sigma) to a stock 
concentration of 100 pmol/µl and stored at -20 °C. This stock was then further diluted 
to 25 pmol/µl which was used for the reactions. The primers were used to introduce an 
EcoRI restriction site on the 5’ end and an XhoI restriction site at the 3’ end of the 
amplified DNA fragment. These restriction sites were then used to check for the 
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correctly sized fragment after cloning into the pGEM-T vector and then to directionally 
sub-clone the fragments into the pCaSpeR injection vector. 
The PCR reactions were done in a total volume of 50 µl using 2 units of 
polymerase, approximately 10 ng of template DNA (the starting point for the constructs 
used for this study was the 1C6 Set3 pGEM clone 3;2 which was generated by S. 
McConnell) and 25 pmol/µl of each primer per reaction (see Table 2.3.2 for all primers 
used in this study). All reactions were initially optimised with Taq-Polymerase (Bioline) 
and then performed with Dynazyme (Finnzyme), which is mix of a proof-reading and 
non-proof-reading polymerase. Thus, this amplified fragment was suitable for the A/T-
cloning. The fragment generated in the reaction with the proof-reading polymerase was 
then subsequently cloned into pGEM-T and the sequence verified (see attached DVD 
for all sequence data). A list of all primers and the constructs generated used in this 
study can be found in Table 2.3.2. 
 
 
2.3.12 RNA probe synthesis 
 
The template plasmid (a minimum of 2 !g template DNA) for the RNA probe 
(Him cDNA sequence cloned into pBluescript, D. Liotta, pers. communication) was 
linearised at the 5’ end of the cDNA insert using the appropriate restriction enzyme (for 
Him: Hind III, NEB) in a total volume of 10!l. Of this reaction, 5 !l (for probe used in 
regular RNA in situ; for probe used in FISH, the whole reaction (10 !l) was used) were 
added to the polymerase-mix (total final volume 20!l) that contains 2 !l 10 x DIG 
labelling mix (Boehringer), 1 !l RNase Inhibitor (Boehringer) and 1 !l (20 units) of the 
appropriate polymerase (Boehringer) for the plasmid (Him: T7 polymerase). This was 
incubated for 2-3 hours at 37°C. Then a DNase mix (1 !l 10 x DNase1 buffer, 3 !l (30 
units) DNase1, 6 !l dH2O; Boehringer) was added to destroy the plasmid template and 
incubated for 15 minutes at 37°C. This reaction was stopped by the addition of 80 !l 
125 mM sodium carbonate buffer (pH 10.2) and incubated at 60°C for 15 minutes. The 
reaction was then immediately stored on ice and 50!l of 7.5M ammonium acetate were 
added and the solution was mixed. Then 375!l of ethanol were added on ice and the 
reaction was left to precipitate on ice for a minimum of 10 min and centrifuged at 
maximum speed for 15 minutes. The supernatant was then removed and the pellet was  
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Table 2.3.2: Primers used to generate the enhancer constructs used in this study. 
Forward primers introduced an EcoRI restriction site, reverse primers introduced an 
XhoI restriction site into the PCR product. 
Name Notes sequence 
1C6_reg1_Fw
d-EcoRI 
Introduced an EcoRI site; 
forward primer for the 
PCE!reg1 construct 
5’GGGAATTCCGAGATATTC
CCAAGCGGC 3’ 
1C6_reg1/-
tin_Fwd-
EcoRI 
Introduced an EcoRI site; 
forward primer for the 
PCE!tin1 construct 
5’GGGAATTCCACTCTGAAA
CATCTTGAAGTC 3’ 
1C6-
reg3/4_Rev-
XhoI 
Introduced an XhoI site; 
reverse primer for the 
PCE!tin2 construct 
5’GGCTCGAGTGTTCTGTGTG
CGCAATG 3’ 
1C6SET3FOR Introduced an EcoRI site; 
designed by S. McConnell; 
forward primer for the 
standard PCE construct 
5’GGGAATTCGGGTTTGTCG
GCAATGATTTAC 3’ 
1C6SET3REV Introduced an XhoI site; 
designed by S. McConnell, 
reverse primer for the 
standard PCE construct 
5’GGCTCGAGCATCATCGTG
TCGAGCGTCATAATC 3’ 
 
Set3_S1_fwd Introduced an EcoRI site; 
designed by S. McConnell; 
forward primer for the PCE 
S1 construct 
5’GGGAATTCGTATATATGT
ATGTATGTA 3’ 
Set3_S2_rev Introduced an XhoI site; 
designed by S. McConnell 
5’GGCTCGAGCATATTATAA
ATAGCGCCTG 3’ 
Set3_S4_fwd Introduced an EcoRI site; 
designed by S. McConnell; 
forward primer for the PCE 
S4 construct 
5’GGGAATTCCTCTTCCCCCC
TCCAAA 3’ 
Set3E-
Box_EcoRI_F
wd 
Introduced an EcoRI site; 
forward primer for the 
PCE!Ebox construct 
5’GGGAATTCCATACACATG
TATATATGTATGTATGTAC 
3’ 
Set3med_Eco
RI_Fwd 
Introduced an EcoRI site; 
forward primer for the 
PCE!Med construct 
5’GGGAATTCCTAGCAGAGA
GACCCACAATA 3’ 
Set3_extreg1_
Fwd 
Introduced an EcoRI site; 
forward primer for the 
PCE!extreg1 construct 
5’GGGAATTCATTCCCCGAG
A<TATTCCCAAG 3’ 
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air-dried and resuspended in 30!l TE:formamide (1:1) for regular in situ use or in 150!l 
FISH hybridisation buffer for use in FISH. 
 
 
2.3.13 Quantification of RNA probes 
 
For use in the non-fluorescent in situ protocol, the generated RNA probe was 
diluted to a concentration of 5 ng/!l. In order to achieve this, specific dilutions of the 
synthesized probe were compared to standard concentration of a control RNA 
(Boehringer). 1!l of each dilution was spotted onto a positively charged nylon 
membrane (Roche, product number 1 209 272) and crosslinked using the “auto-
crosslink mode” to the membrane (UV Stratalinker). The membrane was then washed 2 
x 5 minutes in blocking solution (10 % (w/v) blocking reagent (Roche catalogue 
number 11096176001) in maleic acid buffer (4 ml 1M maleic acid, 6 ml of 1M NaCl for 
40 ml, filter before adding blocking reagent and adjusting pH to 7.5)). The membrane 
was blocked for 30 minutes in blocking solution at room temperature and then 
incubated in a 1:2000 dilution of anti-DIG-AP Fab fragment in blocking solution for 30 
minutes. The antibody was removed and the membrane was washed 2 x 15 minutes in 
blocking solution, rinsed once and washed twice for 10 minutes in washing solution (for 
20ml: 2ml 1M NaCl, 100!l 1M MgCl2, 2ml 1M Tris pH9.5, 200!l 10 % Tween). The 
colour reaction was left to develop in the developing solution in the dark (washing 
solution + 4.5!l/ml NBT + 3.5!l/ml BCIP). This reaction was stopped by repeated 
washes in PBT and the intensity of the spotted probe dilutions was compared to that of 
the RNA standard. 
 
 
2.3.14 Generation of the deletion constructs 
 
All enhancer fragments were amplified with specifically designed primers and a 
high fidelity polymerase and then cloned into the pGEM-T vector (pGEM-T Kit; 
Invitrogen). Once the PCR product was cloned into the pGEM-T vector, a medium scale 
DNA preparation was produced (Qiaquick Filter Plasmid Midi Kit, see section 2.3.2 b). 
This DNA was sequenced by Lark Technologies, Inc. (to their Silver Standard) to verify 
the correct sequence (see attached DVD for all sequencing data). The DNA preparation 
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was treated with restriction enzymes and the insert was sub-cloned into a lacZ reporter 
vector (pCaSpeR, Thummel et al., 1988). The reporter vector was injected into 
Drosophila embryos in the blastoderm stage. Eclosing flies were screened for 
transgenic animals (see Section 2.1.7). A list of the generated deletion transgenic flies is 
available in Table 2.1.4; Table 2.3.2 contains a list of all primers used to generate the 
analysed deletion constructs and Figure 3.5.1 is an overview about all enhancer 
constructs generated in this study. 
 
 
2.3.15 Site-directed mutagenesis 
 
The site-specific mutations of transcription factor binding sites were introduced 
using the QuickChange Site-Directed Mutagenesis Kit (Stratagene). This kit uses the 
ability of certain DNA polymerases to allow sequence mis-matches in the middle of a 
primer sequence. Combined with the use of the DpnI endonuclease, which specifically 
recognizes methylated DNA (i.e. only the template DNA produced and methylated in 
bacteria) and not the DNA produced by the in vitro polymerase reaction, this kit allows 
for the efficient introduction of mutations into known sequences. 
The Set3 *S5/S6 and Set3 *S5 constructs and the primers for the Set3 *S6 
construct had been created previously (S. McConnell & M. Taylor, unpublished data). 
All other primers were designed with “QuickChange primer” program available from 
the Stratagene homepage (http://labtools.stratagene.com/QC). The polymerase reaction 
to introduce the mutated primer into the sequence was done according to the 
manufacturer’s instructions. All potential mutated clones were sent off for sequencing 
to Lark Technologies, Inc. Once the correct sequence was verified (see attached DVD 
for sequencing data), the sequences were cloned into the pCaSpeR vector as described 
in Section 2.3.14. Table 2.3.3 lists all primers used to introduce mutations into the PCE 
sequence and Table 2.1.4 lists all fly lines generated in this study. 
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Table 2.3.3: Primers used to introduce point-mutations into the PCE sequence. 
Name Sequence 
Set3_LSA_1-
5_Fwd 
5’ACAGATATGTATATTCCCCGAGAGCGGACCAAGCGGC
CAAAAATAGACGC 3’ 
Set3_LSA_1-
5_Rev 
5’GCGTCTATTTTTGGCCGCTTGGTCCGCTCTCGGGGAAT
ATACATATCTGT 3’ 
Set3_LSA_reg
1_Fwd 
5’CAGATATGTATATTCCCCGAGAGCTCTAGAGCAGGCC
AAAAATAGACGC 3’ 
Set3_LSA_reg
1_Rev 
5’GCGTCTATTTTTGGCCTGCTCTAGAGCTCTCGGGGAAT
ATACATATCTG 3’ 
Set3_LSE_reg
2_Fwd 
5’GGGTTGCATTGCGCACACACAGAATGCTCTAGACGAG
AGTTCAAGTGCATGCCG 3’ 
Set3_LSE_reg
2_Rev 
5’CGGCATGCACTTGAACTCTCGTCTAGAGCATTCTGTGT
GTGCGCAATGCAACCC 3’ 
Set3_LSD_4-
9_Fwd 
5’GTAACGCACTTGAAGTGCACTCTGAACACGATTGAAG
TCCAAATAAAATAGCAGAGAGAC 3’ 
Set3_LSD_4-
9_Rev 
5’GTCTCTCTGCTATTTTATTTGGACTTCAATCGTGTTCAG
AGTGCACTTCAAGTGCGTTAC 3’ 
Set3*oct-
1.1_Fwd 
5’CCCAAGCGGCCAAAAATAGACATGGCTTGTAACGCAC
TTGAAGTGCACTC 3’ 
Set3*oct-
1.1_Rev 
5’GAGTGCACTTCAAGTGCGTTACAAGCCATGTCTATTTT
TGGCCGCTTGGG 3’ 
Set3*S5C-
T_fwd 
5’CAGAACATGTGAATGCAGAGTTTAAGTGCATGCCG 3’ 
Set3*S5C-
T_rev 
5’CGGCATGCACTTAAACTCTGCATTCACATGTTCTG 3’ 
Set3*S5T-
A_fwd 
5’ACATGTGAATGCAGAGTACAAGTGCATGCCGTGAC 3’ 
Set3*S5T-
A_rev 
5’GTCACGGCATGCACTTGTACTCTGACATTCACATGT 3’ 
Set3*S6new_f
wd 
5’GCCAAAAATAGACGCAAATTGTAACGGTCTTTCAGTG
CACTCTGAAACATCTTGAAGTC 3’ 
Set3*S6new_r
ev 
5’GACTTCAAGATGTTTCAGAGTGCACTGAAAGACCGTTA
CAATTTGCGTCTATTTTTGGC 3’ 
Set3_LSF_reg
2_Fwd 
5’GCAGAGTTCAAGTGCATGCCGATCACACTCAACGCAC
ACACACACACGC 3’ 
Set3_LSF_reg
3_Rev 
5’GCGTGTGTGTGTGTGCGTTGAGTGTGATCGGCATGCAC
TTGAACTCTGC 3’ 
1C6Set3S5-
FOR 
5’GCAAATTGTAACGGTCTACAAGTGCACTCTG 3’ 
1C6Set3S5-
REV 
5’CAGAGTGCACTTGTAGACCGTTACAATTTGC 3’ 
1C6Set3S6-
FOR 
5’GGAATGCAGAGTTGTAGACCATGCCGTGAC 3’ 
1C6Set3S6-
REV 
5’CTCACGGCATGGTCTACAACTCTGCATTCC 3’ 
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2.3.16 Purification of DNA fragments from agarose gels 
 
The correct size of the DNA fragments produced in the PCR reactions was 
verified using gel electrophoresis. Depending on their size, 1 to 1.5 % 1 x TBE agarose 
gels were used to separate the DNA fragments (for 500 ml TBE: 54 g Tris base, 27.5 g 
oric acid, 20 ml 0.5 M EDTA (pH 8.0), autoclave; pH 8.3). The bands were cut out 
under long wavelength UV light (bulbs used were Sylvania 8W F8T5 Black Light; too 
short wavelength can interfere with the cloning of the DNA fragment) and transferred 
into pre-weighed 1.5 ml tubes. The weight of the cut out agarose piece was determined 
and the DNA fragment was then purified using the Qiaquick Gel Extraction Kit 
(Qiagen) according to the manufacturer’s instructions. The final elution step was done 
with 30 !l of dH2O, which yielded approximately 100 ng/!l DNA. 
 
 
2.3.17 In vitro translation of the Tinman protein  
 
To generate in vitro translated Tinman protein, the TNT Coupled Reticulocyte 
Lysate System (Promega) was used. The reactions were carried out according to the 
instructions provided with the TNT Kit. Based on these instructions, the reaction for the 
translation of the Tinman protein was set up as follows: 25 !l reticulocyte lysate, 2 !l 
reaction buffer, 1 !l SP6 polymerase, 0.5 !l aminoacid mix –Meth, 0.5 !l aminoacid 
mix –Leu (these two aminoacid mixes need to both be added to ensure all aminoacids 
are present; if supplied separately these aminoacids can be used to introduce a 
radioactive label), 1 !l RNasin, 1 !l linearized tin cDNA (1 !g/!l; kindly provided by 
M. Frasch) and 19 !l ddH2O (DNase and RNase free, Sigma). This reaction was 
incubated at 30ºC for 90 min. For storage, equal amounts of glycerol were added and 
the reaction was kept at -20 ºC. 
 
 
2.3.18 Electrophoretic Mobility Shift Assay (EMSA) 
 
The oligos used for the EMSAs were 24-mers containing the putative Tinman 
binding sites and the surrounding sequence. Oligos were ordered from MWG Biotech. 
A list of all oligos used for the EMSAs can be found in Table 2.3.4. 
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Table 2.3.4: Oligos and their sequence used in the Electrophoretic Mobility Shift 
Assay. 
Name Sequence Purification Supplier 
Set3_tin1_Wt(+) TTGTAACGCACTTGAAGTGCACTCTGA HPLC MWG 
Set3_tin1_Wt(-) TCAGAGTGCACTTCAAGTGCGTTACAA HPLC MWG 
Set3_tin1_Mut(+) TTGTAACGGTCTACAAGTGCACTCTGA HPLC MWG 
Set3_tin1_Mut(-) TCAGAGTGCACTTGTAGACCGTTACAA HPLC MWG 
Set3_tin2_Wt(+) TGCAGAGTTCAAGTGCATGCCGTG HPLC MWG 
Set3_tin2_Wt(-) CACGGCATGCACTTGAACTCTGCA HPLC MWG 
Set3_tin2_Mut(+) GATCTGAGTACAGGTAAGGGCTTC HPLC MWG 
Set3_tin2_Mut(-) GAAGCCCTTACCTGTACTCAGATC HPLC MWG 
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 500 fmol of the plus strand of each oligo were end-labelled with gamma32P-ATP 
in a 10 !l reaction using 2 !l T4 polynucleotide kinase (20 units; NEB) and 1 !l 10 x 
Polynucleotide Kinase Reaction Buffer (supplied with the enzyme; NEB). This reaction 
was incubated at 37ºC for 30 min. The plus and the minus strand oligos were annealed 
in a total volume of 100 !l TNE buffer (10 mM Tris (pH 8.0), 100 mM NaCl, 1 mM 
EDTA) to yield a final concentration of 5 fmol/!l for the annealed oligo. To purify the 
labelled oligo after annealing approximately 700 !l of G25 matrix (Sephadex G25, 
Sigma) resuspended in TNE buffer were added to a Spin-X column. This was spun for 
30 s at 14000 rpm and then the annealed and labelled probe was added to the column 
and spun again for 30 s. The unincorporated ATP will be retained within the matrix 
while the purified probe will be in the flow-through. The purified probe was then stored 
at -20 ºC. The competitor oligos were not labelled, but were annealed following the 
same protocol. However, the final concentration for the competitors was 500 fmol/!l. 
The EMSAs were run on native Acrylamide gels (5 ml Accu-Gel (29:1, 
Arcylamide:Bis-Acrylamide; National Diagnostics), 1.25 ml 10x TBE, 43.25 ml dH2O, 
50 !l TEMED, 400 !l 10% APS (Ammonium persulfate, Sigma)). 
The binding reaction was carried out in 10 !l final volume. The reaction 
contained 6 !l TNT lysate (protein, this includes 50 % glycerol from storage), 1 !l 
labelled probe, 2 !l 5x buffer (described in Kremser et al., 1999), 0.15 !l dI-dC (2 
!g/!l) and 0.9 !l DTT (50mM). The 5 x binding reaction buffer (Kremser et al., 1999) 
contains 20 mM Tris/Cl (pH 7.5), 200 mM NaCl, 0.1 % Trition X-100, 5 mM DTE, 
0.02 % BSA (w/v) and 5 % glycerol (w/v). The reaction was incubated for 30 min at 
room temperature. 
The gel was pre-run for 45 min at 150 V, then the samples were mixed in a 1:1 
ratio with 2 x SDS Gel-loading buffer (100 mM Tris-Cl (pH 6.8), 4 % (w/v) SDS 
(sodium dodecyl sulfate), 0.2 % (w/v) bromophenol blue, 20 % (v/v) glycerol, 200 mM 
ß-mercaptoethanol) and were loaded onto the gel. The gel was run at 150 V for 
approximately 60 min. The gel was dried and the X-Ray film (FujiFilm) was exposed 
overnight at -80ºC. 
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2.4 Bioinformatics 
 
2.4.1 Alignment programs 
 
The D. melanogaster and D. pseuodoobscura sequences for the PCE (=Set3) 
enhancer fragment were obtained from the BDGP project website 
(http://www.hgsc.bcm.tmc.edu/projects/drosophila/). The sequence data of the other 
Drosophila species were obtained from the NCBI trace archive, which contains all the 
raw sequence project sequences and which was updated every 24 hours 
(http://www.ncbi.nlm.nih.gov/Traces/trace.cgi?). In all cases the D. melanogaster 
sequence was used to search the trace archive using Blast (discontiguous Basic Local 
Alignment Search Tool). The retrieved sequences were then edited, i.e. stretches of 
sequence that did not show up in the BLAST results and did not align with the D. 
melanogaster PCE sequence were deleted. The edited sequences were then analysed 
with various alignment programs. Initially this analysis was done before the release of 
the compiled and annotated sequences of the ten further Drosophila species. However, 
repeats at later time-points have shown similar results. 
Initially only pairwise alignments were generated between D. melanogaster and 
D. pseudoobscura using VISTA (http://pipeline.lbl.gov/cgi-bin/gateway2; Dubchak et 
al., 2000; Mayor et al., 2000; Bray et al., 2003), lalign (http://www.ch.embnet.org/ 
software/LALIGN_form.thml), and ClustalW (http://www.ebi.ac.uk/clustalw/#; Chenna 
et al., 2003). These alignment programs search for homologous regions within the 
submitted sequence. All these alignment programs fall into one of two categories: 
global or local. The aim of global alignment programs is to find the best possible fit 
over the complete submitted sequence, while local alignment programs aim to find 
discrete regions within the submitted sequence data that feature a defined level of 
conservation. Since local alignment tools will show multiple alignment possibilities for 
the same region, they are more flexible than global alignment tools. The programs used 
for the alignments in this study cover both categories: Vista and ClustalW produce 
global alignments, while lalign produces a local alignment. 
With the availability of sequence data of further Drosophila species, it became 
necessary to align multiple sequences with each other. Of the programs used for the 
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previous alignments only ClustalW is capable of calculating multiple alignments. In 
order to be able to compare the result of a multiple local alignment program with the 
global ClustalW, alignments were also generated with PipMaker (Percent Identity Plot; 
Schwartz, S. et al., 2000), which is based on the BLAST Z program, a local alignment 
program. 
 
 
2.4.2 Search for transcription factor binding sites 
 
The search for transcription factor binding sites was superimposed onto the 
generated alignments of the Drosophila species. The complete PCE sequence was 
screened for potential transcription factor binding sites, but special attention was paid to 
the conserved regions identified by the alignment programs.  
For the search for transcription factor binding sites two methods were used. The 
first method was based on the TRANSFAC database (www.gene-
regulation.com/pub/databases.html#transfac; Wingender, E. et al., 2001). This database 
contains information of binding sites of eukaryotic transcription factors in the form of 
position weight matrices. These matrices contain the probability of a particular base at a 
given position within the binding site and are either based on in vitro experimental 
evidence such as Selex or were generated from compiled sites of validated binding sites. 
This analysis included only those sites for which there was experimental evidence. 
Since the TRANSFAC database contains mostly vertebrate transcription factor 
binding sites with very little Drosophila or even insect data, these data have to be 
treated with care as not every factor has a conserved function and/or binding site in 
Drosophila. To ensure the inclusion of the available Drosophila transcription factor 
data, a list of potential Drosophila factors was compiled through a literature search (S. 
Elgar, pers. communication). Potential transcription factors for this list were chosen 
according to their spatial and temporal expression pattern during the development of the 
embryo. As for the TRANSFAC analysis, factors were only included into the list if 
there was experimental evidence for their functionality. 
If there was more than one reported binding site for one transcription factor, all 
available data for this transcription factor were compiled and a “consensus” binding site 
was generated. To allow for different levels of degeneration within the consensus 
sequence, three different consensuses were generated; these were classified as high, 
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moderate and low stringency. This list of potential transcription factor binding sites was 
then converted into a DS Gene ‘analyse subsequence’ file and the D. melanogaster PCE 
sequence was analysed using the “nucleic acid subsequence analysis” function of DS 
Gene (Accelrys). 
 
2.5 Software 
Table 2.5.1: Software used during this study 
Program Manufacturer Used for 
Axiovision Zeiss Imaging software 
Clustal W Chenna et al., 2003 Algorithm for multiple 
sequence alignment 
DS Gene Software Suite Accelrys Prediction of restriction 
and transcription factor 
binding sites, primer design 
Excel 2008 Microsoft Basic statistics and data 
storage 
ImageJ W. S. Rasband (U.S. 
National Institutes of 
Health) 
Image/Video processing 
lalign William Pearson 
(www.ch.EMBnet.org) 
Algorithm for pairwise 
sequence alignment 
Leica Confocal Software Leica Imaging software for the 
confocal microscope 
MatInspector Genomatix Search for transcription 
factor binding sites 
Minitab Minitab, Inc. Statistical analysis 
MultiPipmaker Schwartz et al., 2000 Algorithm for multiple 
sequence alignment 
Photoshop CS2/CS 6 Adobe Image processing and 
creating figures 
Primer3  Primer design 
QuickChange primer Stratagene Primer design for site-
directed mutagenesis 
Vista Mayor et al., 2000 Algorithm for pairwise 
sequence alignment 
VLC VideoLan Organisation Video displaying 
Word 2008 Microsoft Word processing 
Vista Browser 2.0 Dubchak et al., 2009 Whole-genome alignment 
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2.6 Commercial Kits used in this study 
 
Table 2.6.1: Commercially available “kits” used in this study. 
Name Producer notes 
pGEM-T® Promega Cloning 
Qiaquick® Filter Plasmid 
Midi Kit 
Qiagen 
Preparation of plasmid 
DNA for PCR and cloning 
Qiaquick® Gel Extraction 
Kit 
Qiagen 
Purification of DNA from 
agarose gels 
Quick Change® Site-
directed Mutagenesis Kit 
Stratagene 
Used to introduce site-
directed mutagenesis into 
the PCE construct 
TnT Coupled Reticulocyte 
Lysate Systems® 
Promega 
Used to translate Tinman 
protein for the EMSA 
TSA Cy3® and Cy5® kits Perkin Elmer 
Fluorescent labelling of 
RNA in situs 
TSA® Biotin Kit Perkin Elmer 
Signal amplification in 
immunostains 
Vectastain® ABC-Kit 
Vector 
Vector Laboratories 
Signal amplification in 
immunostains 
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Chapter 3 
Him expression and phenotype 
 
3.1 Introduction 
 
Knowledge of the particular expression pattern of a gene is a very useful tool 
when analysing its regulation and function. While adjacent cells might provide key 
regulatory signals, only genes that are expressed in the same tissue at the same time 
point during development are potential direct positive or negative transcriptional 
regulators. Knowing when and where a gene is expressed also allows one to develop 
ideas as to its function. 
The technique of In-Situ-Hybridisation enables one to visualize the distribution 
of an RNA transcript of a gene of interest. This establishes where in the embryo and at 
which stages a gene is transcribed. Where available, the distribution of the protein 
encoded by the gene can also be analysed using an antibody specific to this 
gene/protein. 
 
 
3.2 Him expression in the heart 
 
3.2.1 Him expression in the heart of the developing embryo 
 
The exact expression pattern of Him in the dorsal vessel during development has 
not yet been described. The Him RNA transcript is initially expressed in the whole 
mesoderm from stage 9 onwards (Liotta et al., 2007). Thus, it is expressed in the cells 
that become the heart precursors during stage 11 (Bodmer et al., 1990; Wu et al., 1995; 
see Figure 3.2.1). Expression in all heart precursors is maintained until stage 12. By 
stage 13, Him expression is limited to pericardial cells of the heart (Figure 3.2.1 C and 
C’, Figure 3.2.2 G and H). 
 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.1: Expression of the Him transcript during Drosophila heart 
development. 
Him RNA in situ hybridisation on OR embryos. Images A-E show a lateral view 
of the embryo, images F to H show a dorsal view. Images A’ - H’ show the same 
embryo as in A - H at a higher magnification of the heart. The stars indicate the 
top of the mesodermal crescent in two hemisegments. 
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Initially Him expression in the dorsal mesoderm is weaker than its expression in the 
somatic mesoderm, however, the expression in the dorsal mesoderm increases during 
stage 11 and early stage 12. At the same time, Him expression decreases in the somatic 
mesoderm. The progenitors of the future heart cells are specified during late stage 10 
and early 11 at the very peak of each mesodermal crescent. The precursors for the 
pericardial cells are located at the peak of each crescent (stars in Figure 3.2.1 A’ and  
B'). As can be seen in the images 3.2.1 A’ and B’ the cells at the peak of the crescent 
initially express less Him than the ones slightly more lateral. The peaks of the 
developing mesoderm correspond to the areas of wingless expression in the overlaying 
ectoderm. These observations indicate that the precursors of the Eve-positive heart cells 
are likely to be the last heart cells to start expressing Him. If this is due to an influence 
of wingless is currently still an open question that needs answering. 
From mid-stage 12 onwards Him expression in the dorsal mesoderm is limited to 
the pericardial cells of the heart. Him expression is then maintained at the same level 
until stage 15 (see Figure 3.2.1 G and G’). At this point the expression of the Him 
transcript in the heart becomes weaker. During the following last two stages of 
embryonic development Him expression is lost from all pericardial cells. By stage 16, 
Drosophila embryos show a very weak and patchy Him transcript expression pattern in 
the dorsal vessel and no Him expression is visible by stage 17. 
I used co-localisation with the established cell marker Zfh-1 (Lai et al., 1991) to 
determine whether Him is expressed in all known pericardial cells (arrows in Figure 
3.2.2). Zfh-1 has been established as a marker for pericardial cells; it is initially 
expressed in all known pericardial cells, the two Eve-positive pericardial per hemi-
segment cells lose zfh-1 expression during the later stages of embryonic development 
(Su et al., 1999; Johnson et al., 2003). Zfh-1 is labelled in red in Figure 3.2.2. The Him 
transcript (labelled in blue in Figure 3.2.2) is also expressed in the Zhf-1-expressing 
cells. The Him transcript is mainly located in the cytoplasm of the cells and around the 
nuclear localisation of the Zhf-1 protein (Figure 3.2.2 H), however the purple colour of 
the overlay indicates co-localisation of Him and Zfh-1 even within individual cells. The 
so-marked cell populations are identical, thus, one can conclude that Him is expressed 
in all pericardial cells that also express Zfh-1. 
Two of the ten pericardial cells per hemisegment lose Zfh-1 expression in late 
embryogenesis, these two cells also express the cardiac marker Tinman (Frasch and  
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Figure 3.2.2: Him is expressed in all pericardial cells and not in the cardioblasts. 
Him RNA fluorescent in situ hybridisation on OR embryos. Images A, C, E, G show 
a dorsal view of a stage 13 embryo. Images B, D, F, H show the same embryo at a 
higher magnification. The arrows indicate areas where the Him transcript and Zfh-1 
are coexpressed and the stars mark the Mef2-positive cardioblasts. 
A, B Him RNA in situ (blue); C, D Dmef2 antibody (green); E, F Zfh-1 antibody 
(red); G, H overlay of all images 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3: Him expression in the Tin-positive pericardial cells. 
Him RNA in situ hybridisation and Tinman antibody stain on OR Embryos. 
Images A, C, E show a dorsal view of a stage 13 embryo. Images B, D, F show 
the same embryo at a higher magnification. The arrows point towards the Eve-
positive pericardial cells. 
A, B Him RNA in situ (red); C, D Tinman antibody (green); E, F overlay of all 
images. 
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Levine, 1987). Figure 3.2.3 shows the co-localisation of Him transcript and Tinman, 
which is expressed in six of the ten pericardial cells, including the Eve-positive 
pericardial cells (arrows in Figure 3.2.3). 
Within the cardiac mesoderm of Drosophila embryos Him expression is limited to 
the pericardial cells as shown in Figure 3.2.2 G and H. Mef2 is a protein expressed in 
contractile muscle cells and not in the pericardial cells of the heart (Taylor et al., 1995; 
Yin et al., 1997; Bour et al., 1995 and Lilly et al., 1995) and Mef2 and Him expression 
do not overlap in wild-type embryos past embryonic stage 12/13 (the stars in Figure 
3.2.2 H indicate the Mef2-positive cardioblasts). I was unable to take an image of an 
earlier embryo that would allow for the study of Him and Mef2 co-localisation in the 
early and in some cases shared progenitors of the pericardial cells and cardioblasts. 
 
 
3.2.2 Him expression in the heart during the three larval stages 
 
 As described previously in the introduction, the pericardial cells continue to 
undergo differentiation during larval development. Especially noteworthy is the 
decrease in the number of pericardial cells between the first and third instar from around 
120 Zfh-1-positive pericardial cells in a stage 17 embryo (Alvarez et al., 2003) to about 
40-50 pericardial cells by the third instar (Rizki et al., 1978, Sellin et al., 2006). The 
loss of pericardial cells occurs mainly between 36 and 40 hours AEL (after egg laying). 
This loss of some pericardial cells is accompanied by the increase in the size of some 
hand-GFP-positive nuclei through endoreduplication in the remaining hand-GFP-
positive pericardial cells (Kambysellis & Wheeler, 1972; Sellin et al., 2006, see chapter 
1). It is possible that the removal of Him from the pericardial cells prior to these steps is 
necessary to “allow” the further differentiation of the pericardial cells. Prior to my 
work, nothing was known about the expression of Him in the heart during larval life. I 
have used several reporter and Gal4-lines to identify if and where Him is expressed in 
the heart after embryonic development. For this analysis, I immobilized larvae at 
different time points (first instar (26-28h AEL), second instar (52-54h AEL) and third 
instar (100-102h AEL)) and evaluated the live animals for the fluorescence of the GFP 
reporter protein under the Zeiss microscope. 
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 The p43 (Eco/Xho) construct was made in this lab previous to my work and 
contains the sequence between the EcoRI and XhoI restriction sites upstream of the Him 
gene linked to a minimal promoter and GFP reporter (S. McConnell & M. Taylor, 
unpublished data). The EcoRI/Xho fragment is about 2.8 kb in length and does not 
contain the 1 kb of sequence immediately upstream of the transcriptional start site of 
Him. Its larval expression pattern is shown in Figure 3.2.4. During the first instar, the 
GFP expression observed during embryogenesis is still visible in all of these cells 
(arrow in Figure 3.2.4), but I do not observe any GFP expression in the heart during the 
second or third instar. Most likely the GFP expression I observed for the first instar is 
due to the persistence of the GFP protein expressed during embryogenesis. During the 
second and third instar, I observe a group of cells that do express GFP. These cells are 
located in close proximity to the heart. The GFP expression in these cells is initially 
weak in the second instar, but increases in strength by the third instar (see arrows in 
Figure 3.2.4 C and D). The cells are located towards the anterior of the animal but 
posterior to the lymph gland and the expression pattern is not similar to that described 
for the hand-GFP reporter (Sellin et al., 2006). The overall level of GFP expression in 
these cells is not very strong, which makes identifying them difficult. A step towards 
this would be to create larvae that carry both the p43 and the hand reporter constructs 
expressing GFP and RFP, respectively, to clearly identify any overlaps in expression 
and to verify my assumption that these cells are indeed separate from the pericardial 
cells expressing the hand reporter construct. 
 In addition to this construct, our lab has generated two different Him-Gal4 
driver lines, Him-Gal4 L3-5 and Him-Gal4 L4-1, which I also tested for larval 
expression using a UAS-GFP construct (Dutta et al., 2002). The construct I used 
throughout the remainder of my thesis, Him-Gal4 L3-5, is known to reproduce the 
embryonic expression pattern of Him (D. Liotta, PhD thesis) but so far any expression 
in larval stages has not been determined. This Gal4-construct contains the same 
sequence as the p43 (Eco/Xho) construct. My tests revealed that it does not drive any 
GFP expression during the later larval stages. Figure 3.2.5 D and F show the lack of 
GFP expression during the second and third instar in animals carrying the Him-Gal4 
L3-5 construct. There is only weak expression of GFP during the first instar (Figure 
3.2.5 B). The observed levels of GFP expression for the p43 (Eco/Xho) construct were 
stronger (Figure 3.2.4.B). As both constructs contain the same sequence, I conclude that 
the reduction of the larval GFP expression in the Him-Gal4 L3-5 construct is due to the  
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Figure 3.2.4 Larval expression pattern of the p43 (Eco/Xho 2.8kb) construct. 
Expression pattern of the GFP reporter gene used in the p43 (Eco/Xho 2.8 kb) 
enhancer construct during all three larval instars. The arrows point to the area of 
observed GFP expression and the arrowhead indicates the position of the lymph 
gland. C, E and G are magnifications of the images to the left. 
A overview of the available constructs to study Him expression past embryogenesis. 
The star indicates the p43 (Eco/Xho 2.8 kb) construct shown in B to G; B, C 1st instar 
larvae transgenic for the p43 (Eco/Xho 2.8kb) construct; D, E 2nd instar larvae 
carrying the p43 (Eco/Xho 2.8kb) construct; F,G 3rd instar larvae carrying the same 
GFP reporter construct. 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.5 Expression pattern of the available Him-Gal4 driver lines. 
Two different Him-Gal4 lines (L3-5 and L4-1) were used to drive GFP expression to 
verify their expression pattern during larval development. The arrows point to the 
areas where GFP expression observed in the Him-Gal4 L4-1 larvae and the 
arrowhead indicates the position of the lymph gland.. C, E, G, I, K and M show 
magnifications of the areas the arrow in B, D, F, H, J and L point to. 
A overview of all available constructs to study the larval expression pattern of Him 
(the L3-5 line contains the same sequence as the p43 construct). The star indicates 
the constructs used in this figure; B, C 1st instar larvae shows only very weak GFP 
expression in the heart if the Him-Gal4 L3-5 line is used; D, E the Him-Gal4 L4-1 
line also only shows weak GFP expression in the heart during the 1st instar; F, G no 
GFP expression in the 2nd instar larvae with the Him-Gal4 L3-5 construct; H, I very 
weak GFP expression in cells along the anterior part of the aorta if the Him-Gal4 L4-
1 line is  used; J, K I observed no GFP expression during the 3rd instar if the Him-
Gal4 L3-5 line drives the UAS-construct; L, M strong GFP expression in cells along 
the anterior part of the heart if the Him-Gal4 L4-1 construct is used. 
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variability of the UAS/Gal4 system and the different insertion points of the constructs 
into the genome. It is also possible that the reporter construct integrated into a part of 
the genome that is heavily repressed during larval development. This could explain the 
difference in GFP expression levels between the p43 (Eco/Xho) and the Him-Gal4 L3-5  
constructs. However, I only tested one transgenic line of the Him-Gal4 construct (L3-5; 
chosen for its strength of expression in the embryo) for larval expression and it is 
possible that other lines have a stronger/different effect. In addition to this, the 
Gal4/UAS-system is temperature dependent and if these experiments were repeated at a 
higher temperature (these experiments were all done at 25°C), one might be able to 
observe larval GFP expression in the Him-Gal4 L3-5 construct. 
 
More recently, a second reporter construct was made in the lab, Him-Gal4 L4-1, 
which contains the ca. 1 kb part of the 5’ upstream sequence of Him that is missing in 
the Him-Gal4 L3-5 construct in addition to the p43 (Eco/Xho) sequence (D. Hancock, 
PhD thesis). The larval expression pattern of the Him-Gal4 L4-1 construct is shown in 
images 3.2.5 D, E, H, I, L and M. This construct drives expression similar (in strength) 
to that observed for the p43 (Eco/Xho) construct in the second instar larvae. In the third 
instar, GFP expression is strong in a group of cells close to the heart but there is no 
expression within the actual heart cells (see arrow in Figure 3.2.5 M). The GFP-
expressing cells are in the same position as the GFP-positive cells that I saw with the 
p43 (Eco/Xho) reporter construct. Under these conditions the cells are easier to observe 
than before but I am still not able to identify them by their position alone. However, 
these cells appear to have many, relatively small nuclei in close proximity to each other 
and based on my observation I hypothesize that these GFP-positive nuclei are part of a 
multi-nucleated cell or tissue. 
In addition to the constructs generated in our lab, there are two further reporter 
constructs for the 5’ region of Him available. These Him reporter constructs were 
published by Rebeiz et al. and are a 2.2 kb and a 3.6 kb enhancer fragment (in their 
paper these constructs are called a 2.0kb and a 4.0kb enhancer/reporter construct, 
respectively), located upstream of the ORF (open reading frame) of Him, which have 
been cloned in front of a GFP reporter (Rebeiz et al., 2002). 
The results for this analysis of the 2.0 kb construct is shown in Figure 3.2.6. 
During the first instar larvae (see Figure 3.2.6 B) the GFP expression pattern is identical 
to that I observed in stage 16/17 embryos. This indicates that the 2.0 kb construct is at 
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least active until late in embryogenesis as the GFP protein will persist for a while after 
its expression ceases. During later larval stages (2nd and 3rd instar; Figure 3.2.6 C and D) 
this expression pattern is not visible anymore. This result corresponds to the expression 
pattern I observed with the constructs generated in our lab. Similar to the reporter 
constructs established in our lab, I have also detected GFP expression in a group of cells 
very close to the heart tube during these stages (see arrows in Figure 3.2.6 C and D). 
This expression is initially relatively weak during the second instar larvae but then quite 
pronounced in the third instar animals. These GFP expressing cells are in the same 
location as those previously described for the other Him-GFP reporter constructs. The 
analysis of the expression pattern of the endogenous Him transcript is hampered by the 
larval cuticle and will require dissections of the animal to allow the probe to penetrate 
into the tissues. 
 Based on these results, Him expression in the heart is limited to the embryonic 
stages. The GFP expression in the heart that I observed during the first instar is most 
likely due to the stability of the GFP protein. The identity of the GFP-positive cells 
observed in the majority of constructs in the anterior to middle part of the larval body 
during the second and third instar is currently not known, however, my results point 
towards the importance of the 1 kb region immediately upstream of the ORF for Him 
expression in these unidentified cells, as I have only observed GFP expression in these 
cells when the constructs included these 1kb of DNA. 
 
 
3.3 Him null phenotype in the heart 
 
As shown above, Him is expressed in all pericardial cells of the embryonic heart. 
The Him transcript can be visualized until the late stages of embryogenesis before 
possibly being re-expressed in a set of un-identified cells in the second and third instar 
larvae (see above). The pericardial cells of the Drosophila heart are non-myogenic cells 
thought to be involved in ultra-filtration of the haemolymph (Rizki, 1978; Rugendorff et 
al., 1994; Das et al., 2008; Weavers et al., 2009). Previously this lab has shown, that, in 
the somatic mesoderm, Him has a role in down-regulating Mef2 activity and that Him 
may contribute to keeping the Adult Muscle Precursors (AMPs) in a committed but 
undifferentiated state during embryogenesis (Liotta et al., 2007). Only recently, it has  
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Figure 3.2.6: Larval expression pattern of the 2.0 kb construct of Rebeiz et 
al., 2002. 
Expression pattern of the GFP reporter gene used in the 2.0 kb enhancer 
construct (Rebeiz et al., 2002) during all three larval instars. The arrows point to 
the areas of observed GFP expression. 
A overview of the available constructs to study Him expression in larvae. The 
star indicates the construct used in this figure; B 1st instar larvae transgenic for 
the 2.0 kb construct shows GFP expression in all heart cells; C 2nd instar larvae 
carrying the 2.0 kb construct only show GFP expression in unidentified cells 
close to the heart; D 3rd instar larvae carrying the same GFP reporter construct 
also show GFP expression in the unidentified cells. 
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been shown that two sub-populations of the pericardial cells contribute to the muscle 
tissues of the wing hearts and ventral heart muscle during the larval and pupal 
development (Tögel et al., 2008; Shah et al., 2011). This poses the question if Him plays 
a similar role in the pericardial cells as it does in the embryonic somatic mesoderm. If 
Him is needed to establish a non-myogenic identity (potentially by regulating Mef2 
activity) within the pericardial cells during their embryonic development, it is likely that 
the mis-expression of Him in closely associated cells like the cardioblasts or loss of Him 
in the pericardial cells will have an effect on their number and possibly on their cell 
fate. 
 There were three lines of Him null mutants available to me. One was made in 
this lab and the other two null lines were created by Zhe Han (D. Hancock, PhD thesis, 
Han, Z. pers. communication). The Him 52 null mutant was established in our lab by 
Dan Hancock. He targeted an area of 98 kb containing six genes in total (Frq1, andorra, 
Frq2, Her, Him and CG33639) using P-element mediated recombination (D. Hancock, 
PhD thesis). The other two Him null mutants, Him 74 and Him 195, were created by 
ends-out homologous recombination by Dr. Zhe Han (in the lab of E. Olson). All three 
Him null mutant lines are negative for Him transcript expression and homozygous 
viable, indicating that Him is not essential for survival of the fly. This fact allows me to 
analyse both Drosophila embryos and larvae for a potential Him phenotype in the heart 
during development. 
Over-expression of Him in the developing dorsal vessel was accomplished using 
the Gal4/UAS-system (Brand & Perrimon, 1993), which allows for the targeted 
expression of a gene of interest at a specific time and place. The Gal4-drivers I used for 
these experiments are the hand-Gal4, Mef2-Gal4 and the TinC!4-Gal4 drivers (Bour et 
al., 1995; Lo & Frasch, 2001; Sellin et al., 2006) as these allow mis-expression in the 
whole heart (hand-Gal4) or specifically within the cardioblasts (Mef2- and TinC!4-
Gal4). 
 
 
3.3.1 Him null phenotype in the heart of the embryo 
 
 In order to analyse any potential phenotype in the developing embryonic hearts 
of the Him null mutant lines, I used the expression of several known markers for 
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pericardial cells and cardioblasts. Zfh-1 is initially expressed in all pericardial cells and 
subsequently lost in the two Eve-positive pericardial cells per hemisegment during stage 
15 (Lai et al., 1991; Su et al., 1999; Johnson et al., 2003), while Odd-skipped (Odd) is 
expressed in a row of 4 pericardial cells per hemisegment from stage 13 onwards (Ward 
and Coulter, 2000; Ward and Skeath, 2000) and Even-skipped (Eve) is expressed in two 
dorsally positioned pericardial cells per hemisegment (Frasch and Levine, 1987). 
To visualize the cardioblast cell population, I have used ß3-tubulin. It is 
expressed in four of the six cardioblasts per hemisegments (Gasch et al., 1988). I have 
chosen !3-tubulin as my standard cardioblast marker as it is known to be unaffected in 
Mef2 mutants and should thus be expressed in any present cardioblasts. According to 
my hypothesis Mef2 function is likely affected by altering the Him expression pattern. 
As Myosin expression is reduced in Mef2 mutant embryos (Ranganayakulu et al., 
1995), I have included a Myosin stain in the section discussing the Him over-
expression. 
 
As explained in the introduction (Chapter 1) several of the pericardial cells are 
generated through an asymmetric division, which generates a pericardial cell as one 
daughter cell and a myogenic cell (cardioblast or somatic muscle cell) as the second 
daughter cell (Carmena et al., 1998; Park et al., 1998, Ward and Skeath, 2000). Thus the 
relationship between the non-myogenic pericardial cells and the contractile muscle cells 
of the heart and the dorsal somatic mesoderm is very close. It has been shown that loss 
or mis-expression of a key regulator is capable of increasing one cell population at the 
cost of another. For example, Hedgehog (Hh) is necessary for the specification of the 
correct number of Eve- and Ladybird- (Lbe) positive cardiac cells (Liu et al, 2006), 
while Pannier (Pnr) generally promotes all heart cells and Pointed (Pnt) promotes the 
specification of pericardial cells at the expense of the cardioblasts (Alvarez et al., 2003). 
 The influence Him has on the specification and differentiation of the heart has 
not been previously analysed. In order to investigate this I have assayed the expression 
of the above mentioned marker genes in the available Him deficiency lines. The lines I 
used were Him 52; If/cyo; handCGFP3.1, Him 74; handCGFP2.3, TM2/MKRS and 
Him 195; +/+; +/+. The hand-GFP construct was introduced in the Him lines to allow 
analysis of the same line in both embryos and larvae. However, I was not able to 
introduce the hand-GFP reporter fragment into the Him 195 line. 
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Figure 3.3.1: Zfh-1 expression in Him null mutants. 
Stage 16/17 embryos were labelled for the distribution of the Zfh-1 protein. The 
arrows indicate the gaps within the zfh-1 expression pattern and the stars indicate 
areas of clustered Zfh-1 expressing cells. 
A OR wild-type embryo; B Zfh-1 expression in the Him 52 null mutant line; C 
Zfh-1 expression in the Him 74 null mutant line; D Zfh-1 expression in the Him 
195 null mutant line. 
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 The first marker whose expression I tested was Zfh-1. It is expressed in all 
pericardial cells up until stage fifteen and after that in eight out of the ten pericardial 
cells per hemisegment (Lai et al., 1991; Su et al., 1999). As can be seen in Figure 3.3.1 
Zfh-1 is expressed in the pericardial cells of all three Him deficient fly lines. However, 
when compared to the wild-type expression pattern it can be seen that the Him null 
mutant embryos have fewer Zfh-1-positive pericardial cells. As this loss of Zfh-1-
positive pericardial cells is spread evenly along the anterior-posterior axis, it becomes 
only visible upon close inspection of multiple embryos (for all these assays n = 20). 
This even loss of cells along the anterior-posterior axis also indicates that the same cells 
of each hemisegment are affected. However, just based on the Zfh-1 expression pattern 
I am not able to identify which sub-sets of pericardial cells are affected. This loss of 
pericardial cells could either be caused by a lack of the Zfh-1-positive pericardial cells 
or by the loss of Zfh-1 expression in a subset of the pericardial cells. In about half of all 
three Him null embryos I have observed small gaps that are never larger than one 
hemisegment (arrows in Figure 3.3.1) and most embryos do not show more than one 
gap at a time. The position of this gap varies along nearly the complete A/P axis of the 
heart with the exception of the segments containing the lymph gland and the 
immediately adjacent segment. Approximately 50 % of the Him 74 embryos shows an 
accumulation of the pericardial cells around the attachment sites of the alary muscles, 
which can be identified in this line (see stars Figure 3.3.1). Neither the accumulation of 
pericardial cells nor the alary muscles were visible in the other two alleles. Counting the 
exact number of Zfh-1-positive pericardial cells has proven unreliable. The three-
dimensional arrangement of the pericardial cells around the inner heart tube causes cells 
to lie “on top” of each other when viewed dorsally, it thus becomes difficult to count 
every cell present. 
 In contrast, numerical analysis of the pericardial cell markers Odd and Eve is 
reliable, as they are only expressed in a subset of pericardial cells. Together Odd and 
Eve mark six of the ten pericardial cells per hemisegment. These two groups of 
pericardial cells also contain those cells that share precursors with either the 
cardioblasts or the dorsal somatic muscles. The four remaining cells express Tinman. 
Tinman is however also expressed by the Eve-positive pericardial cells and the 
cardioblasts which are positioned immediately dorsal to the Tin-positive pericardial 
cells, thus this analysis would suffer from the same problems as that of the Zfh-1 
expression in that counting only the pericardial cells would be extremely difficult. 
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Figure 3.3.2: Expression pattern of Odd in Him null mutant embryos. 
Stage 16/17 embryos were labelled for the Odd protein and the number of Odd-
positive pericardial cells was counted. The arrows indicate the gaps within the 
odd expression pattern and the stars indicate areas of clustered Odd expressing 
cells. 
A Wild-type embryo; B Odd expression in a Him 52 null mutant embryo; C the 
Odd expression pattern in a Him 74 null mutant embryo; D Odd expression 
pattern in a Him 195 embryo; E Histogram showing the obtained numbers for 
the Odd-positive pericardial cells in all three controls (OR, handCGFP2.3, 
handCGFP3.1) and the Him null lines. The error bars indicate the standard error 
and stars indicate a statistically significant difference in regard to the wild-type. 
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Odd is expressed in four pericardial cells per hemisegment and these four cells form a 
line nearly parallel to the inner heart tube, reminiscent of a “pearls on a string” 
arrangement (Ward and Coulter, 2000; Ward and Skeath, 2000; see Figure 3.3.2 A). 
Figure 3.3.2 A-D shows the expression pattern of Odd and Figure 3.3.2 E shows the 
numbers of Odd-positive pericardial cells in all three lines lacking Him and wild-type 
embryos. All three lines null-mutant for Him show a trend towards a loss of Odd-
positive pericardial cells. However, only two of the three lines (Him 52 and Him 74) 
have statistically significant fewer Odd-positive pericardial cells. The observed loss of 
Odd-positive pericardial cells in the Him 195 null embryos is not statistically significant 
at the chosen confidence interval of 0.05. All three lines show gaps in some areas of the 
arrangement of Odd-positive pericardial cells (see arrows in Figure 3.3.2) while in other 
areas the cells aggregate closer together than they do in wild-type embryos (see stars in 
Figure 3.3.2). The size of the gaps within the row of Odd-positive pericardial cells does 
not vary much between the three different lines. Together these observations indicate 
that loss of Him function results in a disruption of the orderly arrangement of the 
pericardial cells. Whether this organisational phenotype is due to an alteration in cell 
fate or due to a defect in the even distribution of the Odd-positive pericardial cells is a 
currently unanswered question. 
 Eve is expressed in the two pericardial cells per hemisegment that are located 
dorsally to the contractile heart tube. Figure 3.3.3 A-D shows the expression of Eve in 
the pericardial cells of wild-type embryos and embryos null mutant for Him. Figure 
3.3.3 E is a graph of the number of Eve-positive pericardial cells counted in each line. 
Similar to the behaviour of the Odd-positive pericardial cells, there is a decrease in the 
number of these cells in the embryos lacking Him; all three Him null mutant lines lose a 
statistically significant number of Eve-positive pericardial cells. For all three lines, I 
have observed one or both of the cells per hemisegment missing and the expression of 
Eve in the dorsal muscle appears reduced in all three lines if judged by the intensity of 
the staining. This is interesting as the dorsal muscles DA1 and DO2 (the latter of which 
also expresses Eve) and the Eve-positive pericardial cells share a common lineage 
(Carmena et al., 1998; Park et al., 1998). Because of this, it is possible that these two 
dorsal muscles are more affected by the loss of Him than any other somatic muscles. 
Indeed, previous analysis for the presence of the somatic muscles in segments 
A2 to A4 in stage 17 embryos by Dan Hancock has revealed that the DA1 muscle is one 
of the most frequently (27.3 % in the Him 52 line) of all muscles affected by duplication  
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Figure 3.3.3: Expression pattern of Eve in Him null mutant embryos. 
Stage 16/17 embryos were labelled for the Eve protein and the number of Eve-positive 
pericardial cells was counted. 
A Wild-type embryo; B Eve expression in a Him 52 null mutant embryo; C the Eve 
expression pattern in a Him 74 null mutant embryo; D Eve expression pattern in a Him 
195 embryo; E Histogram showing the obtained numbers for the Eve-positive 
pericardial cells in all three controls (OR, handCGFP2.3, handCGFP3.1) and the Him 
null lines. The error bars indicate the standard error and stars indicate a statistically 
significant difference in regard to the wild-type. 
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or loss in all three Him null mutant lines (D. Hancock, PhD thesis). According to his 
results there is no compensation through the loss of another somatic muscle for the 
duplication or vice versa. He also measured the thickness for the DO2 muscle and 
compared his results to those he obtained for wild-type embryos. In his PhD thesis he 
describes a “relative decrease in average thickness” for the DO2 muscle (D. Hancock, 
PhD thesis). This result indicates that there might be fewer cells that contribute to each 
of these muscles. A similar effect on the DO1 muscle has been linked to an increase in 
Tinman-positive pericardial cells in embryos mutant for dpp (Johnson et al., 2007). As I 
have also observed a loss in the Eve-positive pericardial cells in the Him null mutant 
embryos, this would indicate that Him function is necessary early on, during the 
specification of the initially shared precursors of the Eve-pericardial cell and the DO2 
muscle. Him is most likely to play a role in the specification or possibly maintenance of 
these specific precursors. In his thesis, D. Hancock also evaluated the number of 
Krüppel-positive founder cells in the Him 52 null mutant line. The Krüppel-positive 
founder cells are specific for the DA1 and the DO2 muscles and an increase or decrease 
in their number would indicate an effect of Him on their specification. Their number is 
indeed increased when compared to wild-type embryos (D. Hancock, PhD thesis). It is 
possible that these founder cells are formed at the expense of the precursors needed for 
the Eve cell lineage that contributes to the heart and thus accounts for the loss of heart 
cells. This again points towards a role for Him during the specification of the precursors 
of the Krüppel-positive founder cells. 
 
As explained above, some of the cardioblasts and pericardial cells share a 
common lineage during development and the number of one cell type can be increased 
or decreased at the cost of the second cell type in the heart when specific factors are 
missing or over-expressed (Gajewski et al., 1999; Alvarez et al., 2003). As my data 
indicate a loss of Eve- and Odd-positive pericardial cells in embryos lacking Him, I was 
interested to see if this is also the case here.  
I have used ß3-tubulin as a marker for the cardioblasts. ß3-tubulin is expressed 
in four of the six cardioblasts per hemisegment of the embryo (Leiss et al., 1988). I 
scored these embryos under DIC optics, which enables me to also visualize the two 
unlabelled cardioblasts per hemisegment. The number of ß3-tubulin-positive 
cardioblasts is reduced at a statistically significant level in all three Him null mutant 
lines as well as the total number of cardioblasts I observed (see Figure 3.3.4). The 
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expression of this protein shows that the regular pattern of two ß3-tubulin-negative 
cardioblasts followed by four ß3-tubulin-positive cardioblasts per hemisegment is 
disturbed. Within the individual hemisegments, there is a large variation between a loss 
and gain of ß3-tubulin-positive cardioblasts. Contrary to my expectations, these data 
indicate that the loss of pericardial cells in the Him null mutants is not accompanied by 
a corresponding gain of cardioblasts but that Him might also necessary for the 
specification of the correct number of myogenic cardioblasts.  
 In summary, the loss of Him leads to a reduction in all heart cells by embryonic 
stage 16/17 (see section 3.3.1). While initially surprising, these results do agree with the 
results of Dan Hancock’s analysis of the dorsal somatic muscles, that are often 
duplicated or missing without compensation from other somatic muscles. All these 
results point towards a positive role for Him during the early specification of heart cells. 
It is possible that the fate of these early progenitors is changed to that of other 
mesodermal tissues (fat body and/or visceral mesoderm). A second hypothesis is that 
Him is necessary to achieve the correct “number” of cell divisions necessary for the 
generation of all heart precursors. For both scenarios, the lack of Him would result in a 
loss of embryonic heart cells. 
 It must also be mentioned that the number of heart cells scored for each marker 
vary between the three Him null mutant lines. However, all scored cell populations do 
behave in a similar fashion with regard to the loss of cells when compared to wild-type 
cell populations. The differences in numbers can be due to several reasons. All embryos 
of one line where counted at the same time and a continuous counting error cannot be 
ruled out. The three used Him null alleles are also all slightly different in their genetic 
break points due to the different methods used to generate them. Analyses from our lab 
indicate that the Him 74 and Him 195 alleles are possibly equivalent on a molecular 
level but that the Him 52 allele is not. Using PCR, our lab has been able to demonstrate 
that the break points for the Him 52 null allele (the one established in our lab) are in 
agreement with the positions of the P-elements that were used and that five further 
genes are removed by this deletion (J. Han and M. Taylor, pers. communication). The 
equivalent analysis for the other two Him null alleles (74 and 195) has established that 
the 5’ excision point is in between the position 18101901 and 18102546 of the X 
chromosome (the Him coding regions starts at position 18103460 and ends at position 
18104774) according to the annotated genome and that the 3’ excision point is  
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Figure 3.3.4: Expression pattern of ß3-tubulin in Him null mutant embryos. 
Stage 16/17 embryos were labelled for the ß3-tubulin protein and the number of ß3-
tubulin-positive cardioblasts was counted. 
A Wild-type embryo; B ß3-tubulin expression in a Him 52 null mutant embryo; C ß3-
tubulin expression pattern in a Him 74 null embryo; D the ß3-tubulin expression pattern 
in a Him 195 null mutant embryo; E Histogram showing the numbers for the ß3-
tubulin-positive cardioblasts and the total number of cardioblasts in the controls (OR) 
and the Him null lines. The error bars indicate the standard error and stars indicate a 
statistically significant difference compared to the wild-type. 
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contained within close proximity of the 3’ end of the Him gene (J. Han, M. Taylor, pers. 
communication). 
 
 
3.3.2 Him null phenotype in the heart of the larvae 
 
When compared to the embryo, we know relatively little about the development 
of the pericardial cells post the embryonic stages. Sellin et al. (2006) describe the hand-
GFP reporter construct, which drives GFP expression in the heart from stage 12 
onwards throughout embryonic, larval and adult heart development. This allows me to 
visualize the pericardial cells and cardiac cells in live larvae and analyse the behaviour 
of the marked pericardial cells in various genetic backgrounds. This is important as the 
complete heart undergoes vast morphological changes during larval and pupal 
development and it is known that the number of pericardial cells drops sharply from 
first to second instar larvae (Sellin et al., 2006). This indicates that the pericardial cells 
undergo further development at this time. 
Figure 3.3.5 shows the expression of the two independent hand-GFP reporter 
lines used as a wild-type control for these experiments (Sellin et al., 2006). I assayed the 
number, appearance and organisation of the larval pericardial cells at three time points, 
young first instar larvae (28 to 30 hrs AEL), young second instar larvae (52 to 54 hrs 
AEL) and mid-stage third instar larvae (100-102 hrs AEL). The heart cells of the first 
instar larvae (Figure 3.3.5 A, B) are still very similar in number, shape and size to those 
of a late stage embryo. As the pericardial cells are arranged three-dimensionally around 
the heart tube, differentiating between the cardioblasts and pericardial cells (both are 
equally marked by GFP expression) is very difficult at this time point. 
 By early second instar (Figure 3.3.5 C, D) the number of pericardial heart cells 
has decreased as described in Sellin et al (2006), especially in the anterior regions of the 
aorta. The cell body and nuclei of the remaining pericardial cells have increased in size 
by this stage. The difference in cell shape and size make for an easily scorable 
difference between the two cell types. The pericardial cells (arrows in Figure 3.3.5) 
have adopted their typical large round, globular shape with enlarged nuclei while the 
cardioblasts (see stars in Figure 3.3.5) have retained their original size and the structure  
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Figure 3.3.5: Expression pattern of the hand-GFP reporter during larval life. 
Live larvae were photographed under the microscope to visualize the GFP 
expression pattern. Stars indicate the location of the cardioblasts, arrows point 
towards the pericardial cells. 
A Expression pattern of the handCGFP2.3 reporter construct in the first larval 
instar; B Expression pattern of the handCGFP3.1 reporter construct in the first 
larval instar; C Expression of the handCGFP2.3 reporter construct in the second 
larval instar; D Expression pattern of the handCGFP3.1 reporter construct in the 
second larval instar; E Expression of the handCGFP2.3 reporter construct in the 
third larval instar; F Expression pattern of the handCGFP3.1 reporter construct in 
the third larval instar.!
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of the muscular cardiac tube can now also be identified. The size difference between the 
pericardial cells and the cardioblasts results in a noticeable difference in hand-GFP 
expression between these two cell types.  
The difference between second and third instar larvae lies mainly in the overall 
size of the larvae (compare Figure 3.3.5 C with E and D with F). The shape and 
positioning of the pericardial cells in third instar larvae is more or less unchanged from 
that observed in a second instar larvae, with the exception of a general increase in size 
of all the heart cells. In all of the experiments in larva, I have relied on the hand-GFP 
construct to mark the heart cells. The pericardial cells were counted based on being 
hand-GFP positive and not included within the heart tube. 
Him expression is lost from the heart at the end of embryogenesis, thus it is 
possible that this loss of Him expression is necessary for the correct development and/or 
maintenance of the pericardial cells. As described above, in the embryo the loss of Him 
results in a decrease in pericardial cell number. If this were the case, I would expect to 
see a similar reduced number of pericardial cells in the first instar and a change in cell 
number and/or shape during the first two larval instars.  
 For the two of the Him null mutant lines I was able to generate a stable, doubly 
homozygous line carrying both the Him deletion and the hand-GFP reporter construct. I 
was unable to create a viable fly line both carrying the Him 195 null mutation and either 
hand-GFP reporter construct. Crossing the two homozygous fly lines together (Him 195 
and handCGFP2.3 construct) and selecting for the GFP-positive male larvae generated 
the hand-GFP positive larvae for this line. 
 Figure 3.3.6 shows the appearance of the pericardial cells as visualized by the 
hand-GFP reporter construct in first instar wild-type (i.e. both hand-GFP-reporter 
constructs on their own) and Him null mutant larvae. The first instar larvae deficient for 
Him do not appear greatly different to the wild-type larvae, all three lines still express 
the hand-GFP reporter construct, indicating that the identity of the pericardial cells is 
not affected when it comes to the factors necessary for the expression of hand through 
the hand-enhancer fragment. While I initially counted the number of hand-GFP-positive 
pericardial cells at this time point, my analysis pointed to a statistically significant 
difference between the numbers for both wild-type strains used. This is most likely due 
to the similarities in cell shape of pericardial cells and cardioblasts and their position 
around the heart. This has led me to disregard my counts of the pericardial cell numbers 
of this stage, limiting my analysis for this time point to observations only. 
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Figure 3.3.6: Expression pattern of the hand-GFP reporter construct in first 
instar larvae carrying Him deletions. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize 
the GFP expression pattern. 
A handCGFP2.3 reporter construct, wild-type control; B handCGFP3.1 reporter 
construct, wild-type control; C GFP expression pattern in the Him 52 null mutant 
first instar larvae; D GFP expression pattern in the Him 74 null mutant first instar 
larvae; E GFP expression pattern of the Him 195 null mutant first instar larvae. 
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Figure 3.3.7: Expression pattern of the hand-GFP reporter construct in second 
instar larvae carrying Him deletions. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
GFP expression pattern and the number of GFP positive pericardial cells was counted. 
A handCGFP2.3 reporter construct, wild-type control; B handCGFP3.1 reporter 
construct, wild-type control; C GFP expression pattern in the Him 52 null mutant 
second instar larvae; D GFP expression pattern in the Him 74 null mutant second instar 
larvae; E GFP expression pattern of the Him 195 null mutant second instar larvae; F 
Histogram showing the obtained numbers for the handGFP-positive pericardial cells in 
the two controls (handCGFP2.3, handCGFP3.1) and the second instar Him null larvae. 
The error bars indicate the standard error and stars indicate a statistically significant 
difference compared to the wild-type. 
 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#!
Figure 3.3.7 shows representative images of all three Him null lines and the 
control at the second instar time-point. The Him 74 and Him 195 lines show a 
statistically significant loss of pericardial cells, while the number of pericardial cells of  
the Him 52 line is lower than that of the control animals but not significantly so. In the 
larvae of the Him 74 and Him 195 lines the pericardial cells are spaced further apart 
along the anterior-posterior axis than in the wild-type larvae, so that the loss is 
distributed relatively evenly across the whole larval heart and less of a difference 
between the anterior aorta and heart proper is visible. The loss of pericardial cells I 
observed at the end of embryogenesis is maintained in these two lines until the 
beginning of the second instar. The size of the pericardial cells appears not to be 
affected by the loss of Him. However, some cells do have a less round shape than those 
of the control larvae at this time point (compare arrows in Figure 3.3.7). Without the 
help of further markers for sub-sets of pericardial cells I cannot identify if there is a 
specific sub-set of pericardial cells that is more affected by the loss of Him than other 
pericardial cells. 
 Figure 3.3.8 depicts all three Him null mutant lines and the control at the third 
instar time-point. At this time-point, only the Him 52 line shows a significant loss of 
pericardial cells. The pericardial cell numbers for the other two lines, Him 74 and Him 
195, are, while still lower than those of the control animals, not statistically different to 
the control animals at the chosen confidence interval of 0.05.  It appears that the loss of 
pericardial cells that has been described in wild-type larvae between the first and third 
instar larvae does not occur in larvae lacking Him. It is possible that the pericardial cells 
usually lost at this time are the ones that are missing in the embryos already. This would 
explain why the number of hand-GFP-positive pericardial cells approaches the wild-
type level again. Similarly any changes in cell shape are not observable anymore and it 
thus not possible to assign any importance to that observation. It is possible that other 
genes can compensate for the loss of Him function, at least partially. Another possibility 
is that the loss of pericardial cells that occurs between the first and third instar wild-type 
larva, occurs at an earlier stage in Him mutants. 
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Figure 3.3.8: Expression pattern of the hand-GFP reporter construct in third 
instar larvae carrying Him deletions. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
GFP expression pattern and the number of GFP positive pericardial cells was counted. 
A handCGFP2.3 reporter construct, wild-type control; B handCGFP3.1 reporter 
construct, wild-type control; C GFP expression pattern in the Him 52 null mutant third 
instar larvae; D GFP expression pattern in the Him 74 null mutant third instar larvae; E 
GFP expression pattern of the Him 195 null mutant third instar larvae; F Histogram 
showing the obtained numbers for the handGFP-positive pericardial cells in the two 
controls (handCGFP2.3, handCGFP3.1) and the third instar Him null larvae. The error 
bars indicate the standard error and stars indicate a statistically significant difference 
compared to the wild-type. 
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3.3.3 Him is not necessary for the development of functional wing 
hearts 
  
 The wing hearts are pulsatile organs located under the scutellum of the adult fly 
(Tögel et al., 2008; Lehmacher et al., 2009). Recent publications have shown that these 
organs are necessary for the correct formation of the wings and that the lack of them 
results in a non-clearing of the haemolymph from between the wing layers which is 
visible if examined under the microscope as an “opaque” sheen of the wing (Tögel et 
al., 2008; M. Tögel, pers. communication). It has also been demonstrated that these 
organs originate from the anterior most Eve-positive pericardial cells of the larva (Tögel 
et al., 2008). It is thus possible that the effect of the loss of Him extends to these organs 
as Him is expressed in these Eve-positive pericardial cells during embryogenesis. 
Figure 3.3.9 shows the wings of the Him null mutant lines and those of wild-
type animals under the microscope. All wings, including those of the Him null flies 
appear equally clear and translucent. From this I conclude that the loss of Him does not 
affect the function of the wing hearts in clearing out the haemolymph from the wings 
after the fly ecloses. I however cannot exclude the possibility that the function of the 
wing hearts might be impaired as I assayed the wings of 6-hour-old flies. If the wing 
hearts of the Him null mutants function less efficiently than that of wild-type flies this 
stage might be too late to detect any slower clearing of the wings. It is also possible, 
that part of the development of the wing hearts is affected due to the loss of Him but 
that the wing hearts still remain mainly functional. This will require further 
investigation. 
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Figure 3.3.9: The function of the wing hearts is not affected in Him null mutants. 
The wings of young flies were removed and analysed for their clarity under the 
microscope (Zeiss Axiovision). 
A wing of the OR wild-type control; B wing of a fly homozygous for the Him 52 null 
deletion; C wing of a fly homozygous for the Him 74 null deletion; D wing of a fly 
homozygous for the Him 195 null deletion. 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#!
3.4 Him over-expression phenotype in the heart 
 
3.4.1 Him over-expression phenotype in the embryonic heart 
 
It is possible to target the ectopic expression of a gene of interest in spatial and 
temporal pattern using the Gal4/UAS system; the components of which were originally 
isolated from yeast (Brand and Perrimon, 1993). This system uses an enhancer fragment 
to “drive” expression of the Gal4 protein in a known pattern. A fly line containing this 
is crossed to a fly line containing the gene of interest under the control of the UAS 
(Upstream Activating Sequence). The offspring of this cross has copies of both 
transgenes, enabling the Gal4 protein to bind to the UAS and initiate transcription of the 
target gene. This method is a very useful tool when analysing the phenotype of genes as 
this allows an investigation of what happens if the gene is expressed outside its 
“normal” parameters. The Gal4/UAS system has successfully contributed to help define 
the function of genes such as Mef2, twist, tin etc.  
We hypothesise that in the somatic mesoderm of the embryo the Him protein is 
necessary to set apart the AMPs from the remaining somatic musculature by regulating 
Mef2 activity (Liotta et al., 2007). In the established heart, Mef2 is only expressed in the 
contractile cardioblasts, while Him is only expressed in the non-contractile pericardial 
cells (see Figure 3.2.2). The Mef2 transcript is thought to be expressed in the shared 
heart precursors. This has been shown through single in situ hybridisation against the 
Mef2 transcript (Lilly et al., 1994; Nguyen et al., 1994). I have not been able to grab an 
image of an earlier (stage 10 and/or 11) embryo double-labelled for both the Him 
transcript and Mef2 of sufficient quality to analyse their possible co-location in these 
stages. It is likely that both Him and Mef2 are co-expressed in the very early 
developmental stages of the heart progenitors but this hypothesis has yet to be proven. 
Both, cardioblasts and pericardial cells, originate from the dorsal mesoderm and in the 
case of the Seven-up-positive cardioblasts and two of the Odd-positive pericardial cells, 
a cardioblast and a pericardial cell each share a common mother cell (Ward and Skeath, 
2000; see Introduction). It is thus possible that Him has a similar function in the 
developing cardiac tissue as it does in the somatic mesoderm, i.e. delineate contractile 
muscle cells from non-contractile mesodermal cells by regulating Mef2 activity. This 
has led me to the hypothesis that the exclusion of Him from the cardioblasts and the 
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prevention of Mef2 function in the pericardial cells are equally necessary for normal 
heart development. To test this hypothesis, I have used the UAS/Gal4 system to 
ectopically express Him in the cardioblasts and analysed the effects this has on the 
development of the heart. The reciprocal experiments of removing and over-expressing 
Mef2 will be described in the next section. 
Figure 3.4.1 shows the effect of driving Him over-expression in the heart using 
the hand-Gal4 driver and the UAS-Him J7 construct previously generated in this lab 
(Liotta et al., 2007). In the heart, the hand-Gal4 driver is expressed from embryonic 
stage 12 onwards and throughout larval and adult life in all cardioblasts and pericardial 
cells (Sellin et al., 2006, see Appendix). The pericardial cells are labelled for the Zfh-1 
protein. Him over-expression in the heart causes an increase in pericardial cells when 
compared to wild-type. The supernumerary pericardial cells are spread evenly across 
the length of the heart in additional “rows” when compared to the wild-type 
organisation of the Zfh-1-positive pericardial cells. As with the evenly distributed loss 
of pericardial cells in the Him null mutants, this indicates that multiple hemisegments 
are affected in the same way. 
As previously mentioned, an exact numerical analysis of the Zfh-1-positive 
pericardial cells by counting has proven to be unreliable, so instead I have concentrated 
on scoring the number of Eve- and Odd-positive pericardial cells as I did in the Him 
null mutants. Figure 3.4.2 shows the expression pattern of Eve in wild-type embryos 
and those over-expressing Him. There is no detectable visual difference between the 
embryos. Counting of the Eve-positive pericardial cells in both wild-type and Him over-
expressing late embryonic embryos (stage 16/17) confirms this observation (Figure 
3.4.2 C). Thus, over-expression of Him in the heart cells does not affect the expression 
of eve in the heart or alter Eve-positive pericardial cells number. The loss of Him leads 
to a reduction in the number of Eve-positive pericardial cells. This indicates that while 
Him is necessary for the development of the Eve-pericardial cells, over-expression in 
the heart only is not capable of inducing hyperplasia of these cells. Interestingly, neither 
of the two Eve-positive pericardial cells per hemisegment share a common mother cell 
with a cardioblast but have a common lineage with the founder of the DA1 somatic 
muscle (Ward and Skeath, 2000) in which Him has not been over-expressed in this 
experimental set-up. It would be interesting to see how the Eve-positive pericardial cells 
behave if a different driver expressed in the dorsal somatic muscles or at an earlier stage 
than the hand-Gal4 driver, is used. 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#!
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.1: Zfh-1 expression in embryos over-expressing Him in the heart. 
Stage 16/17 embryos were labelled for the distribution of the Zfh-1 protein. 
A OR wild-type embryo; B Zfh-1 expression in an embryo ectopically over-expressing 
Him under the control of the hand-Gal4 driver. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.2: Expression pattern of Eve in embryos expressing ectopic Him in the 
heart. 
Stage 16/17 embryos were labelled for the Eve protein and the number of Odd-positive 
pericardial cells was counted. 
A Wild-type embryo; B Odd expression in an embryo ectopically over-expressing Him 
under the control of the hand-Gal4 driver; C Histogram showing the numbers for the 
Odd-positive pericardial cells in the two controls (OR, handCGFP2.3) and the over-
expression of Him. The error bars indicate the standard error; there is no statistically 
significant difference compared to wild-type. 
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 Figure 3.4.3 shows the effect of Him over-expression on the Odd-positive 
pericardial cells. When image 3.4.3 B is compared to the wild-type embryo in 3.4.3 A, it 
can be seen that over-expression of Him driven by hand-Gal4 causes an increase in 
Odd-positive pericardial cells. While the increase of pericardial cells is generally 
distributed equally along the heart, I have observed clustering of two to five Odd-
positive pericardial cells in a small bunch in about two thirds of the embryos (see stars 
in Figure 3.4.3 B). As can be seen in the graph depicted in Figure 3.4.3 C, counting of 
the Odd-positive cells revealed a statistically significant increase of over ten pericardial 
cells per animal when Him is over-expressed. Thus, at least a part of the hyperplasia of 
the Zfh-1-positive pericardial cells observed but not scored is due to a significant 
increase in Odd-positive pericardial cells. I believe that the Tin-positive pericardial 
cells, which were not assayed in this study, are likely to also have increased in number 
under these circumstances as the hyperplasia observed when labelling for the Zfh-1 
protein appears to be more widespread than that of the Odd-positive pericardial cells 
alone. A sub-set of the Odd-positive pericardial cells shares an immediate common 
progenitor with the Seven-up-positive cardioblasts, while the Eve-positive pericardial 
cells share progenitors with specific dorsal muscles. The genetic regulatory network is 
different in these cells thus explaining the difference in the reaction to an increased 
amount of Him present in these cells. 
 In a similar experiment described in David Liotta’s PhD thesis, he over-
expressed Him using the Him-Gal4 L3-5 driver, which drives expression slightly earlier 
(from late stage 11/ early stage 12) than the hand-Gal4 driver I used but its expression 
is restricted to the pericardial cells only; he observed a similar phenotype (D. Liotta, 
PhD thesis). He describes a slight but significant increase in the Odd-positive 
pericardial cells and no change in the number of Eve-positive pericardial cells. This 
further substantiates my results. 
The origin of these supernumerary pericardial cells is unclear so far. My results 
point towards the cardioblasts as a possible source. In order to investigate this, I 
analysed the organisation and number of the ß3-tubulin-positive cardioblasts in embryos 
that over-express Him in all embryonic heart cells under the control of the hand-Gal4 
driver. ß3-tubulin is expressed in four of the six cardioblasts per hemisegment. Figure 
3.4.4 shows the results of this experiment. Analysing the embryos under DIC optics, I 
did not observe any organisational differences between the wild-type embryo and the 
embryos over-expressing Him (compare Figure 3.4.4 A and B). Furthermore, scoring of  
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Figure 3.4.3: Expression pattern of Odd in embryos that over-express Him in the 
heart. 
Stage 16/17 embryos were labelled for the Odd protein and the number of Odd-positive 
pericardial cells was counted. 
A Wild-type embryo; B Odd expression in an embryo ectopically over-expressing Him 
under the control of the hand-Gal4 driver, stars indicate clustering of cells; C 
Histogram showing the numbers of Odd-positive pericardial cells in the two controls 
(OR, handCGFP2.3) and the over-expression of Him. The error bars indicate the 
standard error and stars indicate a statistically significant difference compared to wild-
type. The UAS-Him construct is called “J7” in the graph. 
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the total cardioblasts and those positive for ß3-tubulin confirms this, as there was no 
significant change in cell number between the two types of embryos.  
 In order to have a more specific look at the behaviour of the cardioblasts under 
these conditions, I exclusively over-expressed Him in the cardioblasts within the heart 
with the TinC!4- and Mef2-Gal4 drivers. These experiments should also establish if the 
exclusion of Him expression from the cardioblasts (see chapter 6) is important for the 
correct development of these cells. I assayed the expression pattern of two different 
marker genes in these embryos, ß3-tubulin (Figure 3.4.4 C and D) and Myosin (Figure 
3.4.5). Myosin is a marker for all cardioblasts; it also marks the two ß3-tubulin-negative 
cardioblasts that arise by asymmetric division. Furthermore, while ß3-tubulin 
expression has been shown to be unaffected in a Mef2 mutant (Bour et al., 1995), we 
know that the expression pattern of Myosin is greatly disturbed in Mef2 mutants (Lilly 
et al., 1995; Ranganayakulu et al., 1995; D. Liotta, PhD thesis). If Mef2 and Him have 
opposing roles during heart development as they do in the development of the somatic 
muscles, it is possible that the Mef2 null mutant phenotype and the Him over-expression 
phenotype resemble each other. As can be seen in Figure 3.4.5 A-C the expression of 
Myosin is affected in the cardioblasts if Him is over-expressed in these. The strength of 
the Myosin expression is very much reduced if Him is over-expressed using the Mef2-
Gal4 driver (compare Figure 3.4.5 A to C). As myosin is a target gene of Mef2 in the 
cardioblasts, this points into the direction of Him interfering with Mef2 function in a 
way similar to what has been described for the somatic mesoderm (Liotta et al., 2007). 
As the expression of myosin is affected in these embryos, scoring them was not 
possible. Figures 3.4.4 C and D show the same result for the ß3-tubulin-positive 
cardioblasts if these drivers are used. The arrangement, shape and number of the ß3-
tubulin-positive cardioblasts is indistinguishable from that of the control embryos. The 
results are further substantiated by the total number of cardioblasts present as counted in 
the ß3-tubulin stain, as these remain very close to that counted for the wild-type. The 
ectopic expression of Him in the cardioblasts leaves at least the Odd-positive pericardial 
cells unaffected as can be seen in Figure 3.4.6. Cell numbers and arrangement of the 
Odd-positive pericardial cells are like that in wild-type embryos when the Mef2-Gal4 
driver controls the UAS-Him construct. It is very likely that this would also be the case 
for the TinC!4-Gal4 driver as Mef2-Gal4 drives mesodermal expression from stage 7 
onwards and thus is expressed in the shared precursors of cardioblasts and pericardial  
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Figure 3.4.4: Expression pattern of ß3-tubulin in embryos that over-express Him 
in the heart. 
Stage 16/17 embryos were labelled for the ß3-tubulin protein and the number of ß3-
tubulin-positive cardioblasts and the total number of cardioblasts were counted. 
A Wild-type embryo; B ß3-tubulin expression in an embryo ectopically over-expressing 
Him under the control of the hand-Gal4 driver; C ß3-tubulin expression in an embryo 
ectopically over-expressing Him in the cardioblasts under the control of the Mef2-Gal4 
driver D ß3-tubulin expression in an embryo ectopically over-expressing Him in four of 
the six cardioblasts under the control of the TinC!4-Gal4 driver; E Histogram showing 
the numbers of ß3-tubulin-positive cardioblasts and the total number of cardioblasts in 
the control (OR) and the different over-expressions of Him. For the hand-Gal4 driver 
the total number of cardioblasts was not determined. The error bars indicate the 
standard error, there is no statistically significant difference compared to wild-type. 
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Figure 3.4.5: Him over-expression in the cardioblasts can disrupt Myosin 
expression. 
Myosin immuno-stain on stage 17 embryos. Depending on the Gal4 driver used, 
ectopic Him expression in the cardioblasts has a disruptive effect on the expression 
of Myosin. 
A Myosin immuno-stain on wild-type embryos (OR). B Myosin immuno-stain on 
embryos over-expressing Him under the control of the hand-Gal4 driver. This 
leads to a general reduction in Myosin expression. C: Myosin expression is 
reduced and/or completely lost from individual cells (see arrowheads) when Mef2-
Gal4 drives Him over-expression. D Myosin expression is not affected if Him 
expression is under the control of the TinC!4-Gal4 driver. 
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cells. Thus, the expression of Him in the cardioblasts has no effect on the Odd-positive 
pericardial cells.  
 These experiments rule out that the supernumerary pericardial cells observed in 
embryos over-expressing Him in all heart cells developed at the expense of the ß3-
tubulin-positive cardioblasts. These experiments however do not directly account for the 
two non-ß3-tubulin cardioblasts per hemisegment with a positive stain as a possible 
source for the extra pericardial cells if the hand-Gal4 driver is used. 
The expression pattern of myosin in the embryos over-expression Him indicates 
that these cells are formed normally but that the expression of at least one Mef2 target 
gene (myosin) is greatly reduced. It would be interesting to see if the number of Svp- 
and/or Mef2-positive cardioblasts, which includes the two ß3-tubulin-negative cells, 
changes as counting the Myosin-positive cardioblasts was not possible. Svp is a marker 
for the two cardioblasts that do not express ß3-tubulin and Mef2 is expressed in all six 
cardioblasts per hemisegment. These two markers should be the next markers to be 
analysed. 
 Another possibility for the origin of the pericardial hyperplasia is that the 
ectopic expression of Him in all of the pericardial cells interferes with the number of 
cell divisions specific for the pericardial cells that would normally occur in a wild-type 
environment. This hypothesis would explain the stable number of ß3-tubulin-positive 
cardioblasts. The results presented in David Liotta’s thesis also point in this direction. 
He showed that just over-expressing Him in the pericardial cells it is intrinsically 
expressed in, is sufficient to generate a slight increase in pericardial cell number. These 
experiments used the Him-Gal4 L3-5 driver, which drives expression slightly earlier 
than the hand-Gal4 driver I used in my experiments. It is possible that by over-
expressing Him at an earlier time during embryonic development, progenitors were 
targeted that usually contribute to a different lineage, likely the somatic mesoderm, 
which loses Him expression much earlier than the pericardial cells and forced them into 
a pericardial cell fate. These embryos show a high degree of disruption of the somatic 
myogenesis at the stage of differentiation (D. Liotta, PhD thesis). 
The result of the over-expression of Him in the cardioblasts also shows that the 
simple ectopic expression of Him in the cardioblasts can, at least partially, mimic the 
Mef2 mutant phenotype of the cardioblasts as the levels of myosin expression are 
reduced in these embryos. This indicates that, in the early heart progenitors, there is a  
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Figure 3.4.6: Expression pattern of Odd in embryos over-expressing Him in 
only the cardioblasts. 
A Wild-type embryo; B Odd expression pattern in an embryo over-expressing Him 
under the control of the Mef2-Gal4 driver; C Histogram showing the number of 
Odd-positive pericardial cells in embryos over-expressing Him in the cardioblasts. 
The error bars indicate the standard error, there is no statistically significant 
difference between wild-type and Him over-expressing embryos. 
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good chance of more than one factor Him and Mef2 interact with. This interaction 
seems to be similar in fashion to what has been described in the somatic mesoderm and 
that the introduction of Him into the cardioblasts alone is sufficient to interfere with the 
development of the myogenic cardioblasts. 
 
 
3.4.2 Him over-expression phenotype in the larval heart 
 
As for the Him null mutant animals, I followed the development of the 
pericardial cells in animals that over-express Him during the larval stages using the 
hand-GFP construct described in Sellin et al., 2006. I wanted to find out if the increase 
in pericardial cells I observed in the embryos over-expressing Him in the heart is 
maintained in the larvae or if this phenotype can be compensated for during larval 
development. 
 Figure 3.4.7 shows the behaviour of the pericardial cells in larvae over-
expressing Him in all heart cells by the hand-Gal4 driver, as marked by hand-GFP 
during the first larval instar. The pericardial cells of the first instar larvae over-
expressing Him appear more crowded and closer together than in the wild-type. There 
also appears to be an increase in the number of pericardial cells but as described 
previously counting their number at this stage is not reliable. The cells themselves have 
the shape and appearance of wild-type pericardial cells and the supernumerary 
pericardial cells are distributed evenly along the length of the heart. 
 The same is true for the second instar larvae (see Figure 3.4.8). The increase in 
pericardial cells is obvious as well, but by this stage the extra cells seem to be located 
more towards the posterior part of the aorta and the heart proper. The pericardial cells 
around the anterior section of the aorta show a normal arrangement with similar large 
gaps between them as observed in wild-type larvae. The shape and size of all the 
pericardial cells are also very similar to the cells of the wild-type larvae. Pericardial 
cells counts reveal a statistically significant increase when over-expressing Him, mainly 
caused by the accumulation of supernumerary pericardial cells in the posterior sections 
of the heart. 
Figure 3.4.9 shows the expression pattern of the hand-GFP reporter construct in 
third instar larvae over-expressing Him. The increase in pericardial cell number is  
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Figure 3.4.7: Expression pattern of the hand-GFP reporter construct in first instar 
larvae that over-express Him in the heart. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
GFP expression pattern. 
A handCGFP2.3 reporter construct, wild-type control; B hand-GFP expression pattern 
in a first instar larvae over-expressing Him under the control of the hand-Gal4 driver. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.8: Him over-expression in the heart causes an increase in pericardial 
cells in second instar larvae. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
hand-GFP expression pattern and the number of GFP positive pericardial cells was 
counted. 
A handCGFP2.3 reporter construct, wild-type control; B GFP expression pattern in a 
second instar larvae over-expressing Him under the control of the hand-Gal4 driver; C 
Histogram showing the numbers for the handGFP-positive pericardial cells in the 
controls (handCGFP2.3) and the second instar larvae that expresses Him ectopically in 
the heart. The error bars indicate the standard error and stars indicate a statistically 
significant increase compared to the wild-type. 
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maintained. However, the organisation of the pericardial cells is affected by the increase 
in number. The pericardial cells in the larvae that over-express Him are closer to each 
other, especially in the heart proper region. In an estimated 80 % of all larvae, the 
pericardial cells in this heart proper region are in two rows or individual hand-GFP 
positive pericardial cells are displaced laterally, disturbing the “pearls-on-a-string” 
arrangement that these cells usually have at this stage (see arrows in Figure 3.4.9 C). In 
the anterior part of the heart, the aorta, the gaps that appear between the pericardial cells 
from the second instar onwards appear shorter than in the wild-type larvae or are 
completely missing (see stars in Figure 3.4.9 C). This shows that the effect of over-
expressing Him is not only restricted to the posterior part of the heart. Counting of the 
cells shows a statistically significant increase of more than ten pericardial cells per 
animal. 
My observations show that if Him expression is maintained throughout larval 
development, the proper development of the pericardial cells is disturbed. It is currently 
unclear if this increase in pericardial cell number is due to the failure of the process that 
reduces pericardial cell numbers during the larval life or if this process does indeed 
occur but further pericardial cells are generated during this time as well. It is important 
for the larvae to generate the correct number of pericardial cells during embryogenesis. 
It would be interesting to see if the change in pericardial cell number has any effects on 
the physiology of the heart and/or the life expectancy of the flies as it has been shown 
that the pericardial hyperplasia in dpp mutant embryos leads to a decrease in the volume 
of pumped haemolymph (Johnson et al., 2007). Analysing the pattern of the heartbeat 
and its response to physiological stress is however beyond the scope of this work. 
 
 
3.4.3 Conclusions for the Him phenotype 
 
These data presented in this section show that Him is important for ensuring the 
specification of the correct number of all heart cells and especially the pericardial cells 
in the embryo. Table 3.4.1 includes all pericardial cell numbers mentioned in the 
previous two sections. My analysis has also shown that while Him expression is  
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Figure 3.4.9: Him over-expression in the heart causes an increase in pericardial 
cells in third instar larvae. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize 
the hand-GFP expression pattern and the number of GFP positive pericardial cells 
was counted. 
A handCGFP2.3 reporter construct, wild-type control; B Over-expression of Him 
using the hand-Gal4 driver causes an increase in pericardial cells of third instar 
larvae and also disturbs their organisation. Arrows point to pericardial cells that are 
laterally displaced and stars indicate areas that should have gaps in the anterior aorta. 
C Histogram showing the numbers of handGFP-positive pericardial cells in the 
controls (handCGFP2.3) and the third instar larvae that express Him ectopically in 
the heart. The error bars indicate the standard error and the star indicate a statistically 
significant increase compared to the wild-type. 
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Table 3.4.1: Heart cell numbers obtained from all Him loss-of-function and gain-
of-function experiments described in this section. OPCs: Odd-positive pericardial 
cells; EPCs: Eve-positive pericardial cells, CB: total cardioblast number, !3: !3tubulin-
positive cardioblast, 2nd instar: number of hand-GFP positive pericardial cells in the 
second instar, 3rd instar: number of hand-GFP positive pericardial cells in the third 
instar, n/a: data not available, a grey underlay indicates a significant change in cell 
number when compared to wild type. 
 
pericardial cells cardioblasts larval stages  
OPCs EPCs !3 CB 2nd instar 3rd instar 
OR 47.9 27 52.2 71.8 n/a n/a 
handCGFP 2.3 48.5 27.4 n/a n/a 45.9 38.3 
handCGFP 3.1 48.1 26.5 n/a n/a 43.4 37.6 
Him 52 37.4 21.4 49.4 65.6 44.3 30.8 
Him 74 43.6 22.1 46.4 65.4 32.6 33.4 
Him 195 46.4 16 45.4 67.2 34.9 34.4 
hand-Gal4 x UAS-Him 59.2 27.5 51.6 n/a 47.2 51 
Mef2-Gal4 x UAS-Him 49.5 n/a 50.3 71.6 n/a n/a 
TinC!4-Gal4 x UAS-Him n/a n/a 51.3 72.1 n/a n/a 
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necessary for the correct development of the pericardial cells, its exclusion from the 
cardioblasts is of importance for the correct development of these cells. 
Too much Him expression in the heart leads to an increase in pericardial cells 
while the loss of Him leads to a loss of pericardial cells and a mild loss of cardioblasts. 
The loss of pericardial cells during embryogenesis is compensated for during larval life 
by the third instar. However, the gain of pericardial cells caused by over-expression of 
Him cannot be compensated for during larval life. These results point to Him being 
directly or indirectly involved in the regulation of the decrease of pericardial cells 
during larval development. It is possible that, if Him is expressed during larval life, this 
loss of pericardial cells cannot happen to the degree normal in wild-type larvae. This 
leads to the “normalized” appearance of pericardial cells number by the third instar. 
Johnson et al. (2007) have shown that an excess of pericardial cells is detrimental to the 
life expectancy and heart function in adult flies. As the pericardial cell number in the 
Him null mutants is within the wild-type range, this effect might be a partial explanation 
for the viability of the homozygous Him null mutant lines. However, continuous over-
expression of Him in the pericardial cells also changes the pericardial cell number, 
resulting in third instar larvae that still show an excess of pericardial cells. Accordingly, 
if these flies were followed into adulthood, they should show a diminished heart 
function and life span. 
These results point to two distinctive roles for Him during heart development. 
During embryogenesis, Him is necessary for the specification of the correct number of 
all heart cells, pericardial cells and cardioblasts. The phenotype described for the 
misexpression of Him in the heart in this thesis and in David Liotta’s PhD thesis is 
reminiscent to that observed in embryos mutant for decapentaplegic (dpp, Johnson et 
al., 2007, Liotta, D. PhD thesis). In both cases the Eve-positive pericardial cells are not 
affected while the Odd-positive pericardial cells increase in number. In their paper 
Johnson et al., show that this increase of Odd-positive pericardial cells correlates with 
the expansion of Zfh-1 expression, which is under the control of Dpp. They also 
describe a reduction in size of some DO1 muscles and an increase in the space between 
the DO1 and DO2 muscles (Johnson et al., 2007). Him null mutants display a “relative 
decrease in average thickness for the DO2 muscle” and also a larger space between the 
DO1 and DO2 muscles (D. Hancock, PhD thesis). These phenotypes resemble each 
other and point towards the possibility that Him might also be involved in mediating the 
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response of dpp, similarly to Zfh-1. The possibility that Him is a target of Dpp 
signalling is discussed in chapter 6. 
Him clearly also has an effect on the cardioblasts. It has been demonstrated that 
the hyperplasia of the Tin- and Odd-positive pericardial cells observed in dpp mutants is 
due to a loss of cells of the dorsal muscles (Johnson et al., 2007). My observations of no 
gain, but rather a loss, of cardioblasts in Him null mutant embryos show that the loss of 
Him affects both cardioblasts and pericardial cells in a very similar fashion and not that 
one cell type gains cells at the cost of the other. Both, the results from previous studies 
in this lab and the results of Johnson et al., point towards the dorsal muscle cells as the 
possibly affected tissue. This should be investigated with priority. Furthermore, it is 
also possible that Him expression is necessary to delineate the heart precursors from 
those for the visceral mesoderm as both develop from the dorsal mesoderm. The 
presumptive heart cells form under the direct influence of wingless (Riechman et al., 
1997). The co-repressor Groucho has been shown to directly interact with dTcf of the 
Wingless/Wnt signalling pathway and with Brinker, a target of the Dpp signalling 
pathway (Cavallo et al., 1998; Lawrence et al., 2000; Brantjes et al., 2001 and Hasson et 
al., 2001). As a previous study in this lab has shown that Him and Groucho also interact 
physically and work together in the regulation of the activity of Mef2 in the somatic 
mesoderm this might be a possible link to these pathways (Liotta et al., 2007; Liotta, D. 
PhD thesis). These possibilities of the mechanistic function of Him still require further 
investigation. 
At later stages in development the temporal regulation of the expression of Him 
is also very important. While Him needs to be present during early and mid 
embryogenesis as described above, it is equally important for the Him protein to not be 
present by the beginning of larval development to allow for the proper development of 
the pericardial cells. Disturbances in the expression of Him lead to a failure in the 
specification of the correct pericardial cell number during larval development. While 
the significance of this reduction is still mainly unclear, it has been shown that 
pericardial cell hyperplasia has a negative effect on the amount of haemolymph 
transported with each heart beat (Johnson et al., 2007). Further investigations need to be 
made into the physiology and function of the pericardial cells of the Him null mutant 
embryos and those over-expressing Him during larval life. In my opinion it is highly 
likely that one will be able to detect aberrant behaviour of these cells and in the over-all 
functionality of the heart in late larval stages and in the adult. We are currently also 
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investigating if the failure to reduce the number of larval pericardial cells happens at the 
expense of the ventral heart muscle that is generated during late larval and pupal life. 
The data collected for the embryo and larvae pericardial cells numbers show that 
all available Him null mutants generally behave in the same way (Table 3.4.1). While 
the genetic mapping of the null mutants is not yet complete with regard to the their 
exact breakpoints, previous tests in our lab have clearly established all three lines as 
deficient for Him (D. Hancock, PhD thesis, J. Han and M. Taylor, unpublished data). 
Any differences in the scored exact cell numbers have to be attributed to human error, 
biological variation or the context of the Him deletions. The Him 52 deletion line lacks 
a further four genes and there is a possibility that the other two lines have retained some 
functional regulatory elements and a small part of the 3’-UTR of the Him gene. These 
sequences might still be capable of producing gene products like microRNA or other 
(partial) RNA fragments that can affect neighbouring genes.  
Him is thus implicated in several different functions within the development of 
the Drosophila heart. Him is necessary for the correct specification of all heart 
precursors and the further specification and differentiation of pericardial cells and 
cardioblasts during embryonic development. In the pericardial cells it also is necessary 
to lose Him expression at the end of embryogenesis to allow the reduction of the 
number of pericardial cells, the failure of which has been linked to physiological 
functions of the heart. 
 
 
3.5 The role of Mef2 in Drosophila heart development 
 
Previous studies in this lab have shown that Him can regulate Mef2 activity in 
the somatic mesoderm and that different levels of Mef2 activity are important during 
development (Liotta et al., 2007; Elgar et al. 2008). Lowering Him levels using RNAi 
helps restore the phenotype of Mef2 hypomorph embryos towards that of a wild-type 
embryo (Liotta et al., 2007). Similarly, the phenotype observed in the somatic 
mesoderm of Drosophila embryos over-expressing Him can be rescued toward a wild-
type phenotype by co-over-expressing Mef2 in the same animal. If this relationship 
between Him and Mef2 function is also of importance in the heart, the loss or gain of 
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Mef2 expression in the heart should result in a phenotype reminiscent of the phenotypes 
I have described for the gain or loss of Him expression. 
The analysis of Mef2 null mutants has shown that the cardioblasts and 
pericardial cells of the heart are formed but lack the expression of muscle structural 
genes likes myosin heavy chain (Bour et al., 1995; Lilly et al., 1995; Ranganayakulu et 
al., 1995; Gunthorpe et al., 1999). The cardioblasts in these animals do express ß3-
tubulin in a regular pattern (Gunthorpe et al., 1999, D. Liotta, PhD thesis), the general 
pericardial cell population appears intact as assayed by the expression of the extra-
cellular marker Pericardin and the Eve-positive pericardial cells are not affected by the 
loss of Mef2 (Bour et al., 1995, Gunthorpe et al., 1999). There have not been any further 
studies of the effect the loss of Mef2 has on the heart of the embryo or larvae.  
  To my knowledge, so far Mef2 has not been over-expressed in the Drosophila 
heart with cardiac-specific drivers. Lin et al., 1997 used a selection of epidermal, pan-
mesodermal, neuronal and heat-shock induced drivers (69B, Gal4-1407 and 24B) and 
describe “no noticeable effect on the viscera and the dorsal vessel”. In a later study 
Gunthorpe et al. (1999) show an effect on the visceral muscles and the heart. In their 
study, the embryos were labelled for myosin expression and they observe a shorter heart 
and an accumulation of cardioblasts in the posterior part of the heart with an over-all 
reduction of the cardioblast number in the embryos over-expressing Mef2. There are no 
reports of the effect of over-expression of Mef2 on the pericardial cells. 
 
 
3.5.1 The heart cells in Mef2 null mutant embryos 
 
 As none of the previously performed studies scored the heart cells of Mef2 null 
mutant embryos and a closer analysis of the images in the studies done by Bour et al. 
and Gunthorpe et al. raised the possibility that the expression of ß3-tubulin might not be 
completely identical to that observed in wild-type embryos, I have repeated some of the 
already published experiments. In addition to this I also scored the Odd-positive 
pericardial cells. 
 As I did for the Him null mutant embryos, I scored the Mef2 null mutant 
embryos for the number of ß3-tubulin-positive cardioblasts and the total number of 
cardioblasts using DIC optics (Figure 3.5.1). While the number of cardioblasts counted 
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using the DIC optics was similar to that of the wild-type embryos, I observed a marked 
drop in the number of ß3-tubulin-positive cardioblasts; this loss of ß3-tubulin-positive 
cardioblasts is statistically significant (see chart in Figure 3.5.1). The arrangement of the 
cardioblasts is also not quite as regular and orderly as they are in wild-type embryos. 
This reduction in the number of ß3-tubulin-positive cardioblasts has not been described 
before. As the total number of cardioblasts is unaffected, I interpret this result as 
follows: while Mef2 is not necessary for the specification of the cardioblasts, it is 
involved in the regulation of genes that contribute to the identity of the cells it is 
expressed in (Bour et al., 1995; Lilly et al. 1995; Ranganayakulu et al, 1995). However, 
according to my results this effect is not exclusively limited to the late expression of 
muscle structural genes but also affects the expression of ß3-tubulin. 
 Scoring the number of Odd-positive pericardial cells (see Figures 3.5.2) showed 
no change in Odd-positive pericardial cell number. There was also no change in the 
arrangement or size of the Odd-positive pericardial cells. The previously published 
experiments (Bour et al., 1995), describe a very similar pericardial phenotype based on 
the expression of Even-skipped and Pericardin. Thus, I have confirmed the previously 
described phenotype and extend the analysis to the Odd-positive pericardial cells and to 
exact cell numbers for all markers I tested. It appears that Mef2 has only a very minor 
role or even no importance for the correct specification and early differentiation of the 
pericardial cells of the embryonic heart, but that it is important for the regulation of 
genes involved in the late differentiation of the cardioblasts. 
 
 
3.5.2 The effect of Mef2 over-expression in the pericardial cells of the 
embryo 
 
 In order to achieve Mef2 over-expression in the pericardial cells I have used two 
different Gal4 drivers: Him-Gal4 L3-5 and hand-Gal4. Hand-Gal4 is expressed in all 
known heart cells from embryonic late stage 12 onwards throughout the animals life 
while the Him-Gal4 only drives expression in the pericardial cells of the embryo from 
stage 11/12 onwards to the end of embryogenesis but is not active during larval life. I 
used two different UAS-Mef2 lines, one more strongly expressing line (UAS-Mef2high, 
Bour et al., 1995) and one less strongly expressing line (10T4A, Gunthorpe et al., 1999)  
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Figure 3.5.1: Expression pattern of ß3-tubulin in mef222.21 null mutant embryos. 
Stage 16/17 embryos were labelled for the ß3-tubulin protein and the number of ß3-
tubulin-positive cardioblasts was counted. Homozygous mutant embryos were chosen 
by absence of the lacZ balancer. 
A Wild-type embryo; B ß3-tubulin expression in a homozygous mef222.21 mutant 
embryo; C Histogram showing the numbers of ß3-tubulin-positive cardioblasts and the 
total number of cardioblasts in the controls (OR) and in the mef222.21 embryos. The error 
bars indicate the standard error and stars indicate a statistically significant decrease 
compared to the wild-type. 
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Figure 3.5.2: Expression pattern of Odd in mef222.21 null mutant embryos. 
Stage 16/17 embryos were labelled for Odd protein and the number of odd-
positive pericardial cells was counted. Homozygous mutant mef222.21 embryos 
were chosen through the absence of the lacZ balancer. 
A Wild-type embryo; B Odd expression in a homozygous mef222.21 mutant 
embryo; C Histogram showing the numbers of Odd-positive pericardial cells in the 
controls (OR) and in the mef222.21 embryos. The error bars indicate the standard 
error; there is no statistically significant difference compared to the wild-type.!
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and tested all four possible combinations. As before I used Zfh-1 to gain a first insight 
into the behaviour of the pericardial cells when Mef2 is over-expressed in these cells. As 
can be seen in Figure 3.5.3, distribution and organisation of the Zfh-1-positive 
pericardial cells is indistinguishable from the pattern observed in a wild-type embryo. 
 For the analysis in the embryos I again assayed the cell number for the same 
markers that I used in the Him null mutant and Him gain-of-function experiments: Odd, 
Eve and ß3-tubulin. Figure 3.5.4 shows the results I obtained for Eve. Again, it is not 
possible to distinguish any of the embryos over-expressing Mef2 from the wild-type 
embryo based upon the expression pattern of Eve. Counting of the Eve-positive 
pericardial cells revealed furthermore that all four of the heart Gal4 > UAS-Mef2 
combinations have cell numbers very close to the number of Eve-positive pericardial 
cells I have counted in wild-type embryos and that there are no significant differences. 
Thus, ectopic expression of Mef2 in the pericardial cells does not affect the number and 
organisation of the Eve-positive pericardial cells in the embryo. 
 As can be seen in Figure 3.5.5, the expression pattern of Odd protein in these 
Mef2 over-expressing embryos it also indistinguishable from the wild-type. The 
organisation of the Odd-pericardial cells is also the same in both, wild-type and Mef2 
over-expressing embryos. The graph in 3.5.5 F shows that the number of Odd-positive 
pericardial cells is close to that observed in wild-type embryos in all Mef2 over-
expressing combinations and that there are no statistically significant differences 
between the embryos over-expressing Mef2 and the wild-type embryos. Thus, the 
ectopic expression of Mef2 also has no influence on the Odd-positive pericardial cells.  
I again used ß3-tubulin to visualize the cardioblasts. Figure 3.5.6 shows these results. 
Here it is important to note that the expression of ß3-tubulin is not affected in Mef2 
loss-of-function mutants according to previous studies, which did not rely on accurate 
cell counts while I have observed a reduction in the number of ß3-tubulin-positive 
cardioblasts (figure 3.5.1; Bour et al., 1995; Lilly et al., 1995; Gunthorpe et al., 1999; 
PhD thesis, D. Liotta). If Mef2 is over-expressed within the heart, I see a mild 
organisational phenotype if the more strongly expressing form of the UAS-Mef2 
construct is over-expressed under the control of the hand-Gal4 driver. The cardioblasts 
do not line up as neatly as in the wild-type and occasionally bunching up of cardioblasts 
occurs (see arrows in Figure 3.5.6). Counting of the ß3-tubulin positive cardioblasts 
showed that all four different Mef2 over-expression combinations are very close to the  
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Figure 3.5.3: Zfh-1 expression in embryos over-expressing Mef2 in the 
pericardial cells. 
Stage 16/17 embryos were labelled for the distribution of the Zfh-1 protein. 
A OR wild-type embryo; B Zfh-1 expression in an embryo if the hand-Gal4 driver 
controls the stronger expressing form of the UAS-Mef2 construct; C Zfh-1 
expression pattern in an embryo if the hand-Gal4 driver controls the less strong 
expressing UAS-Mef2 construct. 
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Figure 3.5.4: Expression pattern of Eve in embryos that over-express Mef2 in the 
pericardial cells. 
Stage 16/17 embryos were labelled for the Eve protein and the number of Eve-positive 
pericardial cells was counted. 
A Wild-type embryo; B Eve expression in an embryo if the hand-Gal4 driver controls 
the less strong expressing form of the UAS-Mef2 construct; C Eve expression in an 
embryo if the Him-Gal4 driver controls the less strong expressing form of the UAS-
Mef2 construct; D Eve expression in an embryo if the hand-Gal4 driver controls the 
stronger expressing form of the UAS-Mef2 construct; E Eve expression in an embryo if 
the Him-Gal4 driver controls the stronger expressing form of the UAS-Mef2 construct; 
F Histogram showing the numbers of Eve-positive pericardial cells in all three controls 
(OR, handCGFP2.3, handCGFP3.1) and the different conditions used to over-express 
Mef2. The error bars indicate the standard error; there is no statistically significant 
difference compared to wild-type. 
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Figure 3.5.5: Expression pattern of Odd in embryos expressing ectopic Mef2 in the 
pericardial cells. 
Stage 16/17 embryos were labelled for the Odd protein and the number of Odd-positive 
pericardial cells was counted. 
A Wild-type embryo; B Odd expression in an embryo if the hand-Gal4 driver controls 
the less strong expressing form of the UAS-Mef2 construct; C Odd expression in an 
embryo if the Him-Gal4 driver controls the less strong expressing form of the UAS-
Mef2 construct; D Odd expression in an embryo if the hand-Gal4 driver controls the 
stronger expressing form of the UAS-Mef2 construct; E Odd expression in an embryo if 
the Him-Gal4 driver controls the stronger expressing form of the UAS-Mef2 construct; 
F Histogram showing the numbers for the Odd-positive pericardial cells in all three 
controls (OR, handCGFP2.3, handCGFP3.1) and the different conditions used to over-
express Mef2. The error bars indicate the standard error; there is no statistically 
significant difference compared to wild-type. 
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Figure 3.5.6: Expression pattern of ß3-tubulin in embryos that over-express 
Mef2 in the pericardial cells. 
Stage 16/17 embryos were labelled for the ß3-tubulin protein and the number of ß3-
tubulin-positive cardioblasts was counted. 
A Wild-type embryo; B ß3-tubulin expression in an embryo if the hand-Gal4 driver 
controls the less strong expressing form of the UAS-Mef2 construct; C ß3-tubulin 
expression in an embryo if the Him-Gal4 driver controls the less strong expressing form 
of the UAS-Mef2 construct; D ß3-tubulin expression in an embryo if the hand-Gal4 
driver controls the stronger expressing form of the UAS-Mef2 construct; E ß3-tubulin 
expression in an embryo if the Him-Gal4 driver controls the stronger expressing form of 
the UAS-Mef2 construct; F Histogram showing the numbers of ß3-tubulin-positive and 
total number of cardioblasts in the controls and the different conditions used to over-
express Mef2. The error bars indicate the standard error; there is no statistically 
significant difference compared to wild-type. 
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ß3-tubulin-positive cardioblast number observed in wild-type embryos and show no 
significant differences to the number of ß3-tubulin-positive cardioblasts in wild-type 
embryos. The total number of cardioblasts is also the same as in wild-type embryos (see 
Figure 3.5.6 F). 
 It must be noted that ß3-tubulin is only expressed in four of the six cardioblasts 
per hemisegment, thus the above analysis excludes a direct analysis the two Svp-
positive cardioblasts of each hemisegment. I have, however counted all cardioblasts 
using DIC optics and not observed a change in this number either. In order to answer 
this question completely, an antibody stain for Svp, Doc, Mef2 or Myosin would help 
identify the fate of the two remaining cardioblasts. As the Zfh-1 expression pattern of 
the embryos over-expressing Mef2 under the control of the hand-Gal4 driver is very 
close to that of wild-type embryos (Figure 3.5.3), I believe that it is relatively unlikely 
that the Tin-positive pericardial cells are affected by the over-expression of Mef2. 
 
 
3.5.3 The effect of Mef2 over-expression in the larval heart. 
 
 I continued the analysis of the pericardial cells in animals over-expressing Mef2 
into the larval stages utilizing the same hand-GFP reporter construct as before. For an 
overview of all cell numbers of this section please refer to Table 3.5.1. While I did not 
observe any phenotype except for a mild organisational phenotype during the 
embryonic development of the heart, my analysis of the function of Him indicates that 
Him has an importance for the correct development of the larval pericardial cells as 
well. I was interested to see if this could be disturbed by continued Mef2 expression in 
the pericardial cells once Him is not expressed in these cells anymore. Such a result 
would further point towards a connection between Him expression and Mef2 function 
and the importance of Him expression to prevent Mef2 function in the pericardial cells 
during embryogenesis. As I have shown previously and as is published, there is a 
marked drop in the number of pericardial cells between the first and third instar of wild-
type animals and this step is disturbed when Him is missing or over-expressed. For 
these experiments of over-expressing Mef2 in the larvae, I have used the same drivers as 
before: Him-Gal4 L3-5 and hand-Gal4. 
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 Figure 3.5.7 shows the behaviour of the pericardial cells in the early first instar 
larvae when Mef2 is over-expressed under the control of hand- or Him-Gal4. The 
organisation and cell number of the pericardial cells are indistinguishable from that of 
wild-type larvae at this stage. Their shape and size is also virtually identical to that of 
the wild-type animals. As I was unable to reliably analyse the exact cell numbers for 
this developmental stage, I have no cell number counts for this and have to rely on these 
observations only. 
 During the second larval instar some of the cells begin to change their shape (see 
arrows in Figure 3.5.8 and Table 3.5.2). Some of the pericardial cells lose their typical 
round and globular shape. The percentage of these aberrant pericardial cells in relation 
to the total number of hand-GFP positive pericardial cell depends on the specific 
combination of Gal4-driver and UAS-construct used. I have observed cell changes in 85 
to 100 % of all scored larvae (see Table 5.3.2 and stars in Figure 3.5.8). There are two 
different changes in cell shape, one is an accumulation of several small nuclei in 
clusters and other individual cells remain large but lose their round, globular shape. 
 The small, clustered nuclei have the same hand-GFP intensity as the “normal” 
pericardial cells but can be as small as half the size of the nuclei of the wild-type cells. 
There are usually at least two or three nuclei in a cluster and these clusters occur more 
readily towards the anterior end of the heart. Other hand-GFP positive pericardial cells 
begin to elongate and form cytoplasmic protrusions (see arrows in Figure 3.5.8 D and 
E), losing the typical globular shape. 
 Counting of all GFP-positive pericardial cells in these experiments revealed that 
for three of the four Mef2 over-expression experiments the number of hand-GFP-
positive pericardial cells is not significantly different to the number I counted in wild-
type larvae; only if the stronger expressing form of the UAS-Mef2 construct is expressed 
under the control of the Him-Gal4 driver is there a statistically significant increase in 
hand-GFP positive pericardial cells (see figure 3.5.8 F). For this developmental stage, 
these numbers include the aberrantly shaped pericardial cells. This is because cells were 
often not easily identifiable as either wild-type or spindly-shaped cells, thus not 
allowing for a reproducible count of how exactly how many non-globular cells are 
present in one larva. This change of pericardial cell type, arrangement and number is 
especially interesting considering that so far no phenotype has been described for the 
embryonic pericardial cells if Mef2 is over-expressed and that the expression of the  
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Figure 3.5.7: Expression pattern of the hand-GFP reporter construct in first instar 
larvae over-expressing Mef2 in the pericardial cells. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
GFP expression pattern. 
A handCGFP2.3 reporter construct, wild-type control; B handCGFP3.1 reporter 
construct, wild-type control; C GFP expression pattern in a first instar larvae expressing 
the weaker UAS-Mef2 construct under the control of the hand-Gal4 driver; D GFP 
expression pattern in a first instar larvae expressing the weaker UAS-Mef2 construct 
under the control of the Him-Gal4 driver; E GFP expression pattern in a first instar 
larvae expressing the stronger UAS-Mef2 construct under the control of the hand-Gal4 
driver; F GFP expression pattern in a first instar larvae expressing the stronger UAS-
Mef2 construct under the control of the Him-Gal4 driver.!
 
 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#$!
Table 3.5.1: Heart cell numbers obtained from all Mef2 loss-of-function and gain-
of-function experiments described in this section. OPCs: Odd-positive pericardial 
cells; EPCs: Eve-positive pericardial cells, CB: total cardioblast number, !3: !3tubulin-
positive cardioblast, n/a: data not available, a grey underlay indicates a significant 
change in cell number when compared to wild type. 
 
 
Table 3.5.2: Percentage of scored Mef2 over-expressing larva that contain 
aberrantly shaped pericardial cells during larval life. 
 handCGFP 
2.3 
hand-Gal4 x 
UAS-
Mef2low 
Him-Gal4 x 
UAS-
Mef2low 
hand-Gal4 x 
UAS-
Mef2high 
Him-Gal4 x 
UAS-
Mef2high 
1st instar 0 % 0 % 0 % 0 % 0 % 
2nd instar 5 % 80 % 85 % 90 % 100 % 
3rd instar 35 % 85 % 100 % 100 % 100 % 
 
 
Table 3.5.3: Average numbers of wild-type and aberrantly shaped pericardial cells 
per animal (third instar). PCs: pericardial cells 
 handCGFP 
2.3 
hand-Gal4 
x UAS-
Mef2low 
Him-Gal4 x 
UAS-
Mef2low 
hand-Gal4 x 
UAS-
Mef2high 
Him-Gal4 x 
UAS-
Mef2high 
globular PCs 37 32.4 44.6 44.5 26.4 
non-globular 
PCs 
0.6 9.8 7.1 15.4 18.4 
% of non-
globular PCs 
per animal 
1.6 23.2 13.7 25.7 41.1 
pericardial cells cardioblasts larval stages  
OPCs EPCs !3 CB 2nd instar 3rd instar 
OR 47.9 27 52.2 71.8 n/a n/a 
handCGFP 2.3 48.5 27.4 n/a n/a 45.9 38.3 
handCGFP 3.1 48.1 26.5 n/a n/a 43.4 37.6 
mef222.21 47.9 n/a 38.3 72 n/a n/a 
hand-Gal4 x UAS-Mef2low 49.5 26.2 52.2 70.4 43.5 42.2 
Him-Gal4 x UAS-Mef2low 47.1 26.3 50.6 70.6 47 51.7 
hand-Gal4 x UAS-Mef2high 47.5 26.6 51.6 71.9 44.8 59.9 
Him-Gal4 x UAS-Mef2high 48.3 26.4 51.5 72 52.2 44.8 
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Figure 3.5.8: Expression pattern of the hand-GFP reporter construct in second 
instar larvae expressing ectopic Mef2 in the pericardial cells. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
GFP expression pattern and the number of GFP-positive pericardial cells was counted. 
Arrows point to elongated non-globular pericardial cells and stars indicate closely 
associated nuclei. 
A handCGFP2.3 reporter construct, wild-type control; B handCGFP3.1 reporter 
construct, wild-type control; C GFP expression pattern in a second instar larvae 
expressing the weaker UAS-Mef2 construct under the control of the hand-Gal4 driver; D 
GFP expression pattern in a second instar larvae expressing the weaker UAS-Mef2 
construct under the control of the Him-Gal4 driver; E GFP expression pattern in a 
second instar larvae expressing the stronger UAS-Mef2 construct under the control of 
the Him-Gal4 driver; F Histogram showing the numbers of hand-GFP-positive 
pericardial cells in the two controls (handCGFP2.3, handCGFP3.1) and the different 
conditions used to over-express Mef2 in the second instar. The error bars indicate the 
standard error and stars indicate a statistically significant difference compared to wild-
type. 
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Him-Gal4 L3-5 driver is limited to the embryonic stages only (see section 3.2.2 and 
Appendix). 
  
 Third instar larvae show an even more pronounced change in cell shape (Table 
5.3.2 and 5.3.3). Figure 3.5.9 shows the expression pattern of the hand-GFP construct in 
third instar larvae over-expressing Mef2. Counts of the number of hand-GFP-positive 
pericardial cells demonstrate a significant increase in these numbers for three of the four 
experiments; only in the animals that drive the strong version of the UAS-Mef2 
construct under the control of the Him-Gal4 driver there is no significant change in 
pericardial cell number (Figure 3.5.9 G) These animals showed an increase in 
pericardial cell number in the second instar (Figure 3.5.8 G). 
 Table 3.5.3 shows the average number of globular and non-globular pericardial 
cells in the third instar larvae of these experiments. As can be seen in the images in 
Figure 3.5.9 C’, D’, E’ and F’, a good part of the pericardial cells in each animal change 
their cell shape from the wild-type globular pericardial cell to a more elongated cell 
with more than one or two cytoplasmic protrusions (see arrows). There are also a 
considerable number of animals where I detect clusters of nuclei as I already described 
for the second instar (see stars in Figure 3.5.9) This “clumping” together of several 
nuclei has so far not been described in the literature and I can only detect it in 
approximately 35 % of the third instar wild-type larvae I analysed (see Table 3.5.2) and 
a much lower percentage of pericardial cells per animals is affected by this change in 
cell shape in these wild-type larvae than in Mef2-overexpressing animals (Table 3.5.3 
and figure 3.5.9). 
 The amount of pericardial cells that change their cell shape per animal is tied in 
with the strength of the UAS-Mef2 construct and driver used (Table 3.5.3). If the strong 
version of the UAS-Mef2 is expressed, all of the larvae assayed show altered cell shapes 
but the used driver determines the percentage of aberrantly shaped cells per larva. If the 
hand-Gal4 driver is used, on average 25.7 % of the hand-GFP positive pericardial cells 
of an animal have a non-globular shape. This percentage rises to 41.1 % if the Him-
Gal4 driver is used.  
 The different expression strength of the two UAS-Mef2 constructs is illustrated 
by the decrease in phenotype frequency. If the same Gal4 driver but the less strong 
expressing UAS-Mef2 construct is used, 85 % (for the hand-Gal4 driver) or 100 % (for  
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Figure 3.5.9: Expression pattern of the hand-GFP reporter construct in third 
instar larvae over-expressing Mef2 in the pericardial cells. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
GFP expression pattern and the number of GFP-positive pericardial cells was counted. 
C’ to F’ show a section of the same larva shown in C to F at a higher magnification. 
Arrows point to elongated non-globular pericardial cells and stars indicate closely 
associated nuclei. 
A handCGFP2.3 reporter construct, wild-type control; B handCGFP3.1 reporter 
construct, wild-type control; C GFP expression pattern in a third instar larvae 
expressing the weaker UAS-Mef2 construct under the control of the hand-Gal4 driver; D 
GFP expression pattern in a third instar larvae expressing the weaker UAS-Mef2 
construct under the control of the Him-Gal4 driver; E GFP expression pattern in a third 
instar larvae expressing the stronger UAS-Mef2 construct under the control of the hand-
Gal4 driver; F GFP expression pattern in a third instar larvae expressing the stronger 
UAS-Mef2 construct under the control of the Him-Gal4 driver; G Histogram showing 
the numbers of hand-GFP-positive pericardial cells in the two controls (handCGFP2.3, 
handCGFP3.1) and the different conditions used to over-express Mef2 in the third 
instar. The error bars indicate the standard error and the star indicates a statistically 
significant difference compared to wild-type. 
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the Him-Gal4 driver) of animals contain differently shaped cells (Table 3.5.2) and the 
percentage of non-globular pericardial cells per animal is also lower (23.2 and 13.7 %, 
respectively). These data illustrate that both the time and location of expression and the 
strength of the used UAS construct have an influence on the observed phenotype. 
However, all third instar larvae show the same changes in cell shape, proving that this is 
indeed a phenotype caused by the introduction of Mef2 into the embryonic pericardial 
cells.    
I have not been able to determine if the clusters of nuclei are indeed one multi-
nucleated cell or a close aggregation of several smaller cells, as all these assays were 
done in whole-mount live larvae and the cuticle and trachea of the larvae interfere with 
the resolution of the image at high power magnification. For this, it would be advisable 
to dissect larvae and then visualize the cell membranes in the dissected animals together 
with the hand-GFP reporter construct. 
As the increase in pericardial cell number and the change in cell shape happens 
in the later larval stages and I did not observe any embryonic phenotype, it is possible 
that these cells are generated from the pericardial cells that are lost in these stages in a 
wild-type situation. Indeed, if one subtracts the number of misshapen cells from the 
total pericardial cell numbers, the resulting numbers for normal, globular shaped 
pericardial cells are not significantly different to the numbers of these cells in the wild-
type if the animals carry the less strongly expressing UAS-Mef2 construct (Figure 3.5.9 
G). The stronger expressed UAS-Mef2 construct has a different effect on the number of 
pericardial cells. If this construct is driven by hand-Gal4, even after subtracting the 
misshapen cells from the total pericardial cell number indicates an increase in the wild-
type shaped cells. This indicates that Mef2, if expressed strongly in both the cardioblasts 
and pericardial cells in the embryo and larva leads not only to the observed changes in 
cell shape but also to an increase in wild-type like pericardial cells by the third instar. In 
order to determine if this observation is due to either an increase in pericardial cells or a 
less severe decrease of these cells during larval development, exact pericardial cell 
numbers for first instar larvae are necessary. As mentioned before, due to the expression 
pattern of the hand-GFP reporter construct I used, counts of this stage have proven to be 
unreliable. 
 If the strong version of the UAS-Mef2 construct is expressed by Him-Gal4 the 
observed phenotype is altered again. The total number of counted hand-GFP-positive 
pericardial cells (including the aberrantly shaped cells) is not statistically significant 
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different to that of the control larvae (Figure 3.5.9 G). Consequently, subtracting the 
number of misshapen hand-GFP-positive pericardial cells leads to a decrease in number 
of wild-type shaped hand-GFP-positive pericardial cells. This indicates that the levels at 
which Mef2 is over-expressed in the Him expression pattern are of importance. 
Introduction of Mef2 into the embryonic pericardial cells leads to a change in cell shape 
and behaviour (see later) in a proportion of the pericardial cells. However, if Mef2 is 
over-expressed at strong levels and in the expression pattern of Him, the phenotype 
differs from these previously described phenotypes and the misshapen cells are most 
likely formed at the expense of the wild-type pericardial cells. It is possible that the loss 
of normal pericardial cells is an extension of the observed cell-shape phenotype which if 
extreme might lead to apoptosis. Further investigation is needed to establish if this loss 
of normal pericardial cells is due to apoptosis or if these cells contribute to other tissues 
and/or organs. 
 Interestingly, over-expression of Mef2 (at high or low levels) during the 
embryonic development only is sufficient to derail the normal development of the 
pericardial cells during larval life. And the observed phenotypes are more severe with 
the earlier of the two used drivers. (For an overview of all scored pericardial cell 
numbers refer to Table 3.5.1.) This stresses the importance of preventing any Mef2 
function in the pericardial cells during embryogenesis. Him is known to counteract 
Mef2 function in other mesodermal tissues. 
 
In addition to the changes in cell shape, I have also observed individual 
contractions of these non-globular but hand-GFP positive cells (refer to the movies on 
the DVD submitted with this dissertation). These contractions occur intermittently in 
bundled bursts of activity. The majority of the contractions follow each other in very 
short and fast succession until all activity again ceases for an indeterminate amount of 
time. As far as I have been able to tell from visual observations under the microscope, 
these contractions are independent of body wall and gut contractions (refer to the 
movies on the DVD with this dissertation). This is surprising as pericardial cells are 
defined as non-myogenic cells and are not known to express any myogenic markers, nor 
has any contractile activity been described for them. I have included several movies on 
a DVD showing this phenotype with this thesis. While not every animal contained these 
contractile pericardial cells, animals usually had more than one of these very aberrant 
pericardial cells. These contractions are more likely to happen in animals that carry the 
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stronger expressing version of the UAS-Mef2 construct. I have only observed 
contractions in cells that appear more “spindle-like”. As some of the GFP is present in 
the cytoplasm of the cells, I was also able to observe a regular striped arrangement of 
stronger and less strong GFP accumulation within the cytoplasm in these contracting 
cells (Figure 3.5.10). The cytoplasm of the pericardial cells of the control larvae and 
that of normally shaped cells in the Mef2 over-expressing larvae have an even and 
relatively low degree of GFP fluorescence. This observed structure might reflect some 
form of organisation within the cells, possibly the cytoskeleton and/or the cell 
membrane are affected by the actin arrangements that a contractile cell needs. 
Currently, little is known about the expression of marker genes in the larval or 
adult pericardial cells, but it would be very interesting to see which genes become de-
regulated as a result of over-expressing Mef2 in the (embryonic) pericardial cells. A first 
step towards proving that these cells have indeed been altered towards a myogenic fate 
would be a Phalloidin stain to visualize any filamentous actin present in these cells. 
  
 These data show how important the exclusion of Mef2 function from the 
embryonic pericardial cells is. While I have shown that by stage 13 Mef2 and Him 
expression are mutually exclusive, there is evidence that the Mef2 transcript is 
expressed in the pericardial cells earlier (Lilly et al., 1994; Nguyen et al., 1994). It is 
highly likely that Him is part of a fail-safe mechanism that ensures that any Mef2 still 
present in the pericardial cells after these early stages of development cannot derail the 
differentiation of the cells. 
 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#$!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5.10: Images from the movies show the internal organisation 
visible in some pericardial cells. 
The arrows point towards the striped internal organisation that can be 
seen in the pericardial cells of some third instar larvae that over-express 
Mef2. 
A pericardial cell of a handCGFP2.3 third instar control animal; B, C 
pericardial cell of third instar larvae over-expressing the stronger 
expressing version of the UAS-Mef2 construct under the control of the 
Him-Gal4 driver. 
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3.6 The role of zfh-1 in Drosophila heart development 
 
 The gene zinc-finger-homeodomain-1 (zfh-1) has a very similar expression 
pattern to the Him gene that is the focus of this work. Like Him, zhf-1 is initially 
expressed pan-mesodermally after gastrulation to then be limited to the heart precursors 
and the adult muscle precursors (AMPs) within the mesoderm during germ-band 
retraction (see section 3.2.1 and Lai et al., 1991). During embryonic stage 15 both, Him 
and zfh-1 expression changes. The expression of the Him transcript in the heart is 
reduced and eventually not visible anymore, while zfh-1 expression is lost from the Eve-
positive pericardial cells. Within the heart, no other genes than Him and zfh-1 are 
expressed exclusively within the embryonic pericardial cells and change their 
expression pattern at this point of embryogenesis are known. Zhf-1 is a DNA-binding 
transcription factor that has been shown to be necessary for the differentiation of the 
Eve-positive pericardial cells (Su et al., 1999). Both genes, Him and zfh-1, are 
associated with the down-regulation of Mef2 function in mesodermal tissues (Postigo et 
al., 1999; Liotta et al., 2007). These similarities in expression pattern and function raise 
the question if both of these genes, Him and zhf-1, have redundant functions or if they 
possibly might work together during the development of the pericardial cells and the 
AMPs. 
 
 
3.6.1 zfh-1 loss-of-function 
  
zhf-12 null mutant animals die during the last stages of embryonic development 
(Lai et al., 1993). Johnson et al. (2007) describe the embryonic heart phenotype of the 
zfh-12 null mutant as falling in either of two categories, the heart of these embryos often 
show a “kink” in the heart (in or around segment A4) and an “uneven, spindly structure 
elsewhere in the heart” while the second phenotype category is described as having 
“breaks in the anterior parts of the heart and possible duplication of cardioblasts”. They 
also report a loss of Odd- and Tin-positive pericardial cells and a “greatly reduced 
expression domain of Pericardin” (Johnson et al., 2007). This loss of pericardial cells is 
reminiscent of the phenotype I have observed in the Him null mutant animals, thus 
furthering the possibility that both genes might be involved in the same processes. 
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Johnson et al. also raise the possibility that the zfh-12 null mutant might not be a true 
null allele as they can detect some zfh-1 expression if they use antibodies generated 
against different parts of the protein (the original Zfh-1 antibody produced by Lai et al., 
1993 did not detect any zfh-1 expression in these null embryos, this is also the antibody 
I have used). It is thus possible that this line is only a very strong hypomorph and still 
expresses a truncated version of the Zfh-1 protein that might be partially functional. 
However, as they also state, the zfh-12 line is the strongest loss-of-function allele 
available for zfh-1 and is the line most other studies have used to study the role of zfh-1 
in the heart. 
 In order to assess the zfh-12 null allele in the context of my work, I undertook 
the entire embryonic cell counts with the same markers I used previously. Figure 3.6.1 
shows the results of this analysis for the ß3-tubulin-positive cardioblasts. As previously 
described in the literature, I have observed breaks and kinks in the anterior part of the 
dorsal vessel in about 60 % of the mutant embryos and also a disorganisation of the 
cardioblasts, their arrangement is not as orderly as in the wild-type embryo (compare 
Figures 3.6.1 A and B). However, the numbers of ß3-tubulin-positive cardioblasts and 
the numbers of total cardioblasts are not significantly affected in these embryos. This 
result is also very similar to those described in previously published work. However, 
these studies did not report cell counts for all heart cell markers in zfh-12 null mutants. 
Two different labs have reported “nearly normal” expression patterns for Myosin and 
Mef2 in the cardioblasts of the zfh-12 null mutant (Lai et al., 1993; Su et al., 1999). My 
results add a third marker gene to these two marker genes. As neither of these two 
studies gives exact cell numbers, my results go further than their general statements and 
I have specific numbers to support these observations. I have, however, observed a high 
degree of disorganisation of the ß3-tubulin-positive cardioblasts, which is at similar to 
the general heart phenotype described for the zfh-12 null mutant. In a wild-type embryo 
one would expect to see the repetitive two plus four pattern in the abdominal segments 
A1 to A6. This pattern is disturbed in approximately 80 % of all zfh-12 null mutants. All 
embryos with a disrupted ß3-tubulin expression pattern contain hemisegments with 
fewer than four ß3-tubulin-positive cardioblasts in a row. In addition I have observed 
more than four ß3-tubulin-positive cardioblasts in a row in 55 % of all scored embryos 
(Figure 3.6.1. B). As the total number of cardioblasts and that of the ß3-tubulin-positive 
cardioblasts are unaffected in zfh-12 mutants, this indicates an irregular arrangement of  
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Figure 3.6.1: Expression pattern of ß3-tubulin in embryos that are homozygous 
deficient for zfh-1. 
Stage 16/17 embryos were labelled for the ß3-tubulin protein and the number of ß3-
tubulin-positive cardioblasts was counted. 
A Wild-type embryo; B ß3-tubulin expression in an embryo homozygous null mutant 
for zfh-1; C Histogram showing the scored numbers for the ß3-tubulin-positive 
cardioblasts and the total number of cardioblasts in all the controls (OR) and the zfh-12 
deficiency. The error bars indicate the standard error; there is no statistically significant 
difference in regard to the wild-type. 
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the cells. This observation points into the direction that zfh-12 might be involved in the 
proper arrangement and/or organisation of the cardioblasts. 
 Figure 3.6.2 shows the expression pattern of Eve in wild-type embryos and those 
homozygous for the zfh-12 null allele. As can be seen in the images, the Eve-positive 
pericardial cells are severely affected in the zfh-1 null mutant embryos; the loss of Eve-
positive pericardial cells is more pronounced in these mutants than in the Him null 
mutants. The loss of Eve-positive pericardial cells is substantiated by the scoring 
results, which shows a significant loss of Eve-positive pericardial cells (see chart in 
Figure 3.6.2 C). This result is very close to the previously published results by Su et al. 
(1999), who describe a complete loss of Eve-positive pericardial cells in all mutant 
embryos. I have, however, seen a variation with this described loss of Eve-positive 
pericardial cells in zfh-12 mutants. I have observed mutant embryos with no Eve-
positive pericardial cells at all to zfh-12 mutant embryos that show a nearly normal 
distribution of Eve-positive pericardial cells. These two different results can only be 
explained by biological variance between the individual embryos. 
 The expression pattern of Odd in the zfh-12 null mutant embryos is shown in 
Figure 3.6.3. With the exception of the typical zfh-12 phenotype, i.e. kinks and breaks in 
the anterior part of the dorsal vessel, the Odd-positive pericardial cells seem generally 
unaffected by the loss of zfh-1. Counting the Odd-positive pericardial cells also shows 
no significant difference when compared to wild-type. Similarly, the Su et al. (1999) 
paper states that other than the Eve-positive pericardial cells no other group of heart 
cells appears to be affected by the loss of zfh-1. However, they only analysed the 
expression pattern of Eve, Mef2 and Pericardin (Prc). As the pericardin gene encodes a 
protein secreted into the extra-cellular space from the pericardial cells, its expression 
pattern is only of limited usefulness to determine the gain or loss of pericardial cells. 
The 2007 study of Johnson et al. investigated the pericardial cell population in more 
detail and they report a loss of Odd- and Tin-positive pericardial cells in embryos 
homozygous for the zfh-12 null allele. This is in direct contradiction with my findings 
that the Odd-positive pericardial cells are not affected. I did however notice when I 
compared my stainings to the staining in Johnson et al. (2007), their staining for the 
Odd protein appears to be generally weaker. It is possible that the difference in the 
results between Johnson et al and my analysis is due to differences in the staining 
levels. If the level of Odd expression is affected in zfh-12 null embryos, it is possible 
that I let my reaction develop for longer and was thus able to see more Odd-positive  
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Figure 3.6.2: Expression pattern of Eve in embryos that are homozygous deficient 
for zfh-1. 
Stage 16/17 embryos were labelled for the Eve protein and the number of Eve-positive 
pericardial cells was counted. 
A Wild-type embryo; B Eve expression in an embryo homozygous null mutant for zfh-
1; C Histogram showing the obtained numbers for the Eve-positive pericardial cells in 
the two controls (OR, handCGFP2.3) and zfh-1 deficiency. The error bars indicate the 
standard error and the star indicates a statistically significant difference in regard to the 
wild-type. 
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Figure 3.6.3: Expression pattern of Odd in embryos null mutant for zfh-1. 
Stage 16/17 embryos were labelled for the Odd protein and the number of Odd-positive 
pericardial cells was counted. 
A Wild-type embryo; B Odd expression in an embryo homozygous deficient for zfh-1; 
C Histogram showing the numbers of Odd-positive pericardial cells in the two controls 
(OR, handCGFP2.3) and zfh-1 null embryos. The error bars indicate the standard error; 
there is no statistically significant difference compared to wild-type. 
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pericardial cells. Johnson et al. also report that the number of Odd-positive pericardial 
cells is normal in stage 13 embryos and only reduced in stage 17 embryos. But as I also  
only selected embryos at this late stage for my analysis, I do not think that this is a 
possible explanation for the discrepancy between the two results. 
Thus, I believe that while the Eve-positive pericardial cells are affected in the 
zfh-12 null mutants, the Odd-positive pericardial cells and the number of cardioblasts are 
not (for an overview of all pericardial cell number scored in this section see Table 
3.7.1). A phenotype of a not correctly organised heart has been described before for the 
whole heart in zfh-12 null mutants (i.e. kinks and breaks; Lai et al., 1993). At least at 
cardioblast level this organisational phenotype is also visible at the level of individual 
cell arrangement, while the organisation of the pericardial cells appears unaffected. The 
regular pattern of ß3-tubulin expression is disrupted in zfh-12 null mutants. Similarly to 
the results I have described for the loss of Him, the loss of zfh-1 also affects some of the 
dorsal somatic muscles. This similarity points to a role for both genes in the 
specification of the shared precursor for the Eve-positive pericardial cells and the dorsal 
muscle precursors. 
  
 
3.6.2 zfh-1 over-expression 
 
Johnson et al. (2007) also analysed the effects of ectopically over-expressing 
zfh-1. They describe an increased expression of Pericardin and from this conclude an 
increase in pericardial cells. Johnson et al. analysed the over-expression in the zfh-12 
null mutant background and used the 24B-Gal4 driver, which is expressed earlier in the 
mesoderm than the driver I used; they also do not show any zfh-1 expression pattern for 
these experiments. I have extended their experiments by working in a wild-type 
background and using the hand-Gal4 driver that is active from late embryonic stage 12, 
assaying all available markers I used before and following the development of the 
pericardial cells throughout the larval life in order to see if the increase in pericardial 
cells I expected to see based on the previous reports is maintained throughout larval life. 
 Figure 3.6.4 shows the expression pattern of the Zfh-1 protein in the embryos 
over-expressing zfh-1 under the control of the hand-Gal4 driver. The number of 
Zfh-1-positive cells appears similar to that seen in the wild-type and there are no 
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obvious organisational problems. This is contrary to what I was expecting. I would have 
expected to see zfh-1 expression in the cardioblasts, which are visible and can be 
identified by their unique shape and position, under DIC optics, or the visceral muscles 
as the hand-Gal4 driver is also active in these tissues. As I have verified both the driver 
line and the line carrying the UAS-zfh-1 construct separately, this leads me to the 
conclusion that zfh-1 is strongly controlled even after transcription and that either the 
Zfh-1 protein or its RNA is not stable in these cells and has no immediate effect. It is 
also possible that this particular UAS-zfh-1 construct only results in low levels of 
ectopic expression, which cannot be detected by the Zfh-1 antibody. 
The images in Figure 3.6.5 show the results for the ß3-tubulin-positive 
cardioblasts. From the expression pattern of ß3-tubulin alone, I am not able to 
differentiate between the wild-type embryos and those over-expressing zhf-1. 
Organisation of the cardioblasts and cell shape and size are identical to that observed in 
the wild-type embryo. Counting the cells also did not show a significant difference 
between the two types of embryos as can be seen in the graph in Figure 3.6.5 C. 
 Figure 3.6.6 shows the expression pattern of Eve in wild-type embryos and those 
over-expressing zfh-1 under the control of the hand-Gal4 driver. Again, from the 
expression pattern of Eve alone, I am not able to differentiate between the wild-type 
embryos and those over-expressing zfh-1. The chart in Figure 3.6.6 C shows the results 
of counting the Eve-positive pericardial cells, which shows no significant difference 
between the wild-type and the over-expressing embryos in regard to the number of 
cells. 
 Contrary to my previous two results, Odd is expressed in more cells in the 
embryo over-expressing zhf-1 (Figure 3.6.7). While the cell shape and size remains 
roughly the same, there are more cells spread out along the length of the heart. 
However, this does not alter the “pearls-on-a-string” organisation that is typical for the 
Odd-positive pericardial cells. Counting of these Odd-positive pericardial cells revealed 
a statistically significant increase in cell number. This result is similar to the result 
published in Johnson et al. 2007, who describe “ectopic Tin- and Odd-positive 
pericardial cells” in their over-expression experiments. Ectopically over-expressing zfh-
1 in the mesoderm induces an increase in Odd-positive pericardial cells but does not 
affect the Eve-positive pericardial cells or the ß3-tubulin-positive cardioblasts. Only the 
Odd-positive (and according to Johnson et al. the Tin-positive) pericardial cells are thus 
susceptible to increased levels of Zfh-1 in the later stages of embryonic development.  
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Figure 3.6.4: Zfh-1 expression in embryos over-expressing zfh-1 in the heart. 
Stage 16/17 embryos were labelled for the distribution of the Zfh-1 protein. 
A OR wild-type embryo; B Zfh-1 expression in an embryo over-expressing zfh-1 under 
the control of the hand-Gal4 driver.!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6.5: Expression pattern of ß3-tubulin in embryos that over-express zfh-1 
in the heart. 
Stage 16/17 embryos were labelled for the ß3-tubulin protein and the number of ß3-
tubulin-positive cardioblasts was counted. 
A Wild-type embryo; B ß3-tubulin expression in an embryo ectopically over-expressing 
zfh-1 under the control of the hand-Gal4 driver; C Histogram showing the numbers of 
ß3-tubulin-positive pericardial cells in all three controls (OR, handCGFP2.3, 
handCGFP3.1) and the zfh-1 over-expression study. The error bars indicate the standard 
error; there is no statistically significant difference compared to wild-type. 
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Figure 3.6.6: Expression pattern of Eve in embryos that over-express zfh-1 in the 
heart. 
Stage 16/17 embryos were labelled for the Eve protein and the number of Eve-positive 
pericardial cells was counted. 
A Wild-type embryo; B Eve expression in an embryo over-expressing zfh-1 under the 
control of the hand-Gal4 driver; C Histogram showing the numbers of Eve-positive 
pericardial cells in the two controls (OR, handCGFP2.3) and the zfh-1 over-expression 
study. The error bars indicate the standard error; there is no statistically significant 
difference compared to wild-type. 
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Figure 3.6.7: Expression pattern of Odd in embryos expressing ectopic zfh-1 in the 
heart. 
Stage 16/17 embryos were labelled for the Odd protein and the number of Odd-positive 
pericardial cells was counted. 
A Wild-type embryo; B Odd expression in an embryo ectopically over-expressing zfh-1 
under the control of the hand-Gal4 driver; C Histogram showing the numbers of Odd-
positive pericardial cells in the two controls (OR, handCGFP2.3) and the zfh-1 over-
expression study. The error bars indicate the standard error and stars indicate a 
statistically significant increase compared to wild-type. 
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The likely explanation for this are the different precursors for the different subsets of 
pericardial cells. The precursors of the Eve-positive pericardial cells are the earliest 
precursors to be specified; it is thus likely that a different genetic program targets these 
precursors. 
 
Figure 3.6.8 shows the hand-GFP-positive pericardial cells during the first larval 
instar when zfh-1 is over-expressed under the control of the hand-Gal4 driver. There is 
very little difference in the expression of the hand-GFP construct between the wild-type 
animals and those that over-express zfh-1. Organisation, cell shape and size appear 
normal even when zfh-1 is over-expressed in the heart. This is surprising as the 
embryonic experiments showed an increase in Odd-positive pericardial cells. A possible 
explanation for these results is that more than the four pericardial cells per hemisegment 
in a wild-type embryo gain Odd-expression during embryogenesis. This would allow 
for an unchanged total number of pericardial cells.  
 The second instar larvae that express ectopic zfh-1 also do not show an increase 
in pericardial cells when compared to wild-type larvae (Figure 3.6.9). Counting of the 
hand-GFP-positive pericardial cells in the second instar larvae confirms there is no 
significant difference between wild-type or zfh-1 over-expressing larvae (see chart in 
Figure 3.6.9 D). 
 By the third instar, the number of pericardial cells has increased markedly (see 
Figure 3.6.10). Again it is not possible to say if these cells derive from the pericardial 
cells that are “lost” in wild-type larvae or if they are generated anew from another cell-
type. There are supernumerary cells especially in the aorta and the anterior part of the 
heart proper (see arrows in Figure 3.6.10 C) while in the wild-type third instar larvae the 
anterior pericardial cells appear to be spaced further apart. Counting of the number of 
hand-GFP-positive pericardial cells confirms this impression. There is a statistically 
significant increase in pericardial cell number of about ten cells per animal if zfh-1 is 
over-expressed (see Table 3.7.1 for an overview off all cell numbers in this section). 
This increase in pericardial cells in the third instar larva is reminiscent of the increase of 
pericardial cells I observed when over-expressing Him under the control of the same 
driver. However, the phenotypes of the zfh-12 and Him mutants that I have described in 
the embryos and in earlier larval stages differ, this shows that both genes most likely 
affect different aspects of pericardial cell development which result in very similar  
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Figure 3.6.8: Expression pattern of the hand-GFP reporter construct in first instar 
larvae over-expressing zfh-1 in the heart. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
GFP expression pattern. 
A handCGFP2.3 reporter construct, wild-type control; B GFP expression pattern in a 
first instar larvae over- expressing zfh-1 under the control of the hand-Gal4 driver.!!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6.9: Expression pattern of the hand-GFP reporter construct in second 
instar larvae expressing ectopic zfh-1 in the heart. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
hand-GFP expression pattern and the number of GFP-positive pericardial cells was 
counted. 
A handCGFP2.3 reporter construct, wild-type control; B GFP expression pattern in a 
second instar larvae over-expressing the zfh-1 under the control of the hand-Gal4 
driver; C Histogram showing the numbers of hand-GFP-positive pericardial cells in the 
two controls (handCGFP2.3, handCGFP3.1) and over-expression of zfh-1 in the second 
instar. The error bars indicate the standard error; there is no statistically significant 
difference compared to wild-type. 
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Figure 3.6.10: Expression pattern of the hand-GFP reporter construct in third 
instar larvae over-expressing zfh-1 in the heart. 
Live larvae were photographed under the microscope (Zeiss Axiovision) to visualize the 
GFP expression pattern and the number of GFP-positive pericardial cells was counted. 
A handCGFP2.3 reporter construct, wild-type control; B GFP expression pattern in a 
third instar larvae over-expressing zfh-1 under the control of the hand-Gal4 driver; D 
Histogram showing the numbers of handGFP-positive pericardial cells in the two 
controls (handCGFP2.3, handCGFP3.1) and the larvae over-expressing zfh-1 in the 
third instar. The error bars indicate the standard error and the star indicates a statistically 
significant increase compared to wild-type.!
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phenotypes by the end of larval development. This demonstrates once more how closely 
the Him and zfh-1 expression patterns and phenotypes resemble each other. 
 
 
3.7 Him and zfh-1 double null mutant 
  
The Him and zfh-1 null mutant phenotypes and expression pattern are, as 
described above, very similar to each other. This leads to the question if these two genes 
might work as part of the same process during mesoderm development. In order to 
investigate this question, I analysed the embryonic phenotype of flies doubly null-
mutant for zfh-12 and the three available Him null alleles. I chose to analyse all three 
Him null alleles as there is a slight variation between the three alleles, thus it possible 
that not all three alleles show the same phenotype when combined with the zfh-12 allele. 
The embryonic lethality of the zfh-12 null mutant is maintained in these double mutants, 
so that I could only analyse the embryonic heart. 
 Figure 3.7.1 shows the expression pattern of the ß3-tubulin-positive cardioblasts 
in embryos doubly mutant for zfh-12 and Him. All three different Him-zhf-1 double null 
mutant lines show the basic phenotype of kinks and the occasional break that has also 
been observed in the single zfh-1 null mutant. It is however noticeable that the number 
of ß3-tubulin-positive cardioblasts varies between individual hemisegments from one to 
six. I have seen a similar effect on the organisation of the ß3-tubulin-positive 
cardioblast organisation in the single zfh-12 mutants, thus this phenotype is most likely 
due to the loss of zfh-1. Depending on which Him null mutant line is used for these 
double mutations, there are slight but no statistically significant differences in the 
number of scored ß3-tubulin-positive cardioblasts. The total number of cardioblasts as 
counted on embryos stained for ß3-tubulin using DIC optics is also not statistically 
different to the number observed in wild-type embryos. This is a different phenotype to 
what I observed in the single Him null mutants which all lost ß3-tubulin-positive 
cardioblasts and also showed a reduction in the number of total cardioblasts. Clearly, 
the zfh-1 phenotype is dominant over that of the Him null mutants with regard to the ß3-
tubulin-positive cardioblasts. This would imply that, during development of at least the 
cardioblasts, the Zfh-1 protein is active in a process that is upstream of any need of 
Him. However in both zfh-1 single and zfh-1;; Him double mutants, the ß3-tubulin- 
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Figure 3.7.1: Expression pattern of ß3-tubulin in Him;; zfh-12 double null mutant 
embryos. 
Stage 16/17 embryos were labelled for the ß3-tubulin protein and the number of ß3-
tubulin-positive cardioblasts was counted. 
A Wild-type embryo; B ß3-tubulin expression in a Him 52;; zfh-12 null mutant embryo; 
C the ß3-tubulin expression pattern in a Him 74;; zfh-12 null mutant embryo; D ß3-
tubulin expression pattern in a Him 195;; zfh-12 null mutant embryo; E Histogram 
showing the numbers of ß3-tubulin-positive cardioblasts and the total number of 
cardioblasts in the controls and the three different Him;; zfh-12 double null lines. The 
error bars indicate the standard error; there is no statistically significant difference 
compared to wild-type. 
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positive cardioblasts show a disordered arrangement when compared to wild-type 
embryos. 
 The expression pattern of eve in embryos double mutant for Him and zfh-1 is 
shown in Figure 3.7.2. As can be seen these embryos have fewer Eve-positive 
pericardial cells in all available lines tested. Approximately one third of the embryos in 
each line display a severe loss of Eve-positive pericardial cells (defined as less than 10 
Eve-positive pericardial cells per whole embryo) while others appear to have a nearly 
normal distribution of Eve-positive pericardial cells, similar to what I observed in the 
single zfh-1 null mutants. Counting of the Eve-positive pericardial cells shows that each 
doubly homozygous line loses a significant amount of Eve-positive pericardial cells (see 
chart in Figure 3.7.2 E). This is also the case for all of the single null mutant lines. 
While the average scored Eve-positive pericardial cell number is generally lower in the 
Him-zfh-1 double mutants than in the single Him null mutants, the loss of Eve-
pericardial cells observed in the double mutants is not as severe as the loss of these cells 
I observed in the single zfh-12 mutants. This places the phenotype of the double mutants 
between that of the zfh-1 and Him single null mutants with regard to the Eve-positive 
pericardial cells. 
 
In the zfh-12 single mutants the Odd-positive pericardial cells were not affected 
in my analysis. In Him null mutant embryos I observe a loss of these cells. All double 
mutants also show a significant loss to the same extent as seen in the single Him null 
mutants (see chart in Figure 3.7.3 E). In all three analysed Him-zfh-1 double mutants 
there are gaps within the arrangement of the Odd-positive pericardial cells along the 
side of the cardiac tube as can be seen in Figure 3.7.3 (see arrows). This is most severe 
in the Him195;;zfh-12 double mutant (see Figure 3.7.3 D). The Odd-positive pericardial 
cells appear to be more sensitive to the loss of Him than to the loss of zfh-1 as they are 
not affected in the zfh-12 single null embryos I analysed. 
The experiments and results described above demonstrate the differences 
between the individual sub-sets of heart cells in regard to their sensitivity to the loss of 
either or both Him and zfh-1. For an overview of all cell numbers discussed in this 
section see Table 3.7.1. While the cardioblasts seem to be more sensitive to the loss of 
zfh-1 than Him, the Odd-positive pericardial cells are more sensitive to the loss of Him 
and the effect of the loss of both genes on the Eve-positive pericardial cells is not 
pushed into the direction of either gene. 
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Figure 3.7.2: Expression pattern of Eve in Him;; zfh-12 double null mutant 
embryos. 
Stage 16/17 embryos were labelled for the Eve protein and the number of Eve-positive 
pericardial cells was counted. 
A Wild-type embryo; B Eve expression in a Him 52;; zfh-12 double null mutant embryo; 
C the Eve expression pattern in a Him 74;; zfh-12 double null mutant embryo; D Eve 
expression pattern in a Him 195;; zfh-12 double null embryo; E Histogram showing the 
numbers of Eve-positive pericardial cells in the control (OR) and the Him;; zfh-12 
double null lines. The error bars indicate the standard error and stars indicate a 
statistically significant decrease compared to wild-type. 
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Figure 3.7.3: Expression pattern of Odd in Him;; zfh-12 double null mutant 
embryos. 
Stage 16/17 embryos were labelled for the Odd protein and the number of Odd-positive 
pericardial cells was counted. The arrows point towards gaps in the Odd expression 
pattern. 
A Wild-type embryo; B Odd expression in a Him 52;; zfh-12 double null mutant 
embryo; C the Odd expression pattern in a Him 74;; zfh-12 double null mutant embryo; 
D Odd expression pattern in a Him 195;; zfh-12 embryo; E Histogram showing the 
numbers of Odd-positive pericardial cells in the control (OR) and the Him;; zfh-12 null 
lines. The error bars indicate the standard error and stars indicate a statistically 
significant decrease compared to wild-type. 
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Table 3.7.1: Heart cell numbers obtained from all zfh-1 loss-of-function and gain-
of-function experiments described in this section. OPCs: Odd-positive pericardial 
cells; EPCs: Eve-positive pericardial cells, CB: total cardioblast number, !3: !3tubulin-
positive cardioblast, n/a: data not available, a grey underlay indicates a significant 
change in cell number when compared to wild type. 
pericardial cells cardioblasts larval stages  
OPCs EPCs !3 CB 2nd instar 3rd instar 
OR 47.9 27 52.2 71.8 n/a n/a 
handCGFP 2.3 48.5 27.4 n/a n/a 45.9 38.3 
handCGFP 3.1 48.1 26.5 n/a n/a 43.4 37.6 
zfh-12 46.5 6.7 49 74.4 n/a n/a 
hand-Gal4 x UAS-zfh-1 54.6 27.4 52.2 n/a 43.2 49 
Him 52;; zfh-12 39.2 17.1 48.7 72.8 n/a n/a 
Him 74;; zfh-12 44 15 51.7 76.1 n/a! n/a!
Him 195;; zfh-12 41.6 17 47.1 72.8 n/a! n/a!
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 If both genes work together in the same pathway, I would expect to see a more 
dominant phenotype of one above the other gene. If, however, both genes work through 
different pathways that target the same goal, I would expect a more severe phenotype in 
the animals doubly homozygous for both genes, ie. a more dramatic loss of Eve 
expressing heart cells as both individual mutations cause a loss of Eve-positive 
pericardial cells. The double mutants exhibit the phenotype of the zfh-12 null mutants in 
the cardioblasts. This implies that in these cells zfh-1 is necessary for Him function. As 
Zfh-1 has been described as a pericardial cell specific factor (Johnson et al., 2007) and 
both, zfh-1 and Him, are excluded from the cardioblast very soon after their 
specification, this interaction has to take place during the very early stages of mesoderm 
development. 
 
For the pericardial cells the situation is slightly different. In the Eve-positive 
pericardial cells I observe a loss. The degree of this loss is intermediate between that of 
the individual null mutants. This does not allow me to say which of the two genes is 
dominant. My results for the Odd-positive pericardial cells point towards a dominance 
of the Him phenotype over the zfh-12 phenotype as the double mutants exhibit the 
phenotype I observed in the Him null mutants, while I did not detect any changes in the 
number of Odd-positive pericardial cells in the zfh-12 null mutants. It is possible that 
depending on the identity of the individual pericardial cell, Him and zfh-1 are of 
different importance and that one phenotype might supersede the other in these 
particular pericardial cells. This would be especially interesting if it can be shown that 
the different groups of pericardial cells are fulfilling different functions during larval 
and/or adult life. However, one needs to take into consideration that the differentiation 
of any cell type is under the control of many different factors and is likely to include 
networks that contain redundancies and feed-back loops. 
 
 
3.8 Discussion 
  
 In this chapter I have analysed and proven the importance of Him expression and 
function during heart development. My results show that Him plays an important role 
during the early specification of all heart cells as the loss of Him leads to reduction in 
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the number of pericardial cells and cardioblasts (Table 3.4.1). The exclusion of Him 
expression from the cardioblasts is of equal importance for the development of these 
cells as prolonged Him expression in these cells leads to a decrease in myosin. In 
addition to this, the levels of Him expression within the pericardial cells are also crucial 
for the correct development of the pericardial cells in the embryo and larva. An increase 
in Him expression in the pericardial cells leads to pericardial cell hyperplasia that 
cannot be corrected during larval life (Table 3.4.1). The results of both the Him loss-of-
function and gain-of-function experiments also show that the loss of Him expression 
towards the end of embryogenesis is important to allow for the development of the 
correct number of larval pericardial cells. A possible explanation for all these results is 
that Him is part of a genetic program that prevents the premature and thus wrong 
differentiation of heart cells, first separating the cardioblasts from the pericardial cells 
and then, by not being expressed anymore, “allowing” the pericardial cells to undergo 
their correct development during larval life. As Johnson et al. (2007) have shown that 
an increase in pericardial cell numbers interferes with the ability of the heart to pump 
haemolymph during larval life, there is a “physiological need” for these two possible 
“check-points” during pericardial cell development to ensure the correct number of 
pericardial cells is specified. 
  I have also demonstrated that Him likely interacts with Mef2 in similar ways to 
those described in the embryonic somatic mesoderm and the development of the flight 
musculature (Liotta et al., 2007; Soler and Taylor, 2009). The expression of Mef2 
during the embryonic development of the pericardial cells leads to a severe phenotype 
in the later larval stages (Tables 3.5.1, 3.5.2 and 3.5.3). Not only is there an increase in 
the number of pericardial cells as marked by the hand-GFP reporter gene and changes in 
the shape in a proportion of these cells but the physiology of these cells is also severely 
altered from a non-contractile cell to a cell that is capable of independent and individual 
contractions. This not only shows how important Him function is to prevent any activity 
of the possible remnants of the early Mef2 expression in the pericardial precursor cells 
but it also demonstrates that Mef2 on its own is capable of inducing a myogenic fate in 
mesodermal but non-myogenic cells. 
In this chapter I have also described the cardiac expression pattern of Him in the 
developing embryo and larvae. The Him transcript becomes less and less visible from 
embryonic stage 15 onwards, until it is not detectable anymore. During larval life, I 
have been able to detect GFP expression (under the control of various Him enhancer 
!"#$%&'()((*+,(&-$'&..+/0(#01($"&0/%2$&! ! "#$!
constructs) in an area that is closely associated with the heart of second and third instar 
larvae. These cells have a different shape and appearance to the previously described 
hand-GFP positive pericardial cells and I am currently not clear of the identity of these 
cells. As far as I am aware these cells have not been described previously and might 
represent a currently unkown subset of cardiac cells. This larval expression pattern is 
only reproduced with the Him-Gal4 L4-1 driver line and not with the Him-Gal4 L3-5 
driver line that was used throughout my work. This implicates the 1 kb region directly 
upstream of the transcriptional start site in the regulation of the GFP expression in these 
unidentified cells. 
 Analysis of the single zfh-12 null mutant and Him-zfh-1 double mutants has 
emphasised the different identities of the sub-sets of heart cells as different groups, 
identified by different marker expression (Odd, Eve, Tin, Lbe); they show varying 
responses to the individual or combined loss of Him and/or zfh-1 (Table 3.7.1). Both 
zfh-1 and Him are, despite only being expressed in the very early precursors of the 
cardioblasts, of importance for the development of the cardioblasts as the loss of Him 
leads to a loss in cardioblasts. However, in zfh-12-Him double null mutants this loss is 
“rescued”, demonstrating that without zfh-1, Him has little to no influence on the 
cardioblasts. Together with the results I have described for the Him null mutant larvae 
this demonstrates that not only the presence but also the absence and more so the exact 
points when expression of a gene starts and stops are of importance and immediately 
connected with its function. 
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Chapter 4 
The Pericardial Cell enhancer 
 
4.1 Introduction 
 
Knowledge of the specific expression pattern of a gene is a very useful tool when 
analysing its regulation. As shown in Chapter 3, Him is necessary for the correct 
development of all heart precursors and especially for the pericardial cells and its 
exclusion from the cardioblasts is equally important to allow for their specification. 
Both pericardial cells and cardioblasts are closely related and in the case of the Seven-
up-positive cardioblasts and two of the Odd-positive pericardial cells they share an 
immediate progenitor (see Chapter 1). Thus the regulation of Him is interesting and will 
further the understanding of which regulatory mechanisms differentiate the cardioblasts 
and pericardial cells. 
The Drosophila Genome Project (BDGP) and its associated bioinformatic tools 
facilitate the search for potential regulators further. The comparison of equivalent 
sequences from different Drosophilae, called phylogenetic footprinting, enables 
identification of regions that are conserved across those species. This conservation in 
turn indicates that the sequence potentially has some form of functional constraint 
applied towards it. One of the likeliest functional constrains put on non-coding 
sequences is transcriptional regulation. Regions identified in such an analysis are thus 
likely to contain transcription factor binding sites. 
The availability of online transcription factor databases and the research done in 
this area by others allows for a more targeted approach in finding which putative 
transcription factor binding sites are contained within the conserved regions. In this 
chapter, I describe the identification of an enhancer fragment capable of recapitulating 
the Him expression pattern in vivo in the heart. I will then describe the bioinformatic 
analysis performed on this sequence and the conserved regions and putative 
transcription factor binding sites identified. 
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4.2 Him enhancer regions 
 
The gene Him is located on the X-Chromosome between the genes Her and CG33639. 
The upstream region between Her and Him is 4311bp long and the downstream region 
between Him and CG33639 is 2333bp long (Tweedie et al., 2009; www.flybase.org). 
Taking advantage of two restriction sites (EcoRI and XhoI) in the upstream sequence of 
this gene, a fragment spanning from -3734 to -930 was further investigated (S. 
McConnell & M. Taylor, unpublished results). This so called p43 (Eco/Xho) reporter 
contains this part of the upstream region and drives expression in the Him pattern. A 
similar section of the upstream region between Her and Him has also been shown to 
contain regulatory elements that recapitulate Him expression in the third instar wing 
disc (Rebeiz, M. et al., 2002). 
The ~2.8 kb of the p43 (Eco/Xho) fragment were broken down into sub-
constructs, called Set 1 through Set 4 (see Figure 4.2.1; S. McConnell & M. Taylor, 
unpublished results). All constructs overlap each other at the end by approximately 70 
to 80 bp to ensure that binding sites at the start and end of each construct are not 
destroyed by dividing up the ~2.8 kb fragment. The construct Set 4 is further sub-
divided into the Set 2 and Set 3 constructs. 
All sub-constructs were cloned in front of a minimal promotor and a ß-
Galactosidase reporter. The expression pattern of the ß-Galactosidase reporter was 
analysed for all four constructs (Figure 4.2.2). In embryos carrying the Set 1 enhancer 
construct no reporter expression was observed. The other three enhancer constructs 
show ß-Galactosidase reporter expression. 
The ß-Galactosidase expression pattern of Set 4 enhancer is expressed in all the 
pericardial cells (S. McConnell & M. Taylor, unpublished data) and thus recapitulates 
the expression of the Him transcript (Figure 4.2.2 D). Analysis of the Set 2 enhancer 
expression in the heart showed that it is not expressed in the Eve-positive pericardial 
cells (Figure 4.2.2 B; S. McConnell & M. Taylor, unpublished data). As the Set 4 
enhancer, the Set 3 enhancer is expressed in all pericardial cells (Figure 4.2.2 C; S. 
McConnell & M. Taylor, unpublished data). 
The Set3 enhancer is the smallest of these fragments (574 bp) that is capable of 
driving reporter expression in the same pattern in the developing Drosophila dorsal 
vessel as the Him transcript. This fragment is also the closest to the transcriptional start  
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Figure 4.2.1: Overview of reporter constructs available at the beginning of my 
study. 
Schematic representation of the Him upstream region. The sequence between the EcoRI 
and XhoI restriction enzyme sites was subdivided into four reporter constructs: Set 1 
(blue), Set 2 (yellow), Set 3 (red, =PCE) and Set 4 (orange). The schematic is drawn to 
the scale of approximately 750 bp per 1 cm. 
 
 
 
 
 
 
Figure 4.2.2: Overview of the expression pattern of the reporter constructs 
available at the beginning of my study. 
Visualization of the ß-Galactosidase reporter. 
A The Set 1 enhancer does not drive reporter gene expression in the heart. B The Set 2 
enhancer drives reporter gene expression in the majority of the pericardial cells of the 
heart but not in the Eve-positive pericardial cells (see arrow heads and compare with C). 
C The PCE (also called Set3) enhancer drives reporter gene expression in all pericardial 
cells. The Eve-positive pericardial cells are indicated by arrow heads. D The Set 4 
enhancer drives reporter gene expression in all pericardial cells. 
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site of the Him gene with a distance of approximately 930 bp. Because of this, I 
focussed my analysis of regulatory regions for Him on the Set 3 enhancer fragment and 
renamed it Pericardial Cell Enhancer, PCE. 
 
 
4.3 The Pericardial Cell Enhancer (PCE) is expressed in all pericardial 
cells. 
 
In order to establish that the Pericardial Cell Enhancer is expressed in the same 
heart cells as the Him transcript, I co-labelled embryos transgenic for PCE (line 6) with 
an RNA probe for Him and a ß-Galactosidase antibody (Figure 4.3.1). For the same 
experiment with a different transgenic PCE line (34) refer to the Appendix. The initial 
expression pattern of the PCE construct was tested in three different lines (6, 34 and 41; 
see Appendix) which all have the same PCE expression pattern in the pericardial cells. 
The PCE construct recapitulates the expression pattern of the Him transcript. In 
late stage 12 embryos all heart cells expressing Him also express the PCE (Figure 4.3.1 
A-F). The same is true for stage 13 Drosophila embryos (Figure 4.3.1 G-L). From stage 
15 onwards, there is a discrepancy between the PCE and wild type Him expression 
(Figure 4.3.1 M-O). While Him expression decreases and eventually ceases completely 
by stage 17, the PCE reporter is still strongly visible at this stage (not shown). 
This discrepancy is presumed to be due to the higher stability of the ß-
Galactosidase protein than that of the Him RNA. The expression pattern of the ß-
Galactosidase RNA resembles that of the Him RNA expression more closely than the ß-
Galactosidase protein in these late embryonic stages. As the comparison of the ß-
Galactosidase RNA versus its protein in Figure 4.3.2 shows, the protein outlasts the 
RNA considerably (compare 4.3.2 J and K).   
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Figure 4.3.1: Him and the PCE reporter are expressed in the same heart cells. 
Him fluorescent RNA in situ and anti-!Galactosidase immuno-stain on embryos 
transgenic for the PCE construct (line 6; for images of line 34 see Appendix). Images A 
- F show a lateral view of a late stage 12 embryo; Images G - L show a dorsal view of a 
stage 13 embryo and Images M - O show a dorsal view of a stage 15 embryo. 
A, D, G, J, M fluorescent Him RNA in situ (red); B, E, H, K, N anti-!Galactosidase 
antibody (green); C, F, I, L, O overlay. 
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Figure 4.3.2: The !Galactosidase RNA is less stable than its protein. 
!Galactosidase fluorescent RNA in situ (red) and immuno-stain for its protein (green).  
Images A, B, C show a lateral view of a late stage 12 embryo; Images D, E and F show 
a lateral view of a stage 13 embryo; G, H and I show the same embryo as in D, E and 
respectively at a higher magnification; J, K, L show a dorsal view of a stage 16/17 
embryo. 
A, D, G, J fluorescent !Galactosidase RNA in situ (red); B, E, H, K anti-
!Galactosidase antibody (green); C, F, I, L overlay. 
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4.4 The phylogenetic footprint of the PCE sequence reveals three 
conserved areas. 
 
The community of Drosophila researchers has published and annotated the 
sequence of D. melanogaster and D. pseudoobscura (Adams et al., 2000, Celniker et al., 
2002, Richards et al., 2005) and 10 further species (D. sechellia, D. simulans, D.  
yakuba, D. erecta, D. ananassae, D. persimilis, D. willistoni, D. mojavensis, D. 
virilis and D. grimshawi; Drosophila 12 Genomes Consortium, 2007).  These data have 
made detailed comparisons of the different sequences for corresponding regions 
possible. The interpretation of these so-called “Phylogenetic Footprints” (reviewed by 
Dickmeis and Müller, 2004) is based on the theory that a functional sequence has more 
evolutionary pressure to remain the same as a non-functional sequence, thus functional 
sequences should remain more similar across species than non-functional sequences. 
At the time of my analysis the assembly of the ten additional Drosophila species 
was not yet complete and published. Because of this I used the D. melanogaster PCE 
sequence and the BLAST (discontiguous Basic Local Alignment Search Tool) to search 
the NCBI trace archive (http://www.ncbi.nlm.nih.gov/Traces/trace.cgi?) for the raw 
sequence project sequences. I edited the retrieved sequences and analysed them using 
various alignment tools. I retrieved sequence data for ten of the Drosophila species with 
the sequence of D. melanogaster (D. sechellia sequences were unavailable at the time, 
for the different species see figure 1.3.1). 
Even though the Drosophilae genomes were not yet assembled at the time of 
this analysis, a later check of the assembled data supports these results (Figure 4.4.1). 
Using the Vista Browser 2.0 (Dubchak et al., 2009), I retrieved the intergenic region 
between the Him and Her genes. However, even this much later data only contains 
alignment data for 5 Drosophila species (D. simulans, D. yakuba, D. erecta, D. 
ananassae and D. pseudoobscura). As can be seen in Figure 4.4.1 A and B the PCE 
region is one of two instances where conservation is evident in all six Drosophila 
species used in this alignment. If the conservation diagram generated by the Vista 
Browser is compared to the alignment I generated (Figure 4.4.2), it is obvious that using 
more species and retrieving the corresponding sequences manually produces an 
alignment with higher resolution. While the area I identified is conserved between D. 
melanogaster, D. yakuba and D. erecta, its conservation in the other three species (D.  
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Figure 4.4.1: Conservation of the upstream region of Him as generated by the 
Vista Browser 2.0. 
Multiple species alignment, based on the assembled sequences of the 12 Drosophila 
Genome Consortium (2007), generated by the whole-genome alignment browser Vista 
2.0 (Dubchak et al., 2009; http://pipeline.lbl.gov/cgi-gin/gateway2?bg=droMel_caf1& 
selector=visatpoint) 
A Vista plot of the complete intergenic region between the Him and Her genes. B Vista 
plot for the Set 3 sequence. Arrows indicate the approximate position of this fragment 
within the upstream sequence of Him and the boxes show the approximate positions of 
the three conserved regions as identified in Figure 4.4.1 A. C Legend for the annotation 
of the Vista Browser 2.0. 
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Figure 4.4.2: Phylogenetic Footprint of the PCE sequence across 11 Drosophila 
species.  
MultiPipmaker alignment of the D. melanogaster PCE sequences with the putative PCE 
sequences I identified in the ten additional Drosophila species. The conserved regions 
are shaded: region 1 in purple, region 2 in orange and region 3 in yellow. The pink and 
red shaded sequences are putative Tinman binding sites. 
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simulans, D. ananassae, D. pseudoobscura) is less high (see boxes in Figure 4.4.1). 
Based on the results of the Vista Browser alone, I would not have identified the second 
and third conserved region. This illustrates that, despite the availability of such 
alignment tools as the Vista Browser, it is still helpful to manually generate multi-
species alignments for specific region to achieve more detailed results. 
In addition to the multiple alignments, I also generated pairwise alignments 
between D. melanogaster and each of the other ten Drosophila species to further rule  
out any algorithm specific artifacts. For these pairwise alignments, I again used both 
local and global alignment algorithms (ClustalW, VISTA (Dubchak et al., 2000; Mayor 
et al., 2000; Bray et al., 2003; http://pipeline.lbl.gov/cgi-bin/gateway2) and lalign 
(Huang, X. and Miller, M., 1991; http://www.ch.embnet.org/software/LALIGN_form. 
html). Each of these alignments also highlighted the same conserved regions. 
The alignments identified three conserved regions within the PCE sequence, 
region 1 (purple underlay in Figure 4.4.2), region 2 (orange underlay in Figure 4.4.2) 
and region 3 (yellow underlay in Figure 4.4.2). Region 1 has a total length of 71 bp, 
region 2 of 40 bp and region 3 of 35 bp. Because of the high conservation level of these 
regions, I concentrated on these three conserved regions in my next step. 
 
 
4.5 In silico search for transcriptions factor binding sites 
 
To facilitate the search for transcription factor binding sites, I again made use of 
the information gathered in online databases. In order to find possible regulating factors 
for the transcription of Him, I analysed the PCE sequence of Him to find possible 
binding sites of known transcription factors. The PCE sequence was screened with the 
vertebrate and insect transcription factor binding sites derived from the TRANSFAC 
database (Wingende et al., 2001) and for binding sites of proteins found by a literature 
search for Drosophila mesodermal transcription factors (S. Elgar & M. Taylor, 
unpublished data, see Appendix). 
With the help of the MatInspector program (Quandt et al., 1995; Cartharius et al., 
2005), the D. melanogaster PCE sequence (which contains the conserved regions 1 to 3) 
was screened for possible binding sites. MatInspector uses the binding sites contained in 
the TRANSFAC database in its search process. The TRANSFAC database is mainly 
comprised of vertebrate transcription factor sites; however, due to the known 
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conservation of the properties of transcription factors between species, it is possible to 
identify potential transcription factor binding sites by this method. Since this database 
contains mainly vertebrate transcription factors and only very few Drosophila 
transcription factor binding sites, candidate Drosophila transcription factor binding sites 
were compiled into a list through a manual literature search (S. Elgar & M. Taylor, 
unpublished data). Candidate Drosophila transcription factors were chosen according to 
their spatial and temporal expression pattern during the development of the embryo. 
Binding sites were only included within this list if there was experimental evidence for 
their activity in the developing mesoderm. A sequence file was created for these sites 
and the PCE sequence was screened using the DS Gene Software suite (see appendix 
for the list of used binding consenses). 
Figure 4.5.1 shows the three conserved regions of the PCE sequence and the 
binding sites for potential transcription factor binding sites identified in this analysis. 
For the conserved region 1 the analysis yielded the following candidate transcription 
factor binding sites: Tinman (pink underlay), Medea (grey box), vertebrate Oct-1 (blue 
box) and Bagpipe (green box). 
The Drosophila homolog of the vertebrate Oct-1 is nubbin. Both (Oct-1 and 
Drosophila nubbin) are involved in cell fate determination (Neuman and Cohen, 1998; 
Irvine, 1999). Drosophila nubbin is mainly expressed in the ectoderm and plays an 
important role during neurogenesis and neurospecification. So far very little is known 
about its binding preferences. According to the only published DNA footprinting 
analysis it appears to have a fairly degenerate consensus (Neumann and Cohen, 1998). 
In their assay, they found that Nubbin protects four different sequences. The consensus 
sequence used by the TRANSFAC position weight matrix for the vertebrate Oct-1 
(NNNNTGCAAATNAN; matrix identifier V$OCT1_Q6) approximately matches one 
of the four sequences protected by Nubbin (TTATGtAAgTAACC) identified by 
Neumann and Cohen (1998). However, two bases at position 8 and 11 (lower cases in 
the protected sequence) of the vertebrate Oct-1 consensus sequence are not identical to 
the sequence protected by Nubbin. It needs to be noted that the two mismatched bases 
are within the core binding area for Oct-1 as stated by Neuman and Cohen (1998). Thus, 
it is possible that these mismatches interfere with Oct-1 and/or Nubbin binding and that 
this site is not a functional binding site. 
 The conserved region 2 contains many of the same putative binding sites found 
in region 1 (see Figure 4.5.1). As in region 1, there is a Tinman binding site in  
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Figure 4.5.1: Identified transcription factor binding sites in the conserved regions 
of the PCE. 
The sequence of the conserved regions was screened for potential binding sites using 
MatInspector/ TRANSFAC database and a list manually compiled from literature. A 
Results for region 1. The potential Tinman binding site has a pink underlay, other 
identified putative binding sites are boxed: grey for Medea, blue for Oct-1 and green for 
Bagpipe. B shows the results for region 2. The potential Tinman binding site has a red 
underlay and all the other found putative binding sites are boxed: black for E-boxes, 
green for Bagpipe, dark grey for AP-1, light grey for Medea and blue for Oct-1. C 
shows the results for region 3. All potential binding sites are boxed: light blue for 
Dorsal, orange for Brinker, green for Mef2 and pink for Zfh-1. 
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combination with a potential Bagpipe binding site and a vertebrate Oct-1 site in close 
proximity upstream. Towards the 3’ end of region 2 there are two Medea sites. Medea is 
a Smad4 protein that directly activates Tinman in response to Dpp signalling and is thus 
a potential regulator for Him (Chen and Fishmann, 2000; Cripps and Olson, 2002). 
Overlapping this putative site is a vertebrate AP-1 site. AP-1 is a family of 
transcription factors that contain a basic region leucine zipper (bZip) and include the 
Jun, Fos and ATF subfamilies. A Drosophila equivalent of AP-1 family is kayak, which 
is involved in dorsal closure (Noselli and Agnes, 1999; Harden, 2002). However, Kayak  
is a single gene product and contrary to the gene products of the vertebrate AP-1 family, 
it does not need to dimerize to function. 
 The conserved region 3 contains potential Dorsal, Brinker, Mef-2 and Zfh-1 
binding sites in the D. melanogaster sequence (see Figure 4.5.1 C). Yet all these 
candidate sites for transcription factor binding are either a weak match for the consensus 
sequences or are poorly conserved between the different Drosophila species. The 
potential Zfh-1 binding site is not conserved in D. simulans; the Drosophila species 
evolutionary closest to D. melanogaster. Furthermore, the last position of the possible 
Zfh-1 binding site is also not conserved in D. pseudoobscura. The Dorsal site is not 
conserved in D. erecta as two of the basepairs are different in this species. At the time 
of analysis there were no D. mojavensis sequence data available for this region. 
 
 
4.6 Discussion 
 
As shown in Figure 4.2.1, the PCE is the smallest enhancer fragment I have 
identified that is capable of driving expression of the ß-Galactosidase reporter in the 
endogenous Him expression pattern. This adds a good tool for the study of pericardial 
cells, as the PCE construct unambiguously identifies all pericardial cells of the 
Drosophila embryo. There is no similar line available for zfh-1, the only other known 
gene expressed in all pericardial cells during embryogenesis. 
However, the PCE expression in late embryos (stage 15 onwards) does not 
resemble the expression pattern of the Him transcript. This is due to the higher stability 
of the ß-Galactosidase protein than the Him RNA. The comparison of the ß-
Galactosidase protein and its RNA transcript illustrates this. If one compares the 
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expression of both RNAs, Him and ß-Galactosidase, it is obvious that the ß-
Galactosidase RNA expression starts to decrease at a similar stage of the embryo as the 
Him RNA. Hendren et al. (2007) describe a similar effect: “We reasoned that the stable 
ß-Galactosidase protein perdured in the Svp cells at later stages of development. This 
was confirmed by analysis of lacZ expression by in situ hybridisation in stage 15 
transgenic embryos.” 
Of the other possible enhancer regions tested for heart expression, Set 2 and Set 4 
also showed ß-Galactosidase expression (Figure 4.2.2). As Set 2 and PCE (= Set 3) 
together make up Set 4 and each is capable of driving Him-like reporter expression in 
the Drosophila heart, it is likely that Set 2 and Set 3 resemble two different enhancers. 
A search for potential binding sites in Set 2 identified one putative Tinman binding site. 
The enhancer contained within Set 2 might also be a so-called “shadow enhancer” that 
provides a “safety-net” to ensure the appropriate expression pattern of developmentally 
important genes in the case of disturbance or disruption of the “main” enhancer (Perry 
et al., 2010). An alignment of the D. melanogaster Set 2 and PCE (= Set 3) sequence 
might possibly delineate any elements contained in both elements and that are essential 
for Him expression in the pericardial cells and should be considered for the future 
analysis of the complete Him regulation. It is possible that similar structures will 
facilitate the identification of regulatory elements needed for expression in all 
pericardial cells. 
The phylogenetic footprinting performed on the PCE sequence revealed three 
regions of interest. The high levels of conservation across the eleven Drosophila species 
for these areas indicate a functional constraint that allowed these sequences to remain 
relatively unchanged during evolution. This functional constraint imposed upon this 
region is likely to be, at least in part, the transcriptional regulation of Him (The Flybase 
Consortium, 2003). 
One needs to keep in mind that the phylogenetic footprints used for my analysis 
are, except for D. melanogaster and D. pseudoobscura, based on single “traces”, i.e. 
single sequence reads of the sequencing projects and not the assembled genome. Thus, 
based on the trace data alone, it is not possible to say with absolute certainty if the 
region analysed in this study is placed directly upstream of the gene homologous to Him 
in the different Drosophila species. However, because of the similar results I obtained 
using the Vista Browser (see Figure 4.4.1) and the high level of conservation in the 
analysed PCE region of Him between all eleven Drosophila species, it is very unlikely 
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that the sequences I used to generate these alignments are not located in the upstream 
region of the Him homologs. 
In most cases, the BLAST search of the NCBI trace archive yielded several traces 
for each species. As inaccurate sequence data is often generated in the beginning or 
towards the end of a sequence read, all traces retrieved for one species were aligned 
with each other. The resulting consensus sequence for each species used for the 
phylogenetic footprints is the result of these alignments (see chapter 2). Since there 
were very few discrepancies between the aligned single traces, I am confident that the 
used sequence data are correct. 
The phylogenetic footprint identified three regions with a high degree of 
conservation. Studies have shown that approximately 22 to 26 % of the non-coding 
sequence between D. melanogaster and D. virilis are conserved and the average length 
of a stretch of conserved sequence is about 19 bp (Bergman and Kreitman, 2001). The 
conserved region 1 of the PCE sequence has a length of 72 bp, region 2 has a length of 
42 bp and region 3 is 32 bp long. In their paper Bergman and Kreitman state that the 
majority of conserved non-coding sequences (intragenic and intronic) in Drosophila 
have a length ranging from 8 to 75 bp, with the distribution heavily tilted towards the 
shorter lengths. Thus, all three conserved areas of the PCE are within this range; the 
region 1 is however at the “longer” end of the range. The occurrence of conserved non-
coding sequences of this length is fairly improbable, which makes this region and also 
the conserved region 2 highly interesting to me as their extra-ordinary length of 
conserved sequences might be due to the importance of these regions for the regulation 
of Him.  
I based the computational search for possible transcription factors in the D. 
melanogaster sequence on the phylogenetic alignment of the PCE sequence and 
focussed especially on the three conserved regions. The sequence of the PCE element 
was searched for potential transcription factor binding sites with a manually generated 
set of binding sites (S. Elgar & M. Taylor, unpublished data, see appendix) and with the 
help of the Match program available from the TRANSFAC database (http://www.gene-
regulation.com/pub/programs.html#match). 
The search using the TRANSFAC database is only of use for Drosophila 
transcription factors that have similar specificities as their vertebrate orthologs, since 
the database contains mainly transcription factors for vertebrates and only very little 
data on Drosophila or other insect transcription factors. However, it has been shown for 
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Mef-2 for example, that the Drosophila and the mouse protein have identical 
specificities (Molkentin et al., 1996a; Brand, 1997). As there are many similarities in 
heart development between vertebrates and Drosophila on both molecular, 
morphological and physiological levels (Zaffran and Frasch, 2002 Medioni et al., 2009; 
Cammarato et al., 2011; Qian and Bodmer, 2012), it is possible that factors, especially if 
they are already known to be involved in heart or mesoderm development, are available 
in the vertebrate data but have yet to be characterised during Drosophila heart 
development. This makes the TRANSFAC database a useful resource for my study. 
The transcription factors included in the manually generated list were chosen 
according to their expression pattern and, if known, their implication in heart 
development in Drosophila. In each of the two approaches, transcription factors were 
only included if there was experimental evidence for their binding characteristics. 
To reduce the possibility of identifying too many false positive putative binding 
sites, stringency criteria were assigned to the consensus sequences used for the search. 
The threshold was defined at a detection rate of more than one site per 50 bp for all 
binding sites; sites that occurred more often were considered to be of too low stringency 
and were not used in the analysis. Exceptions to this are the sites taken from the papers 
of Knirr et al. (2001), Halfon et al. (2000) and Halfon et al. (2002). The binding sites 
described within these reports were included in the search file for putative binding sites 
as described by the authors, since their functionality and importance in Drosophila heart 
development has been proven and it is unlikely that many, if any, of the detected sites 
are false positive binding sites. 
Potential Tinman binding sites were identified in the conserved region 1 and 2 by 
both search methods. Tinman is a homeobox protein that is necessary for heart 
development (Azpiazu and Frasch, 1993; Bodmer, 1993). Tinman is expressed in a sub-
set of cardioblasts as well as in a sub-set of pericardial cells (Bodmer, 1993). The 
Tinman protein is a good candidate regulator for Him transcription. In their paper 
Hendren et al. (2007) find that “most of the cardiac enhancers for these Tinman target 
genes contain at least two Tinman binding sites within 300 bp of each other, which are 
critical to normal cardiac function”. The putative Tinman binding sites found in the 
conserved regions of the PCE are 224 bp apart and thus well within the criteria 
mentioned in this paper. This supports the possibility of Tinman as a regulator of Him. 
Although Tinman is a very likely candidate regulator for the transcriptional 
regulation of Him, it cannot be the only factor involved in this process, since Tinman is 
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expressed in both pericardial cells and cardioblasts. Him, however, is only expressed in 
the pericardial cells of the heart. Furthermore, Tinman is only expressed in a sub-set of 
pericardial cells, while Him is expressed in all pericardial cells. Thus, it is necessary to 
search for further potential regulators of the PCE element. 
Other putative transcription factor binding sites discovered in the conserved 
regions include two Oct-1, two Bagpipe, one AP-1 site, several E-Boxes and several 
Medea sites. The conserved regions 1 and 2 both contain an Oct-1 site. Even though 
both identified sites do not match the published consensus sequence perfectly, the sites 
are still possible within the position weight matrix used to search the PCE sequence and 
the un-conserved nucleotides in each possible site (in D. pseudoobscura, D. virilis and 
D. ananassae) would only weaken the binding according to the Selex data contained in 
the TRANSFAC matrix (V$OCT1-Q6) used to identify this sequence. 
The sequence of the Bagpipe binding site (Zaffran et al., 2002) is in a large part 
identical to the sequence of the Tinman binding site (cgCACTTAG vs. CACTTGA for 
Tinman), which increases the likelihood of finding a Bagpipe site superimposed on a 
Tinman site considerably. Bagpipe has been shown to promote the differentiation of the 
visceral mesoderm (Azpiazu and Frasch, 1993; Furlong et al., 2001; Jagla et al., 2001; 
Cripps and Olsen, 2002), which, like the heart, also derives from the dorsal mesoderm. 
Because of its distinctive role in the development of the visceral mesoderm and the 
absence of Him expression in the visceral mesoderm at any developmental stage of the 
Drosophila embryo, it is unlikely that Bagpipe is a transcriptional activator of Him 
expression. It is however possible that Bagpipe is involved in Him repression in the 
developing visceral mesoderm and that if Bagpipe is present, it binds to the combined 
Tinman/Bagpipe site and thus precludes Tinman binding and activation of Him. 
E-boxes are the binding sites for transcription factors with a bHLH (basic helix-
loop-helix) motif. The bHLH transcription factors are found throughout the eukaryotic 
kingdom and are involved in the development of many tissues (Atchley and Fitch, 1997; 
Ledent and Vervoot, 2001; Zinzen et al., 2009; Ozdemir et al., 2011). So far, most of 
the described bHLH transcription factors have been shown to play important roles in the 
differentiation and specification of cells and tissues (Molkentin and Olson, 1996a; 
Molkentin and Olson, 1996b). The recognised core sequence of bHLH factors is 
CANNTG (Ferré-D’Amaré et al., 1993; Ellenberger et al., 1994; Ma et al., 1994). The 
two nucleotides in the middle of this sequence are necessary for the specificity of the 
binding and vary according to the bHLH factor. 
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The bHLH transcription factors known to be involved in Drosophila mesoderm 
development include Twist (Bate et al., 1999; Furlong et al., 2001; Cripps and Olson, 
2002; Ozdemir et al., 2011), Nautilus (Keller et al., 1997) and Hand (Kölsch and 
Paululat, 2002). Thus, the detection of E-boxes within the enhancer fragment of Him 
might be expected. 
The identified AP-1 site is based on the data available for the vertebrate 
transcription factor AP-1 (activator protein 1). The vertebrate AP-1 protein consists of 
dimers of the Jun/Fos protein (Jonat et al., 1990; Ameyar et al., 2003). A Drosophila 
equivalent of AP-1 is the gene kayak. The kayak gene is expressed in the ectoderm and 
is involved in the dorsal closure of the embryo (Noselli and Agnes, 1999). The process 
of dorsal closure and the formation of the heart tube along the midline of the embryo are 
closely connected. Thus, there is a possibility for Kayak to be involved in the formation 
of the heart through signalling cues from the ectoderm to the mesoderm. 
The transcription factor Medea is part of the transforming growth factor beta 
(TGFß) receptor-signalling pathway in the nucleus (Wisotzkey et al., 1998; Lall and 
Patel, 2001). Among others, it has also been shown to interact genetically with Dpp and 
Mad (Mothers against dpp). Mad and Medea are both part of the Smad family of 
transcription factors. Some functions of the Medea protein are in the dorsal-ventral axis 
specification and in the development of the Drosophila heart (Chen and Fishmann, 
2000; Cripps and Olson, 2002). Knirr and Frasch, 2001 show that Dpp is capable of 
activating the even-skipped enhancer through activating the phosphorylated form of 
Mad (pMad), this is also necessary to maintain eve transcription in vivo. However, 
because of the short published Medea binding sequence of 4 nucleotides (GTCT, 
described in Knirr and Frasch, 2001), this site is found approximately every 256 bp. 
This high probability of finding this sequence within any other sequence makes it very 
hard to distinguish between potential genuine Medea sites and the average occurrence 
of this sequence. The degree of conservation of a potential site between the species 
might be able to help discriminate genuine from “false-positive” Medea sites. Because 
of its implication in Drosophila heart development and its location within the highly 
conserved regions of the PCE element, Medea remains an interesting potential regulator 
of Him transcription. 
Within the conserved region 3 of the PCE, the discovered binding sites were less 
well conserved. This is most likely due to the fact that the degree of conservation of this 
region is generally lower than that of the other two conserved regions. Furthermore, 
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there is less sequence data available for this region. The Dorsal binding site is fairly 
well conserved in all Drosophila species, there are only two nucleotide differences in D. 
erecta. The Dorsal protein is important for the establishment of the dorsoventral axis of 
the developing embryo (Simpson, 1983; Lall and Patel, 2001). Around stage 7 and later 
Dorsal is expressed in the mesoderm and it is thus possible that it plays a role in the 
early development of the presumptive heart mesoderm (Rushlow et al., 1989; Roth et 
al., 1989). 
Brinker is a transcriptional repressor (Lall and Patel, 2001), involved in the Dpp 
pathway (Affolter et al., 2001) and expressed in the mesoderm. This potential binding 
site is not conserved in D. pseudoobscura. It is not possible to say anything about the 
conservation of this site in D. ananassae, D. persimilis, D. willistoni, D. mojavensis or 
D. grimshawi, since at the time of analysis it was not yet possible to retrieve sequence 
data for this part of the PCE fragment. 
The potential Mef2 binding site found in the third conserved region of the PCE 
matches the used consensus site only poorly. Again it is not possible to say anything 
about its conservation in D. ananassae, D. persimilis, D. willistoni, D. mojavensis or D. 
grimshawi as the sequence data was lacking at the time of the analysis. Mef2 is an 
important transcription factor involved in mesoderm development and is expressed in 
all cardioblasts of the heart and might be expressed early in the precursors of the 
pericardial cell lineage (Bour et al., 1995; Taylor et al., 1995; Bate et al., 1999; Furlong 
et al., 2001). As Him is only expressed in the pericardial cells of the heart, Mef2 is only 
a candidate for very early transcriptional regulation, if at all. 
The fourth potential binding site found in region 3 of the PCE element is a Zfh-1 
binding site. Zfh-1 is a transcription factor that is expressed in the majority of the 
pericardial cells of the Drosophila heart; its early expression pattern includes all 
pericardial cells (Lai et al., 1991; Su et al., 1999); and it has an expression pattern very 
similar to that of Him. Thus it would be a promising candidate to regulate Him 
transcription. But the consensus for this site has a length of only 4 nucleotides and 
because of this it is hard to distinguish between genuine sites and the average 
occurrence of this site within any sequence as already described for the Medea sites. 
Additionally, this short sequence is not conserved in D. simulans and D. pseudoobscura 
(no sequence data is available for D. ananassae, D. persimilis, D. willistoni, D. 
mojavensis or D. grimshawi). As D. simulans is closely related to D. melanogaster, this 
deviation from the D. melanogaster sequence decreases the likelihood that this Zfh-1 
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site is of functional importance for the regulation of Him. Postigo et al. (1999) show that 
Zfh-1 also binds to E-boxes of the CACCTG sequence; there is not a potential binding 
site with this sequence in the whole of the PCE sequence either.  
The bioinformatic analysis of the PCE sequence described above has generated 
several interesting starting points for the functional analysis of it. The high degree of 
conservation of several of the identified possible transcription factor binding sites 
highlights these sites and factors as potential regulators. Furthermore, the discovery of 
the conserved regions within the PCE might lead to the discovery of so far unidentified 
transcription factor binding sites. In the following two chapters I will describe the 
deletion and mutational analysis I conducted to relate the results described in this 
chapter to their possible function in vivo. In their recent papers, both Halfon et al. 
(2011) and Biggin (2011) stress the importance to “rigorously assess” any data 
generated by computational analyses. 
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Chapter 5 
Tinman regulates Him expression 
 
5.1 Introduction 
  
As described in the previous chapter the transcription factor Tinman is 
implicated as a possible regulatory factor for Him. tinman null mutants do not develop a 
heart (Azpiazu and Frasch, 1993; Bodmer, 1993). Its vertebrate ortholog Nkx2.5 has 
been implicated in vertebrate heart development and, furthermore, in congenital heart 
disease (Schott et al., 1998; Prall et al., 2002). Tinman is the earliest known marker for 
heart development in Drosophila (Bodmer, 1993). Known Tinman targets include ß3-
tubulin, hand, seven-up, pannier, Mef-2, midline, Dsur and Toll (Akasaka et al., 2006; 
Gajewski et al., 1997; Gajewski et al., 2001; Han and Olson, 2005; Kremser et al., 
1999; Ryan et al., 2007; Ryu et al., 2011; Wang et al., 2005). So far, no Tinman target 
that is exclusively expressed in pericardial cells of the heart has been identified. 
The bioinformatic analysis described in the previous chapter points out several 
potential Tinman binding sites in two different conserved regions of the PCE. In 
addition to these results, several separate ChIP studies have found that Tinman binds to 
a region upstream of the Him gene (Liu et al., 2009; Junion et al., 2012; Jin et al., 2013). 
These results strongly indicate Tinman as a regulator of Him transcription; however, as 
pointed out in Biggin (2011) and Halfon et al. (2011), it is still necessary to prove the 
functional importance of Tinman for Him regulation and identify the actual relevant 
binding sites. 
In the conserved region 1 there are two overlapping putative Tinman binding 
sites, one on the plus and one on the minus strand. There is one substitution (G to T) in 
the second last position in both sites. The potential Tinman binding on the minus strand 
is not the ideal consensus (CACTTGA), the G in the second last position is exchanged 
for a C. However, this sequence (CACTTCA) has been shown to be functional and is 
considered as a potential Tinman binding site (Gajewski et al., 2001). Another putative 
Tinman binding site is located within the conserved region 2 of the PCE. This is a 
single site on the plus strand, which is completely conserved between all eleven 
Drosophila species used for the phylogenetic footprint in chapter four. The occurrence 
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of two or more functional Tinman binding sites in close proximity (ca. 300 bp) is a 
prominent feature in most known Tinman targets (Hendren et al., 2007). 
 
 
5.2 Him expression in tinman null mutants 
 
 In wild-type stage 10 and 11 embryos Him is expressed in the dorsal mesoderm, 
including the very top of the mesodermal crest in which the heart precursors are 
specified. tinman null mutants (tinEC40) lack Him expression in the dorsal mesoderm 
(see Figure 5.2.1; compare arrows in B and D). There are two possible explanations for 
the lack of Him expression: either Tinman is necessary for early Him expression in the 
dorsal mesoderm or the cells that express Him are not present in the tinman null mutant 
embryos. The Tinman ChIP-on-chip analysis of the Furlong lab (Liu et al., 2009) 
showed that Tinman binds to a Him upstream sequence in vivo. According to the data 
given in this publication, the regions bound by Tinman do not include the PCE 
sequence. I have, however, identified a few discrepancies between the annotation of 
their data and the data of the GBrowse tool of Flybase that I based my results on, thus it 
is possible that the identified region actually corresponds to the PCE. The region 
identified as binding Tinman in the 2012 paper by Junion et al. contains the PCE 
sequence identified in chapter four, as does the region indicated in the Jin et al., 2013 
paper. Liu et al. (2009) have classified Him as a somatic muscle gene and do not refer to 
Him expression in the heart. None of the cited studies have confirmed the ChIP results 
with any expression studies to link Tinman function with Him expression.  
tinman null mutants do not form a heart and at stage 12/13 lack precursors for 
it (Bodmer, 1993). However, in tinman null mutants the spreading and migration of the 
dorsal mesoderm is unaffected and the lack of visceral and cardiac structures is due to 
the failure to specify these tissues (Bodmer; 1990) and thus the precursor cells should 
still be present and be exposed to other developmental “cues” during stage 10 of 
embryonic development (e.g. Decapentaplegic, Wingless). 
Heartless (Htl) is a FGF receptor necessary for the migration of the mesoderm 
and is expressed in the early mesoderm (stage 9) and its expression is maintained in the 
developing dorsal mesoderm until stage 12 (Shishido et al., 1993). Within the dorsal 
mesoderm, Heartless is only expressed in a distinct cluster of cells that includes the  
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Figure 5.2.1: tinman null mutants lack Him expression in the dorsal 
mesoderm. 
Him RNA in situ; homozygous tinman null mutants were identified by the 
absence of LacZ reporter of the balancer. B and D are close-ups of A and 
C, respectively. 
A, B Control embryo (not a homozygous mutant for tinman as can be seen 
by the LacZ staining (brown)). The arrow indicates the heart precursors 
labelled by Him (blue). C, D Homozyogous tinman null mutant. The arrow 
indicates the location of the heart precursors at the very top of the 
mesodermal crest. 
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precursors of the Eve-positive pericardial cells and the precursors of the somatic 
muscles DA1 and DO2 from stage 10 onwards (Shishido et al., 1993; Michelson et al., 
1998a; Halfon et al., 2000). Michelson et al., 1998b also state that “their experiments 
indicate that Heartless acts independently (or possibly upstream) of tinman”. Based on  
these data, Heartless expression should be unaffected in tinman null mutants, but so far 
this has not been tested. 
Stumps (in the literature also referred to as Heartbroken and Dumbfounded) is 
expressed in a very similar pattern in the dorsal mesoderm to Heartless and in the same 
cell cluster as Heartless (Casal and Leptin, 1996; Halfon et al., 2000; Halfon et al., 
2002). Stumps is also part of the FGF receptor signalling pathway and is a downstream 
target of Heartless and is involved in activation of the MAPK kinase cascade in 
response to FGF signalling (Michelson et al., 1998b; Vincent et al., 1998). Michelson 
et al., 1998(b) state that Heartless acts independently of Tinman regulation with a high 
probability. As Stumps is downstream of Heartless in the signalling cascade, it is likely 
that Stumps expression will also be unaffected in tinman null mutants. 
Upon verifying that Stumps expression is present in tinman null embryos (see 
arrows in Figure 5.2.2 I), I used Stumps to show that the early heart precursors are 
present in the dorsal mesoderm of tinman null mutants but that these cells do not 
express Him (Figure 5.2.2 D). While Stumps is expressed in the early heart precursors of 
tinman null mutant embryos, it is noteworthy to mention, that its expression appears 
less strong than in the wild-type embryos. As these stains were done in parallel and are 
thus comparable this implicates that Tinman function is integrated into the Heartless 
signalling cascade after activation of the Heartless receptor.  
As can be seen in Figure 5.2.2, Stumps and the Him transcript co-localize in the 
early heart progenitors of wild-type embryos (see arrows in Figure 5.2.2 C). Him 
expression can be seen in the progenitors of the later Eve-positive cells (marked by 
Stumps) and a few cells in the surrounding dorsal mesoderm are likely to be the 
precursors of the remaining heart cells. As expected, the expression of Stumps is present 
in tinman null embryos (see arrow in Figure 5.2.2 F). In these embryos, however, the 
Him RNA transcript is not expressed in the precursors of the heart cells. Consequently, 
the Him transcript and Stumps do not co-localize in the heart precursors of the dorsal 
mesoderm. This indicates that the early Him expression in the developing heart cells is 
tinman dependent. 
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Figure 5.2.2: The heart precursors for the Eve-positive pericardial cells 
are present, but do not express Him, in stage 10 tinman null mutant 
embryos. 
Confocal microscopy images of wild-type (OR) and tinman homo- and 
heterozygous mutant embryos stained for the Him and ßGal RNA transcripts 
(red, Fluorescent in situ hybridisation) and Stumps antibody (green). C, F 
and I are merges of the single channel images. 
A, B, C Wild-type embryo showing the Him, ßGal and Stumps expression. 
The arrow indicates overlapping expression. D, E, F Homozygous tinman 
null mutant shows the lack of Him transcript while the Stumps protein is 
expressed in a wild-type like manner (indicated by the arrow). G, H, I 
Heterozygous tinman mutant embryo demonstrates the ßGal pattern and the 
overlap of the Him and Stumps expression patterns as in the wild-type 
embryo (arrow). 
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Figure 5.3.1: Schematic representation of all PCE enhancer constructs 
and their expression in the heart. 
The conserved regions are shaded in grey and the Tinman binding sites are 
indicated by the red stripe. Crosses represent the position of the introduced 
mutation. PC: pericardial cells, CB: cardioblast, tick/cross: the enhancer 
construct is (not) expressed in these cells. The schematic is drawn in scale; 
the length of the PCE is 574 basepairs. 
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5.3 Deletion of the conserved putative Tinman binding sites 
 
Deleting a sequence of interest in the context of a reporter construct is a 
common approach in trying to elucidate the function of a sequence of interest in vivo. 
The question asked is whether the expression pattern of the reporter construct with the 
deletion is altered when compared to the original reporter construct. Several papers 
describing Tinman target genes have utilized this approach in their analyses (for 
example: Gajewski et al., 1997; Wang et al., 2005; Ryu et al., 2011). Figure 5.3.1 is a 
schematic representation of all enhancer constructs generated in this study. 
My initial test of whether Tinman is involved in Him regulation was to delete the 
sequences in the PCE up to and including the potential Tinman binding sites. If Tinman 
does activate Him transcription through any of the putative sites, deletion of these sites 
should abolish or reduce reporter activity if the sites do not function redundantly with 
each other. I made two different deletion constructs, one with a 5’ deletion of 165 bp 
(called PCE !tin1) and the second with a 198 bp 3’ deletion (called PCE !tin2; see 
Figure 5.3.1 for an overview of all constructs generated in this study; all enhancer 
constructs are linked to a !Gal reporter). 
 Both the PCE !tin1 and PCE !tin2 deletion constructs completely abolish 
reporter expression in the pericardial cells. As Figure 5.3.2 shows, there is no visible 
staining of the heart in the transgenic embryos of either construct (see stars in Figure 
5.3.2). All embryos shown in Figure 5.3.2 were stained at and for the same time and 
with the same reagents. This ensures that the lack of staining in the embryos carrying 
the transgenic construct is not due to a mistake in the procedure and that the staining 
intensity (if present) is comparable. A further internal control for the correctly 
functioning procedure is the ectopic expression of the LacZ reporter gene in PCE !tin2 
(see arrowheads in Figure 5.3.2 D). In the fly line carrying the PCE !tin2 deletion 
construct, the LacZ protein is expressed in very large, round cells that are located 
dorsally to the heart. Judging by the size, shape and position of the cells ectopically 
expressing LacZ, they are part of the amnioserosa of the developing embryos. 
These two deletions show that both Tinman binding sites are possibly 
functionally relevant in the transcriptional regulation of Him. Contrary to many 
published examples (Gajewski et al., 1999; Akasaka et al., 2006; Ryan et al., 2007), the 
loss of one binding site within the PCE sequence is sufficient to abolish reporter gene  
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Figure 5.3.2: Deleting the potential Tinman binding sites in the PCE 
(Pericardial Cell Enhancer) abolishes reporter gene expression in the 
heart. 
A Schematic representation of the constructs used in this Figure; the grey 
rectangles represent the conserved regions (see chapter 4) and the red 
triangles indicate the locations of the putative Tinman binding sites. B LacZ 
reporter gene expression for the full-length wild-type PCE construct. C 
LacZ reporter gene expression is lost when the 5’ sequence up to and 
including the first Tinman binding site is deleted. The arrow points to the 
location of the heart. D Deleting the second Tinman binding site and the 
following 3’ sequence abolishes reporter gene expression in the heart 
(position indicated by the arrow) but induces ectopic expression in 
amnioserosa cells (indicated by stars). 
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expression. However, further investigation is needed as both deletions remove large 
stretches of sequence, which could possibly contain other transcription factor binding 
sites or other regulatory elements that cause the loss of reporter expression. 
 
 
5.4 Electrophoretic Mobility Shift Assays (EMSA) 
 
 Electophoretic Mobility Shift Assays (EMSAs) are designed to test if a protein 
specifically and selectively binds to a labelled DNA sequence in vitro (e.g. Mohun et 
al., 1989; for a review see Jiang et al., 2009). Adding un-labelled DNA of the same or 
mutated sequence tests the specificity of the binding. This method relies on the ability 
of a native polyacrylamide gel to separate complexes by size; a DNA-protein complex 
will be larger than just the oligonucleotide on its own, and thus will run slower through 
the gel matrix when a voltage is applied. By labelling the DNA sequence the difference 
of the migratory distance between the bound and unbound labelled DNA 
oligonucleotide becomes visible. 
 I used this system to test if in vitro translated Tinman protein is capable of 
binding to the S5 (the 5' site, deleted in PCE !tin1) and S6 (the 3' site, deleted in PCE 
!tin2) putative binding sites contained within the PCE sequence. The oligonucleotide 
sequence and the introduced mutations were designed as 24-mers as previously 
described (Chen and Schwartz, 1995; Gajewski et al., 2001) by including a minimum of 
8 bp of the surrounding sequence flanking the putative Tinman binding sites (Figure 
5.4.1 B). The mutations I used for this assay have previously been described and shown 
to inhibit Tinman binding by Chen and Schwartz, 1995 and Gajewski et al., 2001 (see 
figure 5.4.1 B for the introduced mutations).  
 Figure 5.4.1 A shows the results of the EMSA for each potential binding site. 
The arrow points to the area containing any DNA probe bound by the Tinman protein. 
Figure 5.4.1 shows that the oligonucleotide for the S6 binding site (towards the 5’ end 
of the PCE, for the location of the S6 site within the PCE refer to Figure 5.5.3) 
specifically binds to the in vitro translated Tinman protein. The unprogrammed lysate 
control (indicated by a star above the lane in Figure 5.4.1 A) shows no binding to the 
oligonucleotide through proteins naturally contained within the lysate used to translate 
the Tinman protein. Upon adding an excess (100-fold) of the unlabelled wild-type  
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Figure 5.4.1: Tinman binds to the S5 and S6 sites in vitro. 
Electrophoretic Mobility Shift Assays (EMSAs) using in vitro translated 
Tinman protein and radioactively labelled oligonucleotides. (-) no competitor; 
(wt) 100x wild-type competitor; (mut) 100x specifically mutated competitor; * 
unprogrammed lysate control. 
A Tinman protein binds in vitro to the Tinman sites in region 1 (S6) and 
region 2 (S5). The binding can be competed by adding 100-fold excess of the 
wild-type oligo (labelled (wt)), but not by adding 100-fold excess of the 
muatated oligo (labelled (mut)) to the reaction. B Sequences of the oligos used 
in the assay. The Tinman binding sites are indicated in bold and italic; the 
introduced mutations are shown in bold red. 
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oligonucleotide into the mix (labelled (wt) in Figure 5.4.1 A), the band in the lane 
containing the labelled oligonucleotide, which has been bound by Tinman is 
considerably less strong than the band in the lane without added competitor (labelled (-) 
in Figure 5.4.1 A). This is due to the fact that both labelled and unlabelled probe 
compete for the available Tinman protein and the excess of unlabelled probe compared 
to labelled probe results in less available labelled probe that is able to bind the Tinman 
protein. However, adding a 100-fold excess of unlabelled, mutated oligonucleotide 
(marked (mut) in Figure 5.4.1 A) to the mix does not compete with the wild-type 
oliognucleotide for binding; the band has the same intensity as the un-competed band. 
Figure 5.4.1 A also shows the behaviour of the S5 oligonucleotide in the same 
assay (for the location of the S5 site within the PCE refer to Figure 5.5.2). Similarly to 
the S6 oligonucleotide, the wild-type S5 oligonucleotide binds to the Tinman protein 
specifically as the binding can be competed with a 100-fold excess of unlabelled wild-
type oligonucleotide (labelled (wt)), but not when a 100-fold excess of unlabelled 
mutated oligonucleotide (labelled (mut)) is added. 
In vitro, Tinman binds to both potential binding sites. When the EMSAs for the 
S6 and S5 site are compared, the competition with the wild-type oligonucleotide is more 
successful for the S5 site, however, both EMSAs were done separately so they cannot 
be directly compared to each other and this observation could be just an artefact, this 
needs to be verified with further experiments such as competing the binding of one 
binding site with the unlabelled wild-type oligonucleotide of the other Tinman binding 
site. The ability of Tinman to bind both binding site sequences in vitro strengthens the 
idea that Tinman may indeed play a role in the in vivo regulation of Him transcription. 
Each experiment only generates one shifted complex per reaction, there are no 
larger (i.e. slower) or smaller (i.e. faster) complexes visible on the X-ray film. This 
indicates that Tinman binds to the sequences in only one form; either as a monomer, a 
homodimer or as a heterodimer (with a protein present in the lysate). Further studies are 
needed to resolve the possibilities of binding partners for Tinman in vitro and also in 
vivo. Zaffran and Frasch (2005) have shown that Tinman can form homodimers and that 
it can also form heterodimers with Binou, so that the appearance of one single band 
does not allow for the exclusion of either possibility. Tinman has also been shown to act 
as either a transcriptional activator or repressor through physical interaction with either 
the p300 coactivator or the Groucho corepressor (Choi et al., 1999). Furthermore, 
several studies have shown that various combinations of transcription factors with 
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Tinman (such as Pannier, Serpent, Dorsocross, dTCF and pMad) are necessary for the 
complete activation of target genes but so far no further evidence for direct physical 
interactions between Tinman and these transcription factors has been presented (Han & 
Olson, 2005; Zaffran & Frasch, 2005; Junion et al., 2012). 
 
 
5.5 Point-mutation of the potential Tinman binding site 
 
Another very informative approach to analysing the importance of a specific 
sequence is mutating a specific region in the context of the complete enhancer and then 
placing this before a reporter gene. This approach is widely used in the study of 
transcription factors (for example: Akasaka et al., 2006; Gajewski et al., 2001; Ryu et 
al., 2011, Wang et al., 2005). The hypothesis behind this approach is that a transcription 
factor requires a specific DNA sequence to bind to the enhancer fragment and that by 
mutating the putative binding site the ability of a regulating transcription factor to bind 
to the DNA is prevented and thus the expression pattern of the reporter gene is altered. 
In order to test if the S5 and S6 Tinman binding sites are of importance in vivo, I 
mutated both sites. The S6 site was mutated from CACTTGAAGTG to 
GTCTACAAGTG (termed *S6) or GTCTAGTAGTG (termed *S6new) and the S5 site 
from TCAAGTG to TGTAGAC (termed *S5). The *S6 and *S5 mutations are identical 
to the mutations used to test the binding specificity in the EMSA, and have been 
previously used and described as capable of disturbing Tinman binding by Gajewski et 
al., 2001. 
The sequences created by the introduction of the mutations were screened with 
the same tests used in the bioinformatic analysis of the PCE sequence (described in 
Chapters two and four) to ensure that no known “new” binding sites for transcription 
factors were introduced by creating the mutations. The *S6 mutation introduces an E-
box (GTCTACAAGTG) into the original sequence (CACTTGAAGTG). For this 
reason, I created the additional *S6new mutation. Instead of the G to C mutation, the 
*S6new mutation changes the following A to a T (GTCTAGTAGTG). According to the 
Tinman position weight matrices (see Figure 5.5.1) available (Zinzen et al., 2009) this 
mutation should also interrupt binding of the Tinman protein. For all following 
constructs, I tested several independent insertion lines for their expression pattern and 
!"#$%&'()((*+,-#,('&./0#%&1(2+-(&3$'&11+4,! "#$!!
show the most representative here (see Figure 5.3.1 for details on constructs and tested 
lines). 
 
Figure 5.5.2 shows the results of the *S5 point mutation. All transgenic fly lines 
were stained at the same time and the same reagents were used to allow for 
comparability. As can be seen in Figure 5.5.2 (arrows), all expression of the reporter 
construct is lost in the heart. This shows that the S5 site is indeed crucial for regulation 
in vivo, and it also implies that the introduced mutation interferes with its ability to bind 
its regulating factor. 
Figure 5.5.3 shows the results of the *S6 and the *S6new point mutations. In 
each case the PCE control and the mutation (*S6 or *S6new) were stained at the same 
time and with the same reagents. The *S6 mutation does not completely abolish reporter 
activity. Figure 5.5.3 (C and E) shows that reporter activity is reduced. There are several 
possible explanations for this reduction. It is possible that the S6 site is only responsible 
for modulating the strength of reporter gene expression and thus mutation of it does not 
completely abolish the reporter activity. It is also possible that the observed reporter 
activity is due to the E-box introduced into the sequence through the mutation. This E-
box has the same sequence (CAAGTG) as the E-box contained within un-mutated S5 
binding site. The importance of this E-box sequence for reporter activation cannot be 
ruled out, as the mutation introduced into the S5 site also affects this E-box and the S5 
mutation abolishes expression. It is also possible that the introduced mutation created a 
currently unidentified binding site that in combination with its transcription factor is 
capable of mimicking wild-type reporter expression at a reduced intensity. 
 To my knowledge, the *S6new mutation does not introduce any new binding 
sites into the PCE sequence while still affecting the S6 binding site; the in vitro analysis 
of the *S6new mutation has yet to be done. Reporter activity for the *S6new mutation is 
slightly reduced from the PCE control but not as weak as the *S6 mutation (see Figure 
5.5.3 G and I). Again, this could be due to the fact that the function of the S6 site is only 
in modulating the reporter activity and not an “on/off” regulatory switch. It is also 
possible that neither of the S6 mutations, *S6 and *S6new, affect a binding site 
involved in the activation of the reporter gene but introduce a new currently unknown 
binding site into the PCE sequence. In all tested lines, expression in the *S6 mutation 
appears to be weaker than for the *S6new mutation (compare 5.5.3 C with G and E with 
the  
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Figure 5.5.1 Tinman Position Weight Matrix (taken from Zinzen 
et al., 2009)!
The Position Weight Matrix (PWM) for the Tinman binding displays 
the most likely base found at each position of the consensus binding 
sequence. 
 
 
 
 
 
 
 
 
Figure 5.5.2: Mutation of the putative Tinman binding site S5 
abolishes reporter gene expression. 
A Schematic representation of the constructs used in this Figure; the 
grey rectangles represent the conserved regions and the red triangles 
indicate the locations of the putative Tinman binding sites (refer to 
chapter 4). The mutated bases are given in red. B, D LacZ reporter 
gene expression in the heart (arrows) for the full-length wild-type PCE 
construct at different stages of embryonic development B: stage 14, D: 
stage 17. C, E LacZ reporter gene expression is lost when the potential 
S5 Tinman binding site is mutated; the arrows indicate the position of 
the heart. C: stage 14, E: stage 17. 
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Figure 5.5.3 Mutation of the putative Tinman binding site S6 does not 
abolish reporter gene expression. 
A Schematic representation of the constructs used in this Figure; the grey 
rectangles represent the conserved regions and the red triangles indicate the 
locations of the putative Tinman binding sites (please also refer to chapter 
4). The mutated bases are given in red. B, D, F, H LacZ reporter gene 
expression in the heart for the full-length wild-type PCE construct at 
different stages of embryonic development B, F stage 15, D, H stage 17. C, 
E Reporter gene expression is greatly reduced but not lost when the *S6 
mutation is introduced into the PCE sequence. C stage 15, E stage 17. G, I 
Introduction of the *S6new mutation into the PCE sequence reduces reporter 
gene expression to a lesser degree than the *S6 mutation. G stage 15, I stage 
17.  
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I). This implies that either the *S6new mutation is not sufficient to prevent the binding 
of transcription factor or that indeed the E-box that was introduced with the *S6 
mutation has an affect on this site. 
 
Figure 5.5.4 shows the results for the combined *S5/*S6 double mutation. As 
can be seen in 5.5.4 (C) and (E) the double mutation does not eliminate reporter gene 
expression as the single *S5 mutation does. In fact, the expression pattern for the 
*S5/*S6 double mutant closely resembles the expression pattern I observed for the 
single *S6 mutation (compare Figures 5.5.3 C and E with 5.5.4 C and E). As each 
generated construct was sequenced and the introduced mutations verified, I can rule out 
that the *S5 mutation is not present in this enhancer construct. However, as the *S6 
mutation introduced in this double mutant is identical to the old *S6 mutation (and thus 
introduces the additional Ebox), it is highly likely that the observed expression pattern 
for the *S5/*S6 reporter construct is due to this *S6 mutation. 
The *S6new mutation only alters the reporter gene expression a little bit in 
intensity while the *S6 mutation weakens reporter expression considerably. There are 
several possible explanations for this: the *S6new mutation only changes three of the 
four bases of the E-box contained within the Tinman binding site consensus sequence. 
As the *S6new mutation is a previously “untested” and unpublished mutation, it is 
possible that it retains or introduces more functionality than the original *S6 mutation 
and thus allows for stronger reporter gene expression. I believe that neither S6 mutation 
affects which pericardial cells express the reporter gene, but to validate this results 
double-labelling experiments with pericardial cell markers such as Tinman, Even-
skipped and Odd-skipped are still necessary. From these results, I conclude that the 
function of the S6 site is either in modulating the level of expression only or that neither 
of the two mutations introduced are involved in the regulation of the PCE. For a 
complete understanding of the importance of the S6 Tinman site, the analysis of the 
*S5/*S6new double mutant will be necessary. 
The S6 site could also be a redundant duplication of the S5 site. In their 2003 
study, Dermitzaki et al. demonstrate “that there are sequences within the regulatory 
regions that are close enough to becoming a functional site that a few substitutions can 
make them potentially functional”. This might also be the case for the S6 site, especially 
if the fact of two overlapping binding sites on the two different DNA strands is taken 
into consideration;  
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Figure 5.5.4: Effect of the *S5/*S6 double mutation on reporter gene 
expression. 
A Schematic representation of the constructs used in this Figure; the grey 
rectangles represent the conserved regions and the red triangles indicate the 
locations of the putative Tinman binding sites (please also refer to chapter 4). 
The mutated bases are given in red. B, D LacZ reporter gene expression in the 
heart for the full-length wild-type PCE construct at different stages of 
embryonic development B stage 15, D stage 17. C, E Reporter gene expression 
is greatly reduced but not lost when the *S5/*S6 double mutation is introduced 
into the PCE sequence. C stage 15, E stage 17. 
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 so far nobody has described a functional Tinman binding site arranged in this way. The 
S5 site is, however, essential for reporter gene expression as mutation of this site 
abolishes all reporter activity in the heart and acts as an “on/off” switch. The binding of 
Tinman to the S5 site activates gene expression in the pericardial cells. This gene 
expression is lacking if the S5 site is mutated in a way known to interfere with Tinman 
binding. These data again point towards Tinman as a regulator of Him expression. 
 
 
5.6 Tinman over-expression induces ectopic Him expression 
 
The Gal4/UAS-system allows one to express genes at times and in places where 
they are normally not expressed. If this “mis-expressed” protein is capable of inducing 
the expression of other proteins normally not expressed at this new location this is a 
good indication that these newly expressed proteins are direct or indirect targets of the 
“mis-expressed” protein. In addition, the expression domain of any protein induced by 
this “mis-expressed” factor is a good indication for further regulatory factors that might 
be involved in its regulation. 
The above-described method is a commonly used approach to demonstrate that a 
specific protein is upstream of the gene of interest in the regulatory cascade. It follows 
that if Tinman is capable of activating Him transcription, then “mis-expression” of 
tinman should also induce Him expression in the tissues that tinman expression is 
driven in and Him is not normally expressed in. 
 
I have used the Da-Gal4, Mef2-Gal4 and En-Gal4 drivers for this experiment. 
Da-Gal4 induces uniform expression throughout the embryo (Wodarz et al., 1995), the 
Mef2-Gal4 driver is specific for the somatic mesoderm from stage 7 until the end of 
embryogenesis (Ranganayakulu et al., 1996) and the En-Gal4 driver drives expression 
in a specific ectodermal stripe (Gaumer et al., 2000; Sandmann et al., 2006). 
In all three cases, the over-expression of tinman in these tissues causes ectopic 
expression of the Him transcript. The Da-Gal4 driver induces ectopic Him expression in 
the somatic mesoderm (arrows in Figure 5.6.1), especially in the ventral areas, similar to 
the described expression pattern of the wild-type Him transcript in stage 12 (see chapter 
3) but this expression is maintained in later stages. In addition to the mesodermal 
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expression, the Da-Gal4 driver also induces ectopic Him expression in a few ectodermal 
areas overlying the somatic mesoderm and the amnioserosa (see arrowheads in Figure 
5.6.1 A). The Mef2-Gal4 driver has a more specific expression pattern that is limited to 
the somatic mesoderm than the ubiquitous Da-Gal4 driver. Thus, ectopic Him 
expression in these embryos is limited to the muscles and within this expression 
domain, ectopic Him expression can mainly be found in the middle and ventral somatic 
muscles towards the posterior of the embryo. The Da-Gal4 driver is not only expressed 
in the mesoderm. When tinman expression is driven in the pattern of the Da-Gal4 
driver, ectopic Him expression can additionally be observed in the ectoderm (arrow in 
Figure 5.6.1 C). Again more cells ectopically expressing Him can be found towards the 
ventral part of the somatic musculature. Ectopic Him expression is also often stronger in 
the posterior three para-segments of the embryo, indicating that this region contains 
regulatory factors that facilitate Him expression. The Hox genes Ubx and abdA involved 
in the establishment of the anterior-posterior axis are good candidates for this function 
along the anterior-posterior axis (Lo et al., 2002; Lovato et al., 2002; Ponzielli et al., 
2002; Perrin et al., 2004, Ryan et al., 2005). The En-Gal4 driver drives expression in 
very distinct ectodermal stripes (see Figure 5.6.1 E). However, Him expression is only 
induced in a sub-set of cells within this stripe (compare Figure 5.6.1 E and D). Ectopic 
Him is expressed in a one cell wide stripe immediately on the boundary of each para-
segment. This corresponds to a one-cell-wide line of the two-cell-wide Engrailed 
expression domain. Determination of the exact anterior-posterior position of the ectopic 
Him expression within the Engrailed expression domain will require a double-labelling 
experiment. It has been shown that both one-cell-wide stripes within the Engrailed 
domain express Mothers against Dpp (Mad, Einers et al., 2009) but that the anterior of 
the two regions within the Engrailed domain is subject to the Wingless signalling 
pathway, while the posterior region is subject to signals from the EGF receptor (DER; 
O’Keefe et al., 1997, Dilks and DiNardo, 2010). Him expression is also mostly induced 
in the middle of the dorsal-ventral axis of each segment with less pronounced ectopic 
Him expression in the dorsal and ventral areas of the embryo. This area corresponds to 
the areas of u-shaped, dorsocross and high (but not highest) decapentaplegic expression 
(Fossett et al., 2000; Fossett et al., 2001; Hamaguchi et al., 2004; Reeves and 
Stathopoulos, 2009). 
Notably, with all three used drivers the ectopic expression domain of Him is 
smaller than the expression domain of tinman. This implies that Him expression needs  
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Figure 5.6.1: Ectopic Tinman expression induces ectopic Him 
expression. 
Him RNA in situ (except where noted) on embryos ectopically expressing 
Tinman under the control of the Gal4/UAS system. 
A Tinman expression construct under the control of the Da-Gal4 driver 
induces ectopic Him transcript expression in the somatic mesoderm (arrow) 
and some ectodermal tissues. B Him RNA in situ on wild-type embryos 
(OR). C Driving Tinman expression with the Mef2-Gal4 construct induces 
ectopic Him expression in the somatic mesoderm (arrow). D Tinman 
expression under the control of the En-Gal4 driver induces ectopic Him 
expression in distinct ectodermal stripes (arrow). E Visualisation of the 
ectopic ectodermal expression (arrow) of the Tinman protein when driven by 
the En-Gal4 driver. 
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further input by other transcription factors or that Him expression is repressed in the 
other cells over-expressing tinman. Based on these over-expression experiments the  
most likely candidate for Him regulators is Decapentaplegic, as it is expressed in the 
dorsal and lateral regions of the embryo and known to be involved in heart 
development. It is further possible that the dorsocross genes, GATA-factors (in 
combination with u-shaped) and Hox genes such as abdA are also involved in Him 
regulation. 
 
In order to show that Tinman is activating reporter transcription through the 
PCE and not some other regulatory region, I have repeated the tinman over-expression 
experiments in the presence of the wild-type PCE reporter using the Da-Gal4 and the 
Mef2-Gal4 drivers. The expression pattern of the PCE reporter protein shows that 
tinman over-expression indeed induces ectopic reporter expression. Over-expression of 
tinman by the Mef2-Gal4 driver causes ectopic PCE expression in the developing 
somatic muscles, mainly in the dorsal and lateral muscles. However, the over-
expression of tinman disturbs the wild-type muscle pattern so that I am unable to assign 
in which specific muscles the PCE reporter is induced in (Figure 5.6.2 F). The ectopic 
expression of the PCE is more pronounced in the dorsal region of each segment, once 
again implicating Decapentaplegic as a potential further regulator, but it can also be 
seen in single cells of the mesoderm (see Figure 5.6.2 B). The ectopic PCE expression 
caused by using the Da-Gal4 driver shown in Figure 5.6.2 can again be found in single 
cells of the somatic mesoderm, some ectodermal cells, in the cells of the gut 
constrictions and in cells along the ventral midline. I have also observed ectopic PCE 
expression in the cardioblasts with this driver. I did not observe this if the Mef2-Gal4 
driver was used. This difference in Him expression within the same tissue can be caused 
by the temporal differences in the driver activity and by the different "strength" of the 
two drivers. 
The PCE expression induced by over-expression of tinman is more widespread 
than the observed ectopic expression of the Him transcript while using the same drivers 
(compare Figure 5.6.2 B and F with Figure 5.6.2 A and E). This is likely due to the fact 
that the PCE sequence has been removed from its context, which might contain 
repressor binding sites, chromosomal structures and other sequences of regulatory 
importance that limit the expression of the intrinsic Him gene. The context of the PCE 
enhancer appears to be of little or no importance in a wild-type environment as the PCE  
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Figure 5.6.2 Tinman over-expression triggers ectopic Him reporter gene 
expression. 
Visualisation of the LacZ reporter gene expression in embryos expressing 
ectopic Tinman under the control of the UAS/Gal4 system. A, C, E, G stage 
13 and B, D, F, H: stage 15/16 
A, B Tinman expression driven by the Da-Gal4 driver induces ectopic PCE 
reporter gene expression in the somatic mesoderm (arrow) and the 
cardioblasts. C, D PCE reporter gene expression in a wild-type background. 
E, F When controlled by Mef2-Gal4, ectopic Tinman is able to induce 
ectopic PCE reporter gene expression in the developing somatic mesoderm 
(arrows). G, H Mef2-Gal4 driven ectopic expression of Tinman is not able to 
induce expression of the PCE carrying the *S5 mutation. 
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region on its own is able of reproducing the expression pattern of the Him transcript 
without additional expression in other tissues. These over-expression results point to the 
presence of such sites that are capable of limiting Him expression in undesired 
mesodermal and ectodermal tissues if at least one activating transcription factor is 
present in a wider than usual expression domain. 
 
To further establish that it is indeed the S5 site within the PCE through which 
Tinman acts, I have over-expressed tinman in the presence of the PCE*S5 reporter 
construct. The S5 site in this construct is mutated and I have previously shown that this 
mutation abolishes all reporter activity in a wild-type background (Figure 5.6.2 G and 
H). The staining for both the PCE and PCE*S5 experiments were done in parallel to 
have a positive staining control and allow for comparability between the two. Figure 
5.6.2 G and H show that over-expression of tinman cannot compensate for the lack of 
the S5 binding site in any tissues in these embryos. This implies that the S6 site cannot 
compensate for a non-functional S5 binding site. It is however difficult to rule out any 
role of the S6 site in the presence of a functional S5 binding site. 
 
Both of these experiments taken together show that the PCE is responsive to 
Tinman and, furthermore, that the S5 site is necessary for the transcriptional activation 
of the PCE through Tinman. Together with the previous results showing that the 
endogenous Him gene is also induced by over-expressing tinman, it is highly likely that 
this response of Him transcription to tinman expression occurs through the S5 site in a 
wild-type in vivo context as well. This proves that the S5 Tinman binding site is indeed 
of functional relevance while the S6 site does not appear to be necessary for Him 
regulation in vivo. 
 
 
5.7 The effect of expressing a dominant-negative form of Tinman on 
Him expression 
 
As previously mentioned, tinman null mutants do not form a heart (Bodmer, 
1993). This complicates the analysis of any potential Tinman target gene in embryos 
mutant for tinman. The targeted expression of a dominant-negative form of Tinman 
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using the UAS/Gal4-system allows for a conditional loss-of-function in specific cells 
without detrimental effects on any other developing tissues or cells of the animal. 
By expressing dominant-negative Tinman in the heart cells after the early 
specification for the cardiac field has taken place, it is possible to impair Tinman 
function while retaining early heart development until the dominant-negative form of 
Tinman becomes active (Han et al., 2002; Han et al., 2005). This will allow me to see 
from which stage onwards Tinman is necessary for Him expression. If Tinman is 
necessary only at the very early stages of heart development, Him expression will be 
unaffected in the embryos expressing dominant-negative Tinman. If, however, Tinman 
is also necessary to maintain Him expression during the middle and late stages of heart 
development, I should then be able to observe a decrease and/or lack of Him 
transcription. 
 
The transgenic fly line carrying the UAS-dominant-negative-Tinman (UAS-DN-
Tin) construct was generated in the Bodmer lab (Han et al., 2002) by fusing the 
Engrailed repressor domain to the Tinman homeodomain (amino acid 291-370) 
according to the strategy described by Fu et al. (1998). When driven with the eme900-
Gal4 line, which drives expression in the mesodermal Eve pattern, Han et al. (2002) 
describe a “significant but variable reduction of Eve expression” but do not comment on 
whether this loss of Eve expression is due to cell loss or not. 
I have used the hand-Gal4, TinC!4-Gal4 and Him-Gal4 L3-5 drivers to express 
the dominant-negative form of Tinman. The hand-Gal4 line drives expression in all 
heart cells from late stage 12 onwards (Sellin et al., 2009; D. Popichenko & A. Paululat, 
unpublished data, see Appendix). The TinC!4-Gal4 driver is specific for the four ß3-
tubulin-positive cardioblasts of the heart from stage 13 onwards (Bodmer lab, K. Jagla 
pers. communication, see Appendix). The Him-Gal4 line drives expression in the heart 
precursors from stage 11/12 onwards and then in all pericardial cells of the developing 
heart (see Appendix). 
 
When the dominant-negative form of Tinman is driven with the Him- or hand-
Gal4 lines the Him transcript is still present at reduced levels as it still can be visualized 
in the Drosophila embryo (see Figure 5.7.1). If the dominant-negative form of Tinman 
is driven with the TinC!4-Gal4 line, the Him transcript levels are not reduced. While 
some of the variation between embryos in each experiment has to be attributed to the  
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Figure 5.7.1: Expression of a dominant-negative form of Tinman 
in the mesoderm reduces, but does not abolish, Him expression. 
Him RNA in situ on developing embryos expressing dominant-
negative Tinman under the control of three different mesodermal 
Gal4 drivers.  
A, E, I Him RNA in situ on wild-type (OR) embryos, B, F, J Him 
expression is reduced when dominant-negative Tinman is under the 
control of Him-Gal4. C, G, K When hand-Gal4 drives the expression 
of the dominant-negative form of Tinman, Him expression is slightly 
reduced. D, H, L Driving the dominant-negative form of Tinman 
with TinC!4-Gal4 does not affect Him expression levels. 
A, B, C, D late stage 12, E, F, G, H stage 13, I, J, K, L stage 15. 
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mechanisms of the UAS/Gal4 system and the most likely incomplete inhibition of 
Tinman activity, the result that Him transcription is not abolished remains constant with 
all Gal4 driver lines used in this study. 
 
The TinC!4-Gal4 driver, which has no effect on Him transcription, is specific to 
a subset of cardioblasts and starts expressing the Gal4 protein latest of all three drivers 
used, thus the dominant-negative form of Tinman and Him should not be co-expressed 
in this experiment which can thus serve as an additional control. The Him-Gal4 driver, 
which has the strongest effect on the levels of Him transcript, is the earliest active driver 
in the group of driver lines I used. This indicates that while Tinman is necessary at early 
developmental stages (from this experiment up to stage 12 and see section 5.2) to 
activate Him transcription, at later stages Tinman is, at most, only one contributing 
factor towards maintaining Him transcription. The reason for this early requirement of 
Tinman might tie in with the fact that the early dorsal mesoderm contains the shared 
precursors of cardioblast and pericardial cells. 
 
Many embryos showed a loss of heart cells reminiscent of the complete heart 
loss in the tinman null mutant when the dominant-negative form of Tinman is 
expressed, irrespective of which driver I used. This loss is least severe when the 
TinC!4-Gal4 driver is used. In their 2002 study, Han et al. described reduced Even-
skipped expression if an enhancer fragment specific for the Eve-positive pericardial 
cells and the dorsal muscle DA1 drives the dominant-negative form of Tinman. They 
have not described this phenotype any further but the likely conclusion from their 
experiment is that these cells are lost in a similar fashion as the heart cells in a tinman 
null mutant. These similar phenotypes that both Han et al. (2002) and I have observed, 
indicate that the dominant-negative Tinman is functioning. Because of the loss of heart 
cells, it is impossible to determine if the loss of Tinman function after the initial steps of 
heart development is specific to certain sub-sets of pericardial cells by the position of 
these cells alone. 
In order to establish if the PCE behaves similarly to the endogenous Him 
transcript, I have repeated the previous experiment with PCE in the background using 
the hand-Gal4 driver only. All staining shown in Figure 5.7.2 were done in parallel, 
allowing for comparability of the intensity of the reporter gene expression. As can be 
seen in Figure 5.7.2, if the levels of reporter gene expression are compared between the 
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control embryos (carrying the hand-Gal4 driver with the PCE in the background) and 
those embryos expressing the dominant-negative form of Tinman, it is obvious that the 
latter embryos express less of the reporter gene. In these embryos reporter gene 
expression is reduced considerably from late stage 12 onwards which coincides with the 
beginning activity of the hand-Gal4 driver. This shows that under these circumstances 
the PCE recapitulates the behaviour of the endogenous Him transcript. The reduction of 
the PCE expression appears to be stronger than the degree I observed for the 
endogenous Him transcript when the dominant-negative form of Tinman was expressed 
under the control of the hand-Gal4 driver. However, to be able to truly compare the 
degree at which the endogenous Him transcript and the PCE LacZ reporter gene lose 
expression strength it will be necessary to compare the level of the Him transcript to that 
of the LacZ transcript and not the translated protein, while keeping in mind that both 
transcripts might also have differing stabilities. 
 
 To further illustrate this point, I have double-labelled the PCE; hand-Gal4 > 
UAS-DN-Tin embryos for both the endogenous Him transcript and the LacZ reporter 
gene. Figure 5.7.3 shows again that the expression for both, endogenous Him and the 
reporter gene, is reduced when compared to the control and that gaps of staining within 
the heart are present. As it is possible that these gaps in staining are caused by the 
complete loss of heart cells in this region and not by absence of the Him transcript or the 
expressed reporter gene, I have also counterstained these embryos for Zn finger 
homeodomain 1 (Zfh-1) to identify pericardial cells. Zfh-1 has, so far, not been shown 
to be a Tinman target and is thus suitable as a marker for pericardial cells in these 
conditions. At stage 13, Zfh-1 is expressed in all pericardial cells (Lai et al., 1991; Su et 
al., 1999; Johnson et al., 2003) and, as shown in the previous chapter, Zfh-1 and the 
Him transcript co-localize in the pericardial cells. Figure 5.7.3 shows that there are 
indeed Zfh-1 positive cells present that do not express either the Him transcript or the 
LacZ reporter (see arrows in Figure 5.7.3). This demonstrates that this system, if the 
dominant-negative form of Tinman is induced early enough, does allow for the 
formation of heart cells that lack tinman but express other established cardiac markers 
and that these non-Tinman expressing cells do not express Him or the PCE reporter 
gene. The loss of Tinman function at later stages of development (stage 12 onwards) 
thus leads to a general reduction of Him expression in the remaining heart cells and in 
few cases can also completely abolish Him expression. As this later phenotype was not  
!"#$%&'()((*+,-#,('&./0#%&1(2+-(&3$'&11+4,! "##!!
 
 
 
 
 
 
 
 
 
Figure 5.7.2: Expression of a dominant-negative form of Tinman reduces 
reporter gene expression. 
Visualisation of the PCE LacZ reporter gene expression during embryonic 
development when dominant-negative Tinman is driven by the hand-Gal4 
construct. The arrows point to developing heart.  
A, C, E “Normal” expression of the PCE reporter gene with the hand-Gal4 
driver in the background. B, D, F The intensity of the LacZ reporter gene is 
greatly reduced if the dominant-negative form of Tinman is expressed under 
the control of the hand-Gal4 driver. 
A, B stage 12, C, D stage 14, E, F stage 17. 
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Figure 5.7.3: Him transcript, PCE reporter gene and Zfh-1 protein 
expression co-localise in embryos expressing the dominant-negative form 
of Tinman under the control of hand-Gal4. 
Confocal microscopy images of embryos triple labelled for the Him RNA 
transcript, LacZ reporter gene and Zfh-1 expression. A, B: Him FISH, C,D: 
LacZ expression, E, F: Zfh-1 expression, G, H: merge of all three images, Him 
staining in blue, LacZ in red and Zfh-1 in green. 
A, C, E, G Wild-type expression pattern of the Him transcript, PCE and Zfh-1 
on a stage 13 OR embryo. B, D, F, H The expression of the Him transcript and 
PCE is reduced in embryos expressing the dominant-negative form of Tinman 
under the control of hand-Gal4. The arrow indicates a single Zfh-1 positive 
nucleus that does not express Him or the PCE reporter gene. 
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observed very often, it is possible that the time point at which Tinman function is 
essential for Him expression is not much earlier than the onset of driver activity which if 
a cell were to lag behind could generate a pericardial cell lacking Him expression. This 
result also shows that the expression of zfh-1 is most likely independent of late Him 
presence. 
 
 
5.8 Him expression in embryos that completely lose late Tinman 
function 
 
The removal of Tinman function is most likely incomplete when the dominant-
negative form of Tinman is expressed and this needs to be taken into consideration in 
the interpretation of the above results. Another way to analyse the importance of 
Tinman function for Him expression is the use of the tinABD-1B2; tin346/TM3 evelacZ 
fly line generated in R. Bodmer and M. Frasch’s labs (Zaffran et al., 2006). These flies 
carry a time-defined Tinman rescue element (tinABD-1B2) on the second chromosome 
within a tinman null mutant background over a “blue balancer” on the third 
chromosome (tin346/TM3 evelacZ). These flies express tinman during the early stages of 
embryonic development but lose tinman expression during stage 11, allowing for a 
normal early specification and development of the mesoderm and the dorsal mesoderm 
that contains the heart progenitors until the loss of Tinman is triggered (Zaffran et al., 
2006). The loss of Tinman at later developmental stages in this fly line is “complete” 
and does not depend on protein interactions like the dominant-negative form of Tinman. 
The loss of Tinman expression in these embryos also occurs, according to the literature, 
slightly earlier as in the embryos expressing the dominant-negative Tinman with the 
hand- (late stage 12 onwards) or Him-Gal4 (stage 11/12 onwards) drivers. 
As can be seen in Figure 5.8.1, while Him expression levels in the tinABD-1B2; 
tin346/TM3 eveLacZ embryos are slightly reduced, the Him transcript is present in these 
embryos. Similar to a tinman null mutant and to the dominant-negative experiment, 
heart cells are also disorganised or missing from stage 11/12 embryos onwards as 
described by Zaffran et al. (2006). While Him expression is affected to a low degree as 
can be seen by the reduced intensity of the staining in these embryos, neither this nor 
the dominant-negative experiment completely abolish Him expression in the developing  
 
!"#$%&'()((*+,-#,('&./0#%&1(2+-(&3$'&11+4,! "#$!!
 
 
 
 
 
Figure 5.8.1: Him transcript expression levels are weakened if Tinman 
function is lost after stage 11. 
Expression pattern of Him in wild-type and tinABD-1B2; tin346/TM3 eve LacZ 
transgenic embryos.  
A, B, C Wild-type expression pattern of the Him transcript. D, E, F Loss of 
tinman transcription from stage 11 (tinABD-1B2; tin346/TM3 eve LacZ ) onwards 
reduces Him transcript levels only slightly. 
A, D stage 12, B, E: stage 13, C, F stage 15 
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embryo. This indicates that, while Tinman is absolutely necessary to activate Him 
expression during the early stages of heart development (stages 10, 11; see section 5.2), 
Tinman is only a contributing factor in the maintenance of Him expression during later 
stages of heart development. These results are also supported by the experiments 
detailed in section 5.7. There is however the possibility that some Tinman protein might 
still be present during the later stages of development even though its transcription has 
stopped as a protein is often more stable than its RNA transcript and there will also be a 
delay in the loss of Tinman function following the loss of tinman expression (Zaffran et 
al., 2006).  
 
 
5.9 Discussion 
 
Tinman is one of the earliest markers for the developing dorsal mesoderm and 
the Drosophila heart, which develops from this dorsal mesoderm. Here, I have shown 
that Tinman is a necessary activator of Him transcription in the early stages of heart 
development and that Tinman contributes towards the full level of Him expression 
during the later stages of heart development. In cases where the function of Tinman is 
reduced or abolished in these later stages (stage 11 or slightly later), the Him transcript 
is still expressed in the majority of the remaining pericardial cells but at reduced levels. 
Tinman function is, however, still necessary for the expression of Him in some 
pericardial cells as it is possible to detect the occasional single pericardial cells that does 
not express the Him transcript but does express the pericardial cell marker Zfh-1. In the 
future it might be interesting to screen for any differences in the susceptibility of the 
subsets of the pericardial cells to the loss of Him expression if Tinman function is 
interfered with. I would expect that the Tin- and Eve-positive pericardial cells are more 
likely to be affected in these experiments than the Odd-positive pericardial cells as 
tinman is not expressed in the Odd-pericardial cells after the initial specification of the 
dorsal mesoderm and heart precursors. However, any such experiments are complicated 
by the loss of heart cells (and any positional information derived from the full set of 
heart cells) that accompanies the loss of tinman and thus these studies will need careful 
co-labelling with markers for the individual sub-sets of pericardial cells. This is further 
complicated by the fact that some of the commonly used markers for these cells are 
dependent on Tinman function for their expression, e.g. Even-skipped and Seven-up 
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(Knirr and Frasch, 2001; Han, Z. et al., 2002; Jagla, 2002) and that Tinman itself is a 
marker for a sub-set of pericardial cells. 
In this chapter I have also shown that the PCE is able to reproduce the 
expression patterns described for the endogenous Him transcript (see chapter 3) on its 
own and also in response to alterations in Tinman function. The PCE is thus not only 
able to faithfully reproduce the cardiac Him expression pattern in a wild-type 
background but also reacts faithfully to changes of at least one known Him regulator, 
Tinman. In addition, the PCE fragment is the only known way to label all embryonic 
pericardial cells until late embryonic stages, when the expression of zfh-1 is lost from 
the Eve-positive pericardial cells. Thus, the PCE is a useful tool for the study of the 
complete pericardial cell population during their complete embryonic life. 
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Chapter 6 
 
Further regulatory input in Him expression 
 
6.1 Introduction 
  
Tinman cannot be the only regulator of Him expression as shown by the 
expression pattern of the PCE construct. If this was the case Him expression should 
mirror tinman expression exactly. However, tinman is expressed in both, cardioblasts 
and pericardial cells and additionally, it is not expressed in all pericardial cells (Bodmer 
et al., 1990; Bodmer, 1993). Only a sub-set of six of the ten pericardial cells express 
tinman. The remaining four pericardial cells, the Odd-positive cells, lose tinman 
expression during stage 12 of the embryonic development (Ward and Coulter, 2000; 
Ward and Skeath, 2000). However, Him and PCE expression persists in these cells after 
the loss of tinman and Him and the PCE are not expressed in the cardioblasts (see 
introduction and chapter 3). 
Usually, several different transcription factors confer the temporal and spatial 
specificity to one downstream target, so it is highly unlikely that Tinman is the only 
regulating input involved in Him expression. All this points to the necessity of at least 
one further activator for the remaining four pericardial cells that also express Odd-
skipped and at least one repressor for the cardioblasts in which tinman is also active, but 
Him is not. It is also possible that Him expression in all pericardial cells is initiated by 
Tinman during the early stages of heart development, but then needs further cues to 
maintain its expression in at least the Odd-positive pericardial cells. The results from 
chapter 5 (sections 5.2, 5.7 and 5.8) show indeed that while the presence of Tinman is 
essential during the early stages of heart development, it is of lesser importance at later 
stages of heart development. 
As none of the putative regulators found in the bio-informatic analysis were very 
strong candidates for this additional activator (see chapter 4) based on the conservation 
of the potential transcription factor binding sites, I decided to do a combination of a 
deletion analysis and a “Linker Scan” analysis of the PCE to identify further regulators. 
McKnight and Kingsberry (1982) and Mohun et al. (1989) describe the technique of 
“Linker Scanning mutation”. I based both of these approaches on the regions of 
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conservation I identified during my computational analysis of the PCE sequence (see 
chapter 4). 
 This approach is based on the assumption that conservation in transcribed and 
non-transcribed DNA regions occurs because of a functional constraint placed upon 
these sequences. This functional constraint could be the binding of a transcriptional 
regulator to the DNA in non-coding areas. By replacing stretches of conserved sequence 
with different, unrelated sequences, I aimed to uncover regions of regulatory importance, 
as the expression pattern of the reporter gene in the Linker Scan constructs should be 
altered if this is the case. To test this hypothesis I mutated sequences of 5, 10 or 11 bp 
lengths within the context of the complete PCE sequence and then analysed the resulting 
construct and its expression pattern in vivo. 
The results I present here are a combination of the results of the Linker Scan 
analysis and a deletion analysis based on the conserved regions identified during the bio-
informatic analysis. 
 
 
6.2 Him expression is repressed in the cardioblasts. 
  
As explained above, the fact that Tinman is an activator for Him expression 
generates a requirement for at least one repressing factor to exclude Him expression 
from the cardioblasts. 
The first conserved region with the PCE sequence is relatively close to the 5’ 
end of the wild-type PCE construct (see chapter 4 and also Figure 6.2.1). The PCE S4 is 
a deletion construct that removes the most 5’ 67 bp of PCE sequence but retains the first 
conserved region and some of the non-conserved 5' sequence. Both reporter constructs, 
PCE and PCE S4, have the same expression pattern (see Figure 6.2.1). However, if the 
upstream 5’ deletion is extended up to the first conserved region (the PCE reg1 reporter 
construct), the construct shows ectopic reporter gene expression in all cardioblasts (see 
Figure 6.2.1 C). The observed ectopic expression in the PCE reg1 construct is at a 
slightly reduced level when compared to the wild-type PCE construct but above any 
background levels. This PCE reg1 construct was made based on the computational 
analysis of the PCE enhancer (chapter 4) and starts exactly at the beginning of the first 
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conserved region. Based upon the detection of the ectopic expression in the cardioblasts 
I investigated the area around this deletion and upstream of it further. 
 The logical conclusion from these results is that there is a binding site that is 
located 5’ to the region where the first conserved region begins. Assuming that the 
degree of conservation I observed for this area has a functional importance and in order 
to rule out that I inadvertently disturbed a binding site at the very beginning of the PCE 
reg1 deletion construct, I created a further deletion construct. This extends the PCE reg1 
construct by 6 bp in its 5’ direction and is called PCE extreg1. If this construct is not 
expressed in the cardioblasts, the area responsible for preventing PCE expression in the 
cardioblasts is located at the very beginning of the first conserved region. Interestingly, 
the PCE extreg1 construct also induces ectopic reporter gene expression in the 
cardioblasts at similar levels observed for the PCE reg1 construct (see Figure 6.2.1). 
This indicates that there is a repressor binding site upstream of the conserved region1 in 
the non-conserved sequence up to the start of the PCE S4 construct. 
Based on these results, I re-evaluated the results of my bioinformatic analysis of 
the 39 bp between the PCE extreg1 and the PCE S4 constructs again for the presence of 
known sites for transcription factors that are expressed in the cardioblast. Even with less 
stringent criteria (accepting more mismatches to the consensus sequences and ignoring 
the degree of conservation between the Drosophila species) the region deleted between 
the PCE reg1 and PCE S4 constructs contained no promising candidates for regulatory 
factors. Interestingly, this stretch of 39 bp does contain a stretch of 14 consecutive 
Adenines. Consecutive A-stretches in DNA are known to alter the 3-dimensional 
structure of the DNA and introduce bends (Koo et al., 1986). These consecutive 
Adenine stretches have been shown to have an influence on the regulation of 
transcription (Lavigne et al., 1997; Olivarez-Zavaleta et al., 2006). Adenine-Thymine 
base pairing also only requires two hydrogen bonds, making it easier to separate the two 
complimentary DNA strands from each other. This is likely to have an influence on the 
surrounding sequences and possibly might have a regulatory significance. For a 
comprehensive review of the role of Adenine tracts see Haran and Mohanty, 2009. 
Within this region I also created two Linker Scan constructs (called PCE LSA 
and PCE LSA1-5) that target the start of the first conserved region of the PCE sequence. 
Both constructs cover the same region and alter the sequence at the very beginning of 
the first conserved region. The PCE LSA construct mutates 9 bp from tattcccaagc to 
GCtCTAGaGCA and the PCE LSA1-5 construct mutates the first 5 bp from tattc to  
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Figure 6.2.1: The deletion constructs PCE reg1 and PCE extreg1 
show ectopic expression in the cardioblasts. 
A Schematic representation of the reporter constructs used in this Figure. 
B Wild-type expression pattern of the full length PCE reporter construct 
in the heart. C The expression pattern of the PCE S4 reporter construct is 
not distinguishable from that of the full length construct. D The PCE 
extreg1 deletion causes ectopic expression in all the cardioblasts (arrow). 
E The PCE reg1 construct also shows ectopic expression in the 
cardioblasts (arrow), this deletion is 5 bp shorter than the PCE extreg1 
deletion. 
!"#$%&'()((*+'%"&'('&,+-#%.'/(01$+%(01(203(&4$'&550.1! "#$!!
GCGGA. Each mutated sequence was screened with the same tests that were used for 
the computational analyses in Chapter 4 to rule out the introduction of any already 
known binding sites by the introduced mutation. As can be seen in Figure 6.2.2 both 
constructs introduce strong ectopic expression in the cardioblasts, similar to what I 
observed for the PCE reg1 and PCE extreg1 constructs. However, different to what I 
observed in those constructs the ectopic expression in the cardioblasts in the PCE LSA 
and PCE LSA1-5 constructs appears very strong and robust. There are several possible 
explanations for the difference in reporter gene expression strength between the PCE 
LSA, PCE LSA1-5, PCE reg1 and PCE extreg1 constructs. All fly lines were generated 
through random integration of the construct into the fly genome, thus it is not 
predictable if the integration happens in a transcriptionally accessible part of the 
genome or not. However, for each construct multiple transgenic lines were analysed 
(see Figure 5.3.1). Furthermore, it needs to be taken into consideration that the Linker 
Scan constructs carry the mutation in the context of the complete PCE sequence while 
the PCE reg1 and PCE extreg1 deletion constructs are missing part of the 5’ sequence of 
the PCE. This deleted region could potentially contain binding sites for factors that are 
necessary for the strong expression of the reporter construct. It is also possible that, as 
all four constructs target a small area, only the Linker Scan constructs (PCE LSA and 
PCE LSA1-5) affect the core binding area of the cardioblast repressor while the deletion 
constructs (PCE reg1 and PCE extreg1) have a lesser effect on the ability of the 
repressor to bind to this region, thus quite likely causing a weaker reporter expression in 
the cardioblasts. 
A further explanation for the difference in expression could be the presence of 
two separate binding sites for the repressor. The results of the PCE S4 and PCE reg1 
constructs implies that the negative regulator lies downstream of the PCE S4 cut-off and 
upstream of the first base of the PCE extreg1 construct. Re-evaluation of the sequence 
region targeted by the PCE LSA and PCE LSA1-5 constructs showed a putative binding 
sites for Scalloped and a GATA site which I initially discarded under the applied 
stringency criteria (see material and methods, chapter 2) as both were neither good 
matches for the described consensus nor were the sites completely conserved between 
the different Drosophila species used to generate the alignment for the foot-print (see 
chapter 4). However, the above described results point strongly to the importance of this 
region. This has led me to investigate these two putative Him regulators despite the 
above-mentioned initial reservations. 
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Figure 6.2.2: Mutation of the beginning of the conserved region 1 also 
induces ectopic expression in the cardioblasts (arrows). 
A Schematic representation of the reporter constructs used in this Figure. 
B Wild-type expression pattern of the full length PCE reporter construct 
in the heart. C Mutating 9 bp at the beginning of the conserved region 1 
as done in the PCE LSA construct induces ectopic expression in all 
cardioblasts. D Shortening this mutation to 5 bp still induces ectopic 
expression in all cardioblasts. 
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 The first of these two sites is a Scalloped binding consensus. The Scalloped 
binding consensus as it occurs in the PCE sequence has a number of substituted bases 
(AGATATTC in the PCE sequence vs. WVDWATKY as published in Halder et al., 
1998), which are likely to at least render any binding of it to this sequence weaker. 
While the majority of these substitutions have been previously described, the site has 
not been described in the form it has in the PCE sequence (Halder et al., 1998; Halder 
and Carroll, 2001). The core ATG binding motif is also not conserved in the PCE 
sequence. In addition to these factors, the putative binding site is not conserved in two 
of the screened Drosophila species, D. mojavensis and D. virilis. The Scalloped protein 
is the only member of the Transcriptional Enhancer Factor-1 (TEF-1) family of proteins 
in Drosophila (Campbell et al., 1992). Scalloped has mainly been described in 
Drosophila wing and bristle development (Campbell et al., 1991; Campbell et al., 1992; 
Bray, 1999). In order to test if Scalloped is expressed in the heart, I generated a RNA 
probe for the scalloped gene (from DGRC cDNA clone RE23308). Figure 6.2.3 shows 
the results of this RNA in situ. My scalloped probe generates a lot of background and 
only a small amount of specific staining. I observed some expression in the somatic 
mesoderm but not in the developing embryonic heart. Based on this experiment, I 
cannot rule out any scalloped expression in the heart as the quality of the probe is too 
poor. Indeed, Deng et al. (2009) report Scalloped expression in the cardioblasts and the 
developing somatic mesoderm at stage 13 and Guss et al. (2013) report Scalloped 
expression in the mesoderm. As the majority of the heart cells are generated in stages 11 
and 12, this reported expression is slightly later than necessary for Him repression in the 
cardioblasts, but, as it is specific for the cardioblasts and nothing is stated about earlier 
expression of scalloped in the developing heart or dorsal mesoderm, the results of Deng 
et al. make Scalloped a strong candidate. Further experiments to analyse the expression 
of Him and PCE in scalloped null or hypomorph mutants are necessary to verify this. 
 
Members of the GATA transcription factor family are expressed in the 
developing heart and regulate the expression of cardiac specific genes in vertebrates 
(Molkentin, 2000; Latinkic et al., 2003). The only GATA factor that is known to be 
involved in the development of the embryonic Drosophila heart is Pannier (Gajewski et 
al., 1999; Gajewski et al., 2001; Alvarez et al., 2003; Klinedinst and Bodmer, 2003). 
pannier is expressed in both, the dorsal ectoderm and the dorsal mesoderm. 
Additionally, pannier is expressed uniformly in all heart cells of Drosophila, both  
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Figure 6.2.3: The scalloped transcript is expressed in the somatic 
mesoderm but not in the cardiac mesoderm.  
A Lateral view of a wild-type embryo (OR) labelled for the scalloped RNA 
transcript. Expression can be seen in a segmentally repeated pattern. B 
Dorsal view of the same embryo as in (A). The scalloped transcript is 
expressed in the mesoderm (arrow) and not in the ectoderm of the embryo. 
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cardioblasts and pericardial cells. So far, Pannier has only been described as an 
activating factor for transcription. The uniform expression of pannier throughout the 
dorsal ecto- and mesoderm does not necessarily imply that the function of the Pannier 
protein is the same in all mesodermal cells as GATA-factors have been shown to 
function together with co-factors. U-shaped is the main co-factor described as working 
together with Pannier and is, like pannier, expressed in both the dorsal ecto- and 
mesoderm (for reviews see: Cantor and Orkin, 2004; Sorrentino et al., 2005). U-shaped 
is mainly required for the maintenance of gene expression and the correct differentiation 
of both cardiac cell types (Klinedinst and Bodmer, 2003). It is possible that different 
heart cells express different co-factors for Pannier and thus could generate different 
specificities for different cell types. This would enable Pannier to function as a 
transcriptional repressor of Him in the cardioblasts without repressing Him expression 
in the pericardial cells. 
In order to test my hypothesis that Pannier (together with a co-factor) is 
responsible for repressing Him expression in the cardioblasts, I initially tried to analyse 
the expression of the Him transcript in pannier null mutant embryos (pnrVX6). However, 
as described previously, the loss of heart cells in these animals is nearly complete from 
an early stage (embryonic stage 12) onwards, making the analysis of the Him expression 
pattern in these embryos very difficult (see Figure 6.2.4 B). Similar observations have 
previously been published (Heitzler et al., 1996, Klinedinst and Bodmer, 2003). The 
identity of the remaining heart cells has yet to be studied using the expression of marker 
genes and it is currently not possible to identify if specific sub-sets of the cardioblasts 
and/or pericardial cells are more affected by the loss of pannier than others.  As U-
shaped is the most common co-factor for Pannier, I also analysed the Him expression 
pattern in embryos null mutant for u-shaped (Df(2)ushrev18; see Figure 6.2.4.C; Cubadda 
et al., 1997). Klinedinst and Bodmer, 2003 describe this line as losing its heart 
precursors from embryonic stage 11. In my experiment, I obtained similar results. I 
observed large gaps in the heart making an analysis of the Him expression pattern 
impossible. Next, I tried to analyse the Him expression pattern in embryos carrying a 
hypomorphic allele of u-shaped (ush2) as its phenotype is less severe (Fossett et al., 
2000). As can be seen in Figure 6.2.4 D, while there are fewer gaps in the developing 
heart, the general anatomy of the embryo is still quite disturbed, making an in depth 
analysis of the Him expression pattern impossible. However, the remainder of the Him 
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expression pattern is close to its wild-type pattern, indicating that u-shaped most likely 
is not involved in the transcriptional regulation of Him. 
 Another approach to reduce Pannier and U-shaped activity is the UAS-pnrD4 
expression construct generated in the Bodmer lab (Klinedinst and Bodmer, 2003). In 
this construct the ability of Pannier to interact with at least one of its co-factors, U-
shaped, is inhibited. When under the control of the pan-mesodermal driver twi-Gal4; 
24B-Gal4 this leads to a stronger and broader activation of tinman expression, 
indicating that U-shaped functions in restricting tinman expression in this context 
(Klinedinst and Bodmer, 2003). As can be seen in Figure 6.2.4 E Him expression is 
stronger in these embryos. The band of Him expression in the pericardial cells is wider 
than in wild-type animals, but I have not been able to observe any ectopic expression of 
the Him transcript in the cardioblasts or other tissues that would normally not express 
Him. The observed wider band of Him expression is most likely a secondary effect on 
the Him expression due to the reported effect this experiment has on the expression of 
tinman and the increase in all heart cells associated with it (Klinedinst and Bodmer, 
2003). This observation is based on the position and shape of the cells stained positive 
for the Him transcript, in order to unambiguously identify these cells as pericardial cells 
a double-labelling experiment with a pericardial cell marker such as Zhf-1 and a 
cardioblast marker such as Mef2, will be necessary. 
My next approach for analysing Him expression in a pannier loss-of-function 
background was to utilize the Gal4/UAS-system to ectopically express a dominant 
negative form of Pannier in the heart cells. The UAS-DN-Pnr expression construct was 
generated in the Bodmer lab (Klinedinst and Bodmer, 2003). The drivers I used were 
Mef2-Gal4 and hand-Gal4 as both are expressed in all cardioblasts and hand-Gal4 is 
additionally expressed in all pericardial cells. This should allow me to see if a (partial) 
removal of Pannier from the cardioblasts is capable of inducing ectopic Him expression 
indicating a repressor function for Pannier and also possibly give me an indication if 
removal of Pannier in the pericardial cells leads to a reduction of Him expression in the 
pericardial cells as Pannier is also a possible activator for Him expression in the 
pericardial cells. As can be seen in Figure 6.2.5 there is no loss of Him expression in the 
pericardial cells if driven with hand-Gal4 ruling out Pannier as an activating influence 
on Him expression in the pericardial cells. The driver I used for this experiment needs to 
be taken into consideration. hand-Gal4 starts Gal4 expression relatively late, a repeat of  
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Figure 6.2.4: Him expression in pannier and u-shaped mutants. 
A Lateral view of a stage 13 wild-type embryo (OR) labelled for the Him 
RNA transcript. B Him expression pattern in an embryo null mutant for 
pannier (pnrVX6). The gaps (arrow) in the expression pattern are caused by 
pronounced cell loss in the dorsal regions of the embryo. C Labelling the 
Him transcript in an embryo null mutant for u-shaped (Df(2)ushref18) shows 
a very severe loss of the cells of the dorsal mesoderm, there are gaps 
(arrow) within the Him expression pattern. D Him expression pattern in a u-
shaped hypomorphic embryo (ush2). While less severe than the previous 
two shown fly lines, the heart development is still too disturbed to allow for 
the analysis of the expression pattern of the Him transcript. The remaining 
Him expression pattern is very similar to wild-type. E Expanded expression 
pattern of the Him transcript in the heart region (arrowhead) in a stage 13 
embryo expressing the UAS-pnrD4 construct under the control of the Him-
Gal4 driver. Ectopic Him expression in the cardioblasts was not observed. 
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 When the dominant-negative form of Pannier is expressed in the cardioblasts 
using Mef2- and hand-Gal4 drivers, there appears to be some additional expression in 
these cells as can be seen in Figure 6.2.5 (arrows). However, although the expression of 
the dominant-negative form of Pannier leads to a less severe phenotype than in the 
previously described pannier mutants, there is still a certain degree of cell loss in the 
heart which in turn results in gaps and organisationally differences in the heart structure. 
As cardioblasts lose their direct neighbours and cellular context within the heart, they 
also seem to lose their distinctive cell shape. This makes it difficult to unambiguously 
identify any cell as a cardioblast or pericardial cell without an additional cell type 
marker. To aid in the identification of the different heart cells, I double-labelled 
embryos driving the dominant-negative form of Pannier under the control of Mef2-Gal4 
and hand-Gal4 with a Him FISH and ß3-tubulin fluorescent immuno-stain which is 
expressed in four of the six cardioblasts and the developing somatic mesoderm. If the 
loss of some Pannier function leads to ectopic Him expression in the cardioblasts and 
does not affect the expression of ß3-tubulin in these cells, I should be able to observe 
co-expression of the Him transcript and the ß3-tubulin protein in the cardioblasts. As 
can be seen in Figure 6.2.6 this is not the case, the Him transcript and the ß3-tubulin 
protein do not co-localize in the same cells in the heart. Thus, Pannier is most likely not 
involved in the regulation of Him expression in the ß3-tubulin-positive cardioblasts. As 
ß3-tubulin is not expressed in the remaining two cardioblasts per hemisegment, I cannot 
comment upon the role of Pannier in these two cells. I also cannot rule out that my 
observed results are due to non-complete removal of functional Pannier from the cells 
the dominant-negative form was expressed in, as this indirect approach will not have 
removed all Pannier activity. 
 
 In summary, these results indicate the possibility of two separate, as of now still 
unidentified, repressors acting on the 5’ end of the PCE sequence to limit Him 
expression in the cardioblasts. The distance between the beginning of the PCE extreg1 
construct and the first mutated basepair of the PCE LSA1-5 is 11 bp. This length is 
exactly one turn of the DNA double helix, thus it is possible that complexes that rely on 
binding sites further away are still capable of binding. While I cannot rule out a large 
repressor complex that requires both regions to be present and intact to function, the 
distance of 11 bp between the beginning of the PCE extreg1 construct and the first 
mutated basepair of the PCE LSA1-5 construct is larger than the most common length 
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Figure 6.2.5: Him expression in embryos expressing a dominant-
negative form of Pannier. 
A Lateral view of a stage 13 wild-type embryo (OR) labelled for the 
Him RNA transcript. B Him expression pattern in an embryo 
expressing the dominant-negative form of Pannier under the control of 
the Mef2-Gal4 driver. There is an increase in Him expression (arrow). 
C Him expression pattern in an embryo expressing the dominant-
negative form of Pannier under the control of the hand-Gal4 driver. 
Similar to (B), there is an increase in Him expression, which is most 
likely due to general cardiac hyperplasia (arrow). 
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Figure 6.2.6: The dominant-negative form of Pannier does not induce 
ectopic Him expression in the cardioblasts. 
Fluorescent In Situ Hybridisation (FISH) for Him (green in overlay) and 
fluorescent antibody labelled for ß3-tubulin (red in overlay). 
A-C Stage 14/15 wild-type embryo (OR). Him and ß3-tubulin expression 
do not overlap (arrow). A Him FISH, B ß3-tubulin antibody, C overlay D-F 
Stage 13 embryo expressing the dominant-negative form of Pannier under 
the control of the Mef2-Gal4 driver. Him and ß3-tubulin expression do not 
overlap (arrow). D Him FISH, E ß3-tubulin antibody, F overlay. G-I Stage 
13/14 embryo expressing the dominant-negative form of Pannier under the 
control of the hand-Gal4 driver. The Him transcript and the ß3-tubulin 
antibody do not colocalize (arrow). G Him FISH, H ß3-tubulin antibody, I 
overlay. 
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of a typical binding site, the core motif of which is usually between five and ten 
basepairs of length. This strengthens the argument for two separate binding sites. One 
also needs to consider that these regions can have a function in shaping the “landscape” 
of the DNA, and not necessarily in transcription factor binding. For example 13 bp into 
the PCE S4 sequence there is a stretch of fourteen continuous adenine bases. As 
previously mentioned, this long repeat of one base will change the landscape of the 
DNA and it is possible that this three dimensional structure due to the long Adenine 
repeat is necessary to prevent PCE and Him expression in the cardioblasts. In this 
context it is also notable to mention again that the ectopic expression observed in the 
cardioblasts is slightly weaker in the PCE reg1 and PCE extreg1 constructs than in the 
PCE LSA and PCE LSA1-5 constructs, further substantiating the possibility of two 
different regulatory mechanisms at work or that one mechanism necessary for Him 
expression in the cardioblasts is affected in two different ways in these four constructs. 
 
  
6.3 Him expression is repressed in the amnioserosa 
  
Additional analysis identified a further repressor active in the dorsal part of the 
embryo. Two separate 3’ deletion constructs reveal at least one repressor that is 
necessary to exclude reporter gene expression from the amnioserosa cells. As 
mentioned in chapter 5, the PCE !tin2 construct induces ectopic expression in the 
amnioserosa cells while losing expression of its reporter in the pericardial cells (see 
Figures 5.3.1 and 6.3.1). A smaller deletion construct, PCE S2, made previously in the 
lab (S. McConnell and M. Taylor, unpublished results) also shows ectopic, but slightly 
weaker, expression in the amnioserosa (see Figure 6.3.1). PCE S2 only deletes the 3’ 40 
bp of the PCE sequence while the PCE !tin2 construct deletes the 3’ 198 bp of the PCE 
sequence. As both deletion constructs show a similar ectopic expression pattern in the 
amnioserosa cells, the most likely explanation for this is that the most 3’ 40 bp of the 
PCE sequence contain a repressor binding site. Again, it is possible that there are two 
different repressors or a large complex at work as the shorter deletion construct gives 
weaker ectopic expression than the larger deletion. However, the computational analysis 
(see chapter 4) has not highlighted any potential known binding sites necessary for the 
maintenance of the amnioserosa. Possibilities are the members of the u-shaped family 
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Figure 6.3.1: The 3’ end of the PCE construct contains an 
amnioserosa repressor. 
A Schematic representation of the reporter constructs used in this 
Figure. B Wild-type expression pattern of the full length PCE reporter 
construct in the heart. Lateral view. C The expression pattern of the 
PCE S2 reporter construct shows ectopic expression in the 
amnioserosa cells (arrow) while the reporter expression in the heart is 
lost. Dorsal view. D Animals carrying the PCE !tin2 construct show 
similar ectopic expression in the amnioserosa (arrow). Dorsal view. 
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of genes (u-shaped, hindsight, serpent, tail-up, dorsocross1, dorsocross2 and 
dorsocross3) as all of them have been shown to be necessary for the maintenance of the 
amnioserosa (Reim et al., 2003; Hamaguchi et a., 2004); in mutants for these genes the 
amnioserosa cells enter apoptosis and the amnioserosa degenerates (Frank and Rushlow, 
1996). Further investigation into the role of any of these genes in Him regulation might 
uncover a second repressor. 
 
 
6.4 Hand does not activate Him expression 
 
The bioinformatic analysis described in chapter 4 also highlighted several E-
boxes within the PCE sequence. The only bHLH transcription factor known to be 
expressed in the heart is Hand. Hand (heart, autonomic nervous system, neural crest-
derived cell types) is a bHLH transcription factor expressed in all heart cells as well as 
in the lymph and garland gland, the visceral mesoderm and a few cells of the nervous 
system (Moore et al., 2000; Kölsch and Paululat, 2002). The consensus binding 
sequence for bHLH transcription factors is called an E-box and has the general 
sequence of CANNTG (Ferré-D’Amaré et al., 1993; Ellenberger et al., 1994; Ma et al., 
1994). The two core basepairs and the surrounding sequences give an E-box its 
specificity for different bHLH transcription factors (Dang et al., 1992; Blackwell et al., 
1993). It is currently unknown which sequence the two core base pairs need to have in a 
Hand E-box. 
Within the PCE sequence there are four E-box sequences. Two of these four E-
box sequences are contained within the consensus for the Tinman (CACTTGA). The 
third of the E-boxes is located in the non-conserved sequence between the conserved 
regions 1 and 2 and the fourth E-box is located just at the beginning of the conserved 
region 2 of the PCE sequence. 
In order to see if Hand is at all involved in the regulation of Him, I analysed the 
expression of the Him and hand transcripts in the deficiency line w1118; Df(2L)Exel7046 
(BDSC, Bloomington stock 7819). This line is a large deletion from 31B1 to 31D9 of 
the left arm of the second chromosome that contains the hand gene and 14 other genes. 
As can be seen in Figure 6.4.1 embryos homozygous for this BL7819 deficiency do not  
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Figure 6.4.1: Hand does not regulate Him expression. 
hand (A,B) and Him (C,D) RNA In Situ Hybridisation on wild-type and hand-
deficient embryos. 
A Expression pattern of the hand transcript in wild-type embryos (OR). B 
Embryos null mutant for the hand gene do not show any hand transcript 
expression. C Him transcript expression pattern on wild-type embryos (OR). 
D The expression pattern of the Him transcript is unaltered in embryos null 
mutant for the hand gene. 
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express any hand transcript (compare 6.4.1 B to the wild-type in 6.4.1 A) confirming 
that this line is deficient for hand. However, Him expression is completely normal in 
embryos homozygous for this deficiency (see 6.4.1 D). This result indicates that Hand 
(or any of the other genes affected by the deficiency) is not involved in the activation of 
Him expression. 
 
 
6.5 Relevance of the E-box sequence contained within the 
Tinman binding consensus 
 
While examining the presence of the E-boxes within the PCE sequence, I noted 
that the Tinman consensus also contains an E-box. The presence of E-boxes in the 
Tinman consensus binding site has so far not been analysed. The only reference 
regarding the E-box contained in the most common Tinman consensus that I have been 
able to find is within the discussion of the Durocher et al. (1996) paper. All previously 
published mutations that have been shown to disturb Tinman binding, target the four 
main basepairs of the E-box sequence within the Tinman binding consensus. 
In order to investigate if the Tinman binding consensus is functional in vivo 
without the E-box, I targeted the S5 site, which I have shown to be necessary for PCE 
activation and to be responsive to Tinman, with two further point-mutations in separate 
constructs. In each construct I mutated only one basepair within the PCE sequence. The 
PCE*S5C-T (TTAAGTG) changes the first C of the E-box sequence within the S5 
Tinman binding site to a T. This should generate a still functional Tinman binding site 
while destroying the E-box. The thus created Tinman binding site has been identified 
and described as functional in vivo by Kremser et al., 1999; Gajewski et al, 1997; Han 
and Olson, 2005. Ozdemir et al. (2011) describe how the introduction of a single 
basepair mutation into the E-box sequence (from CANNTG to GANNTG) within the 
rho enhancer limits reporter expression to a narrower domain and was thus successful in 
interfering between the binding site and its activating protein. 
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Figure 6.5.1: Single basepair mutations introduced into the PCE 
sequence to test the importance of the E-box contained within the 
Tinman binding consensus. 
A Wild-type expression pattern of the full length PCE reporter construct in 
the heart. B Changing the first C of the Tinman binding site to a T, 
maintaining a functional Tinman site but mutating the E-box does not alter 
the reporter gene expression pattern. C Mutating the 5’ T to an A, which 
leaves the E-box intact, also does not alter the expression pattern of the 
reporter genes. 
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The PCE*S5T-A mutation (ACAAGTG) mutates the first base of the S5 Tinman 
binding site from a T to an A. This should not affect the core of 6 bp of the E-box 
binding while destroying the ability of Tinman to bind to this site. According to the 
position weight matrix shown in Figure 5.5.1 (see chapter 5; Zinzen et al., 2009) it is 
highly unlikely for an A to occur in this position in a functional Tinman binding site. As 
can be seen in Figure 6.5.1 neither of the so mutated reporter construct results in a 
change of the expression pattern of the reporter gene in the heart of Drosophila embryos. 
As neither mutation appears to have an effect in vivo, there are two conclusions that can 
be drawn. A possible explanation is that the presence of the E-box within the Tinman 
binding site sequence is of no direct importance for Him expression. If the site is still 
capable of binding Tinman, the destruction of the E-box has no effect on the expression 
of Him in the pericardial cells. It is also possible that mutating just one basepair of the 
whole Tinman/E-box consensus site is not sufficient to interfere with any transcription 
factor binding. This is supported by the fact that the four basepair mutation of the 
Tinman consensus binding sequence described in chapter 5 renders the reporter 
construct inactive and non-responsive to Tinman. Consequently, I expected a similar 
result for the PCE *ST-A construct, which was created with the aim of destroying any 
ability of Tinman to bind to the S5 site. An EMSA will be necessary to verify if these 
mutations affect Tinman binding or not in vitro. 
A further explanation of these results is that both Tinman and a bHLH factor are 
capable of activating Him transcription and Him transcription is only lost if both factors 
cannot bind to the S5 site. The identity of the bHLH factor is currently unknown, a likely 
remaining candidate is Twist. Initially the ideal Twist E-box was described as CATATG 
(Halfon et al., 2000), but recent studies show that in vivo Twist favours a CA or TG core 
(Zinzen et al., 2009, Ozdemir et al., 2011). According to these studies, Twist is unlikely 
to bind to the E-box contained within the Tinman binding consensus. As there are no 
other ways of delineating the E-box from the Tinman consensus binding site, of which 6 
of the 7 bp are part of both the E-box and the Tinman consensus binding site, I could not 
pursue this any further. 
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6.6 Further activator sites are contained within the PCE 
sequence 
 
 As explained previously, Tinman alone is not sufficient to explain the Him 
expression pattern in the pericardial cells; at least one further activator is needed. 
Combining the results from all available PCE enhancer constructs highlights the region 
between the PCE !reg1 and PCE !tin1 deletion constructs (see Figure 6.6.1).  
 The PCE !reg1 construct exhibits wild-type like reporter gene expression in the 
pericardial cells (and ectopic expression in the cardioblasts) while reporter gene 
expression is completely lost in animals carrying the PCE !tin1 deletion construct (see 
Figure 6.6.2). My previous experiments (chapter 5) have eliminated the S6 site as a 
major input into the transcriptional regulation of the PCE, the activator must be located 
upstream of this site. The difference in length between these two constructs is only 53 
bp. This area is well conserved as can be seen in the computational analysis of the PCE 
sequence in chapter 4. These 53 bp correspond to the beginning of the conserved region 
1. As explained in part 6.2 the first 5 bp of the conserved region 1 are important to 
repress activity in the cardioblasts. From the analysis of this region I can exclude the 
first 11 bp as important for the activation (see Figures 6.2.2 and 6.6.1, PCE LSA 
construct) in the pericardial cells. This leaves me with 5 bp upstream of the mutated 
PCE LSA construct and 38 bp between the end of this mutated construct (PCE LSA) 
and the beginning of the PCE !tin1 construct that should contain the potential activator 
binding site (see Figure 6.6.1). This sequence contains a consensus binding site for the 
vertebrate Oct-1 protein. The Drosophila homolog of Oct-1 is nubbin. Both, the 
vertebrate Oct-1 and its Drosophila homolog Nubbin, have been shown to be involved 
in cell fate determination (Neuman and Cohen, 1998; Irvine, 1999). Drosophila nubbin 
is mainly expressed in the ectoderm and plays an important role during neurogenesis, 
neurospecification and wing development (Ng et al., 1995; Yeo et al., 1995). So far, 
very little is known about its binding preferences. According to the only published DNA 
footprinting analyis, Nubbin has a fairly degenerate binding consensus (Neuman and 
Cohen, 1998). In their paper, Neuman and Cohen describe four different sequences that 
Nubbin protects. The putative binding site in the PCE sequence was identified with the 
vertebrate Oct-1 consensus sequence in the TRANSFAC public database. The  
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Figure 6.6.1: Expression construct overview highlighting the area 
(between the arrows) where a further activator for Him should be 
located. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6.2: Between the cut-off points for the PCE !reg1 and PCE 
!tin1 construct lies another activator site. 
A Schematic representation of the reporter constructs used in this Figure. B 
Wild-type expression pattern of the full length PCE reporter construct in the 
heart. C The expression pattern of the PCE !reg1 reporter construct is not 
distinguishable from that of the full length construct in the pericardial cells. 
D The deletion construct PCE !tin1 lacks any reporter gene expression in the 
heart. 
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Figure 6.6.3: Mutation of the vertebrate Oct-1 consensus in the PCE 
sequence does not alter reporter gene expression of the PCE. 
A Schematic representation of the reporter constructs used in this Figure. B 
Wild-type expression pattern of the full length PCE reporter construct in the 
heart. C Stage 16/17 embryonic heart of an animal transgenic for the PCE *oct1 
construct. Mutating the putative Oct-1/Nubbin binding site does not alter the 
construct’s expression pattern. 
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consensus sequence used by the TRANSFAC position weight matrix 
(NNNNATGCAAATNAN; matrix identifier V$OCT1_Q6) matches only one of the  
four protected sequences (TTATGtAAgTAACC) found by Neumann and Cohen except 
for two bases at position eight and eleven (lower cases in the protected sequence) of the 
vertebrate Oct-1 consensus sequence. So far, there are no reports of mesodermal 
expression for nubbin. However there are cases where the expression of one factor in a 
different germlayer is crucial for mesoderm development in Drosophila through an 
indirect effect of gene transcription (for example see Carmena et al., 2002). Despite this, 
I mutated five base pairs at the beginning of the vertebrate Oct-1 binding consensus 
found in the PCE sequence from CGCAAATTG to ATCCGATTG. Again, this mutation 
was checked with the bioinformatic tools available to me to rule out the introduction of 
any additional known binding sites. If this sequence of the PCE is important for its 
regulation, this mutation should alter the expression pattern of the reporter gene. As 
shown in Figure 6.6.3 this is not the case. Reporter gene expression is unaffected in 
embryos transgenic for this construct; its expression in the heart of the developing 
embryos is identical to that of the wild-type PCE construct. 
 The previous experiment rules out this area as essential for the activation of gene 
expression. This points towards the 5’ 11 basepairs upstream and the 19 basepairs 
downstream of the binding consensus for the vertebrate Oct-1 protein and the initial 5 
basepairs of the PCE !reg1 reporter construct. Further experiments aiming to find a 
second activator of the PCE and Him should concentrate on analysing these areas. The 
11 basepairs 5’ of the vertebrate Oct-1 consensus contain a potential Medea binding 
site. Medea is a downstream component of the Dpp signalling cascade (Hudson et al., 
1998; Wisotzkey et al., 1998). Dpp itself is necessary for mesoderm development (see 
chapter 1) and has been shown to be important for the development of the embryonic 
Drosophila heart (Frasch 1995). This makes the 11 basepairs upstream of the Oct-1 
binding consensus very interesting. As it is possible to mutate all 11 basepairs in one 
enhancer construct, this should be one of the next constructs to be made and tested.  
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6.7 Other sequence areas of PCE that can be excluded 
 
Initially, I chose to create further enhancer constructs based on the degree of 
conservation uncovered in my bioinformatic foot-printing analysis and search for 
potential binding sites (see chapter 4). Using this approach, I made numerous different 
PCE constructs and several deletion constructs not yet mentioned in this dissertation. 
For all these constructs I analysed either the distribution of the LacZ reporter protein or 
the lacZ transcript in the developing embryo as the protein is usually more stable and 
might obscure a more transient regulatory event that might be visible when analysing 
the expression pattern of the transcript. Constructs based upon this approach that have 
already been mentioned are the PCE !reg1, PCE !tin1, PCE !tin2, PCE LSA, PCE 
LSA1-5 and PCE*oct1 (for an overview Figure including all created reporter constructs 
please refer to the Figure 5.3.1). These constructs will not be discussed again. With the 
exception of the PCE*oct1 and the reporter constructs known to show no expression or 
ectopic expression (PCE !tin2, PCE LSA1-5, PCE LSA1-5) all these constructs were 
also analysed for the expression pattern of the lacZ RNA and no differences were found 
in regard to the protein expression pattern. 
 The PCE LSD4-9 enhancer construct mutates five consecutive base pairs 
towards the 3’ end of the first conserved region; these 5 bp are not deleted within the 
PCE !tin1 construct and are completely conserved in the bioinformatic footprint (see 
chapter 4). I chose to analyse the expression pattern of the transcript rather than that of 
the reporter protein to ensure that I would not miss any later events during heart 
development. As mentioned above, the stability of the LacZ protein might obscure more 
dynamic changes in the expression pattern. These changes are more readily visible if 
one screens for the expression pattern of the less stable lacZ transcript instead. As can 
be seen in Figure 6.6.4 B mutating the 5 bp of the PCE LSD4-9 enhancer construct does 
alter the expression pattern of the reporter gene when assayed for the distribution of the 
lacZ reporter transcript. In general the transcript is distributed similarly as in animals 
carrying the wild-type PCE construct. However, the expression pattern of the lacZ 
transcript appears much less uniform and shows repeated areas of lower and higher 
expression levels. This indicates that the sequence mutated in the PCE LSD4-9 
construct might be involved in a part of the regulation of the PCE construct and Him 
expression. 
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Figure 6.6.4: Further areas of the PCE sequence, which are not 
involved in its expression. 
lacZ In Situ Hybridisation on stage 13 embryos. 
A Schematic representation of the reporter constructs used in this Figure. 
B Wild-type expression pattern of the full length PCE reporter construct 
in the heart. C Mutation of 5 well-conserverd basepairs 3’ from the 
putative Tin1 site alters the levels of the expression of the PCE LSD4-9 
construct. D Mutation of the first 10 bp of the second conserved region 
also does not alter the expression pattern of the PCE LSE construct. E 
Changing the sequence of 10 bp towards the 3’ end of the second 
conserved region does not alter the expression pattern of the PCE LSF 
construct. 
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Two further mutated constructs, termed PCE LSE and PCE LSF, mutate 11 and 
10 bp 5’ and 3’ of the S5 Tinman binding site in the second conserved region of PCE. 
Figure 6.6.4 shows the transcript expression pattern of the reporter gene for both 
constructs. Similarly to the PCE LSD4-9 construct these two constructs do not show 
any alterations to their expression pattern when compared to the wild-type PCE 
construct. The area covered in the PCE LSE construct covers an E-box and a second 
binding consensus for the vertebrate Oct-1 protein and the PCE LSF mutation affects 
the first four basepairs of a putative AP-1 binding site (see chapter 4). A Drosophila 
equivalent to the vertebrate AP-1 family is the gene kayak, which is involved in the 
process of dorsal closure (Noselli and Agnes, 1999; Harden, 2002). As mutation of any 
of these does not affect the expression pattern of the reporter gene, all of these areas can 
be excluded from the analysis of regions involved in the regulation of the PCE fragment 
and of Him. 
 The stretch of “unconserved” sequence between the first and second conserved 
region contains several potentially interesting putative transcription factor binding sites. 
It contains two Medea sites in short succession followed by a Zfh-1 site and an E-box. In 
order to analyse this area, I created two further deletion constructs. The first one of these 
two constructs is called PCE E-box. The construct design is based upon two separate 
observations: The deletion construct PCE S1 previously created in the lab by Stewart 
McConnell deletes the 5’ 237 bp of the PCE sequence (McConnell and Taylor, 
unpublished results). As can be seen in Figure 6.6.5 this construct shows no reporter 
gene activity. While scanning the whole PCE sequence for E-boxes, I also found that 
this deletion exactly cuts off an E-box located in the unconserved sequence stretch 
between the first and second conserved regions of the PCE. The sequence of this 
particular E-box (aCACATGt) has previously been shown to be capable of binding 
Twist and to be of functional importance for the regulation of even-skipped (Halfon et 
al., 2000). Recent studies by Zinzen et al. (2009) and Ozdemir et al. (2011) have shown 
that in vivo Twist prefers a CA E-box core sequence and that Twist also has a preference 
for the surrounding nucleotides (a leading-A and lagging-T residue). These surrounding 
nucleotides for this E-box are within these preferences; thus it is a good candidate site 
for possible activation through Twist. 
 In order to determine if this E-box is of any importance to the regulation of the 
PCE fragment, I created the PCE E-box construct. This construct extends the PCE S1 
construct by 8 bp in the 5’ direction, restoring the E-box and the 3 bp upstream of it. If 
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this E-box is of relevance for the regulation of the PCE, this should restore at least some 
aspects of the PCE reporter expression. As can be seen in Figure 6.6.5, Drosophila 
embryos transgenic for this construct show a very faint reporter expression in the 
developing heart. This faint reporter gene expression has been verified in several 
independent lines (see Figure 5.3.1). This shows that this E-box is of importance for the 
expression of the reporter gene. It also shows that just the presence of the S5 Tinman 
binding site and this E-box is not enough to achieve wild-type expression levels. 
Interestingly, the longer PCE !tin1 construct does not result in reporter expression (see 
figure 5.3.1 and figure 5.3.2). This indicates that there are likely further repressor 
binding sites located in the area between these two deletions. If these binding sites are 
included within the enhancer construct, the E-box is of less importance than the 
currently unidentified activator that binds further 5'. It is thus possible that this E-box is 
of importance for modulating the expression levels of the wild-type. Twist is a good 
candidate transcription factor for binding this site. 
 A little further upstream from this E-box my bio-informatic analysis has revealed 
two potential Medea and one potential Zfh-1 binding site. These sites are also in a non-
conserved region. As discussed earlier in this chapter Medea is a possible regulator and 
Zfh-1 is the only other known factor that is expressed in all pericardial cells (up to stage 
14/15, Johnson et al., 2003; Su et al., 1999; Lai et al., 1991). I created a second deletion 
construct (PCE Medea) that extends the PCE E-box construct by adding another 35 bp in 
the 5’ direction to include these potential binding sites. Again, I assumed that if any of 
these sites were of importance in vivo, I would be able to observe a change in expression 
pattern. As can be seen in Figure 6.6.5 including these three potential binding sites 
results in a very faint expression of the reporter gene, similar to that observed for the 
PCE E-box construct. This low expression could be explained if several Medea binding 
sites (some of which are further towards the 5’ end of the PCE construct and not 
included in the PCE Medea construct) are needed to achieve full expression levels. It is 
also possible that, as the expression levels of both the PCE Medea and PCE E-box 
construct are both low, the weak levels of expression are completely due to the E-Box 
included in both constructs and the missing activator binding site I mentioned before. 
 
From these results for the PCE E-box and PCE Medea constructs, I conclude 
that the sequence of the 48 bp upstream of the starting point of the PCE S1 deletion 
construct is possibly involved in modulating PCE reporter gene expression, potentially  
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Figure 6.6.5: The PCE Medea and PCE E-box deletion constructs show 
a very faint reporter expression. 
A Schematic representation of the reporter constructs used in this Figure. B 
Wild-type expression pattern of the full length PCE reporter construct in the 
heart. C Drosophila embryo transgenic for the PCE Medea deletion 
construct which deletes the 5’ PCE sequence up to the 2 putative Medea 
binding sites in the unconserved sequence between the first and second 
conserved region. There is a faint but clear reporter expression visible. D 
The PCE E-box reporter construct deletes even more of the 5’ PCE sequence 
up to the E-box in the unconserved sequence between the conserved regions 
1 and 2. It also shows faint but distinct reporter activity. 
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making sure that the correct expression levels are reached. It is notable that even though 
the S5 Tinman binding site (see chapter 5) is included in all these constructs, this site 
alone is not capable of inducing reporter gene expression. This points, as previously 
discussed, to the sequence between the PCE !reg1 and the PCE !tin1 deletion 
constructs. With a high probability this region contains a second major activator 
involved in PCE and Him regulation. This activator will have a similar importance for 
PCE and Him expression as the S5 Tinman binding site. 
 
 
6.8 Discussion 
 
I have shown that, as expected, in addition to Tinman, several other signals are 
integrated through the PCE to regulate Him expression. These results are in agreement 
with the results from the Junion et al. (2012) paper who have found that a region 
upstream of the transcriptional start site of Him that contains the PCE fragment 
described in my study binds to all five transcription factors (pMad, dTCF, Dorsocross, 
Pannier, Tinman) they tested (supplementary information, Junion et al., 2012). Using a 
combined deletion and Linker Scan analysis I have been able to identify an area for the 
binding of a second activator. This second activator is of similar importance as Tinman. 
The area, in which this activator binds, is within the first conserved region and through 
my analysis I can already exclude several short stretches of sequence within this 53 bp 
region. Decapentaplegic signalling and especially Medea are very strong candidates for 
this second activator of Him expression. decapentaplegic expression from the ectoderm 
is known to have a regulatory influence on the activation of several mesodermal genes 
during embryonic development (Taylor et al., 1995; Riechmann et al., 1997; Yin et al., 
1997) and the Eve-positive pericardial cells are formed underneath the ectodermal stripe 
with the highest Decapentaplegic expression (Dunin Borkowski et al., 1995). 
As stated at the beginning of this chapter, Him expression requires a repressor in 
the cardioblasts as tinman is expressed in both, the pericardial cells and the cardioblasts, 
while Him is only expressed in the pericardial cells. My analysis of the PCE sequence 
has proven this hypothesis to be true and has, additionally, also revealed the presence of 
a second site involved in repressing Him expression in the cardioblasts and a further 
repressor responsible for preventing Him expression in the amnioserosa. Two candidate 
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regulators for the cardioblast repressor, Pannier and Scalloped, are, according to my 
results, not involved in excluding Him expression from the cardioblasts. However, the 
results from Deng et al. (2009) and Guss et al. (2013) indicate a role for scalloped in 
Drosophila mesoderm and heart development and thus I cannot completely rule out that 
Scalloped might be involved in the repression of Him expression in the cardioblasts. 
Investigations into whether the removal of Scalloped by RNAi has an effect on the Him 
expression pattern are ongoing. 
Additionally I cannot rule out that a multi-protein-complex is necessary to limit 
Him expression in the cardioblasts as there are two repressor binding sites in close 
proximity to each other. It is possible to separate these two sites from one another by 
different enhancer constructs that delete or mutate different areas, thus implicating that 
both sites are equally and independently of each other necessary to exclude Him 
expression in the cardioblasts. As I have demonstrated in chapter 3, it is necessary to 
exclude Him from the cardioblasts to allow for the correct expression of Mef2-target 
genes like myosin. 
The fact that Him expression is also actively repressed in the amnioserosa sheds 
light on which other potential positive regulators are necessary for Him expression as 
tinman is not expressed in the amnioserosa cells. It is thus necessary that any activating 
factor of Him expression is also expressed in the amnioserosa. This once again, furthers 
the possibility of Decapentaplegic signalling having an influence on Him expression. 
This factor is equally important for Him regulation as Tinman, as the removal of the 5’ 
region of the PCE sequence does not show high levels of reporter expression (see PCE 
Ebox and Medea constructs), despite the intact S5 Tinman binding site being included 
in these experiments. 
I have also found evidence for factors augmenting Him activation. Deletion of 
the 5’ sequences of the PCE between the conserved regions 1 and 2 reduces PCE 
reporter expression considerably but does not abolish reporter activity completely. The 
most likely site for this factor is the Twist E-box located in the middle of the 
unconserved sequence between the first and second conserved regions. As this E-box 
sequence has been described to bind Twist (Halfon et al., 2000) and Twist is known to 
be an early activator of mesodermal genes and specifically a tinman activator 
(Riechmann et al., 1997), it is possible that these two genes act in concert to achieve the 
correct level of Him expression. I have been able to show that Hand, a bHLH protein 
with prominent expression in the developing heart from stage 12 onwards (Kölsch and 
!"#$%&'()((*+'%"&'('&,+-#%.'/(01$+%(01(203(&4$'&550.1! "#$!!
Paululat, 2002), is most likely not involved in the regulation of Him expression and the 
only other known bHLH protein expressed only in the Drosophila mesoderm is Twist. 
Furthermore I have tried to investigate the importance of the E-box found within 
the Tinman binding consensus within the context of the PCE. My results allow for two 
possible interpretations; either the E-box within the Tinman consensus is of no 
importance for Him regulation or mutating only one base within the six basepair 
consensus is not sufficient to destroy its binding ability. In their 2010 paper, the 
modENCODE Consortium et al. report that a difference of one basepair within a 
binding site might be enough to differentiate between a Sna-motif in a HOT-spot and a 
Sna-bound region and in their 2011 paper, Ozdemir et al. show that a single basepair 
mutation in a Twist E-box is sufficient to reduce expression of the rho enhancer. If this 
were indeed the case for transcription factor binding at enhancers this result would 
indicate that the E-box contained within the Tinman binding consensus is of little 
importance for Tinman binding. 
In all, the results presented in this chapter should allow for the identification of 
further regulators of Him expression, which will allow us to fine-tune the position of 
Him within the regulatory mechanisms of Drosophila heart development beyond it 
being a Tinman target gene. 
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Vector Map 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1: Vector map for the pCaSpeR-AUG-ßGal vector used to create 
transgenic fly lines (Thummel et al., 1988). 
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Embryonic expression pattern of Gal4 drivers 
 
 
Figure A2: Embryonic expression pattern of the Mef2, hand, and 
TinC!4-Gal4 drivers used in this study. 
These embryos are labelled for GFP expression as this driver test was 
done with an UAS-GFP construct. 
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Figure A3: Embryonic expression pattern of the different Him-Gal4 
driver lines available. 
These embryos are labelled for GFP expression as this driver test was 
done with an UAS-GFP construct. I used the Him-Gal4 L3-5 throughout 
this study as it reproduces the expression pattern of the Him transcript 
best. 
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Expression pattern of the lacZ transcript of three PCE 
 
 
 
 
 
 
 
 
 
 
 
Figure A4: Three independent transgenic PCE fly lines show the same 
expression pattern for the lacZ transcript. 
In-situ-hybridisation of the PCE lines 6, 14 and 34. All three constructs 
show thesame expression pattern of the lacZ transcript throughout 
development. 
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LacZ reporter expression in the PCE line 34 
 
 
 
 
 
Figure A5: Him and the PCE reporter (line 34) are expressed in the same 
heart cells. 
Him fluorescent RNA in situ and anti-!Galactosidase counterstain on embryos 
transgenic for the PCE construct (line 34). A, D, G, J, M fluorescent Him RNA 
in situ (red); B, E, H, K, N anti-!Galactosidase antibody (green); C, F, I, L, O 
overlay. 
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Manually compiled list of Drosophila mesoderm 
transcription factors (S. Elgar & M. Taylor, unpub. 
data) 
 
 
Factor Sequence 
twist CAKVTG 
zhf-1a CACCTG 
zhf-1b CTAATYRRNTT 
sup.airless RTGRGAR 
daughterless CACCTG 
ETS CGCGGAGC 
Tinman TCAAGTG 
Mef2 YTAWWWWTAR 
dTCF/pangolin CTTTGA 
Ladybird YTAAYTAG 
Eve1 TCAATTCAAT 
Eve2 TCAGCACCG 
Mad/Medea GCCGNSB 
Dorsal GRGAAANCC 
Glivertebrate TGGGTGGTC 
Lameduck CGCAGNGTTT 
Paired GWCAGGS 
Homeodomain/minimal TTAAT 
Homeodomain/full TAATNNATTA 
Forkhead/biniou RTAAYA 
Eve_high ACATTAAAGT 
Eve_med WCAKYWAMDY 
Ebox CANNTG 
Krupple_meme_high AACGGGTTAA 
Krupple_meme_med AMSGGRTTAW 
Krupple_matrix_high AACGGGTTAA 
Krupple_matrix_med AMYGGGTTAW 
Su(H)_matrix_med YGTGRGAAM 
Su(H)_matrix_low GTGRGAA 
Dorsal_matrix1_ungapped GGHHWTTMC 
Dorsal_matrix1_gapped GGHHTTMC 
Dorsal_meme_high GGGAAAACCC 
Dorsal_meme_med GGGAAAAYCC 
Pannier GATA 
Bagpipe TCAAGTKC 
Paired_High CGATTAAG 
Paired_Med CRRTKMHR 
Tinman TCAAGTG 
Biniou_high RTAAAYAAA 
Biniou_low TAAAYA 
d/TCF_high CCTTTGATCTT 
d/TCF_med1 TTTGAT 
d/TCF_med2 CTTTGA 
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Mad_high GCCGNCG 
Scalloped_high TGGAATGT 
Scalloped_med WVDWATKY 
Brinker GGCGYY 
Tinman TCAAGTG 
Mef2 YTAWWWWTAR 
Mad1 GGCGGC 
Mad2 GTCGTTGG 
Mad3 GCGGGGGC 
PanA CATCAA 
Tin1 CAATTAA 
FD TAAACA 
MedA GTCT 
Mad4 GGTTCGGCCGCAGAT 
MedB GCCGC 
Tin2 CCAAGTG 
MedC GGCGGGC 
PanB ATCAAAG 
Mad6 GCGACG 
TinA ACTTCAC 
PanC TTCACAG 
TinB CACTTAA 
PanD CACTTAA 
MedD TCTG 
MedE GCCGG 
TinC CCCTTGA 
MedF GGCGGCC 
Zfh1 TAAT 
PanE CCTTTGGAT 
TinD CACTTGA 
PanF TCCTTTAAT 
PanG GATCTAAT 
 
 
 
 
Appendix  246 
 
Buffer and Solutions 
 
AP buffer 
 100 mM Tris (ph 9.5) 
 100 mM NaCl 
 50 mM MgCl2 
 0.1 % Tween-20 
 
Apple juice agar plates for embryo collection (2 l) 
 24 g agar (Brian Drewitt) 
  in 1 l dH2O and boil in microwave until agar is dissolved 
 24 g sucrose 
  in 500 ml dH2O and heat until dissolved, then add 
 500 ml apple juice 
dissolve 2 g Nipagen (p-Hydroxybenzoic acid methyl ester, Sigma) 
in 10 ml ethanol 
   mix everything together and heat to just under boiling point 
   pour into 55 mm petridishes (Fisherbrand) 
   leave to set and then store at 4 °C 
 
Blocking solution for fluorescent antibody stain 
 1 x PBT 
 2 % goat serum (Sigma) 
 
Blocking solution for RNA probe quantification 
 10 % blocking reagent (w/v; Roche Applied Science) in maleic acid 
buffer 
 autoclave, do not filter 
 
EMSA binding buffer (5 x; Kremser et al., 1999) 
 20 mM Tris/Cl (pH 7.5) 
 200 mM NaCl 
 0.1 % Trition X-100 
 5 mM DTE 
 0.02 % BSA (w/v) 
 5 % glycerol (w/v) 
 
Fluorescent Mounting Medium 
 90 % glycerol in PBS 
 25 mg/ml DABCO (1,4-Diazabicyclo[2.2.2]octane) 
 
Fly Food Recipe (60 l) 
 42 l dH2O 
 504 g agar (Brian Drewitt) 
  start heating and stir frequently 
 135 g Nipagen (Hydroxybenzoic acid methyl ester; Sigma) 
 1.529 l analytical grade ethanol 
  dissolve and then add to the heating agar mix 
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 4.0232 kg Maize (organic, Dove’s Farm) 
 1048 g yeast 
 4.32 kg dextrose 
 12 l dH20 
  dissolve and ensure everything is mixed well 
  when the agar mixture reaches ca. 70 °C add the maize-yeast-
dextrose mix. 
  Heat until the temperature reaches 85 °C while stirring frequently, 
then add 
 4.272 l dH2O (at room temperature) 
  wait until the temperature cools down to 68 °C or less, then add 
 210 ml proprionic acid 
  mix well. 
  Dispense food. 
 
Hybridisation buffer for whole mount in-situ hybridisation 
 50 % Formamide 
 4 x SSC 
 1 x Denhardt’s 
 250 !g/ml tRNA 
 250 !g/ml salmon testis DNA 
 50 !g/ml heparin 
 0.1 % Tween-20 
 
Hybridization buffer for whole mount FISH 
 50 ml Formamide 
 25 ml 20x SSC 
 0.1 ml heparin (50mg/ml) 
 1 ml 10 % TritonX-100 
  bring to 100 ml with DEPC treated H2O 
 
Maleic acid buffer 
 100 mM maleic acid (1 M stock) 
 150 mM NaCl (1 M stock) 
  adjust to pH 7.5 with solid NaOH 
  filter before adding blocking reagent 
 
LB agar 
Prepare LB medium and add 
 15 g Bacto Agar per liter 
  sterilize by autoclaving 
 
LB medium (Luria-Bertani Medium; 1 l) 
 950 ml dH2O 
 10 g tryptone 
 5 g yeast extract 
 10 g NaCl 
  dissolve 
  adjust to pH 8 with 5 N NaOH 
  adjust volume to 1l sterilize by autoclaving 
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Loading buffer for agarose gels 
 5 % (w/v) Xylencyanol 
 5 % (w/v) Bromphenolblue 
 40 % (v/v) glycerol 
  in 1 x TAE buffer 
 
Loading buffer for SDS gels 
 100 mM Tris-Cl (pH 6.8) 
 4 % (w/v) SDS 
0.2 % (w/v) bromophenol blue 
 20 % (v/v) glycerol 
 200 mM ß-mercaptoethanol 
 
PBS (phosphate buffered saline; 1 x) 
 140 mM NaCl 
 6.5 mM KCl 
 2.5 mM Na2HPO4 
 1.5 mM KH2PO4 
 adjust to pH 7.5 and autoclave 
 
PBT (1 x) 
 1 x PBS 
 0.1 % Tween-20 
 
PBS-TX (1 x) 
1 x  PBS 
 0.1 % Triton X-100 
 
Paraformaldehyde (4 %; in PBS) 
 2.142 g Pearl NaOH 
 85 ml dH2O 
  dissolve 
 20 g Paraformaldehyde 
  add dissolved NaOH 
  heat to a max of 60°C 
  allow to cool 
 10.58 g NaH2PO4x2H2O 
 400 ml dH2O 
  dissolve 
  add to cooled Paraformaldehyde solution 
  adjust to pH 7 with NaOH if necessary 
  store in aliquots at -20°C 
 
Ribofix solution for embryo fixing (2.5ml) 
 250 !l 10 x PBS 
 250 !l 0.5 M EGTA (pH 8.0) 
 600 !l dH2O 
 1.4 ml 16 % formaldehyde, methanol-free (Polysciences) 
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Spradling buffer (1x) 
 1mM Sodium Phosphate buffer pH 6.8 
 0.5mM KCl 
 
SOB medium (1 l) 
 950 ml dH2O 
 20 g tryptone 
 5 g yeast extract 
 0.5 g NaCl 
  dissolve 
 10 ml 250 mM KCl 
  adjust to pH 7.0 with 5 N NaOH 
  adjust total volume to 1 l 
  sterilize by autoclaving 
  then add 
 5 ml 2 M MgCl2 (sterile) 
 
SOC medium (1 l) 
 950 ml dH2O 
 20 g tryptone 
 5 g yeast extract 
 0.5 g NaCl 
  dissolve 
 10 ml 250 mM KCl 
  adjust to pH 7.0 with 5 N NaOH 
  adjust total volume to 1 l 
  sterilize by autoclaving 
  allow to cool below 60 °C, then add 
 20 ml 1 M glucose (sterile) 
 5 ml 2 M MgCl2 (sterile) 
 
STET-buffer 
 10 mM Tris (pH 8.0) 
 25 mM EDTA 
 100 mM NaCl 
 0.1 % Triton X-100 
 8 % sucrose 
  sterilize by autoclaving or filtering 
 
TBE (500 ml, 10 x) 
 54 g Tris Base 
 27.5 g Boric Acid 
 20 ml 0.5 M EDTA (pH 8.0) 
  bring to 500 ml with dH2O 
 
TE buffer 
 10 parts Tris/HCl (pH 8.0) 
 0.1 parts EDTA (pH 8.0) 
 
 
Appendix  250 
 
TFB1 buffer 
 100 mM RbCl2 
 50 mM MnCl2.4H20 
 30 mM KAc 
 10 mM CaCl2.2H20 
 5 % glycerol 
  filter sterilize, store at 4 °C in a sterile bottle 
 
TFB2 buffer 
 10 mM MOPS 
 10 mM RbCl2 
 75 mM CaCl2.2H20 
 15 % glycerol 
  adjust to pH 6.8 – 7.0 
  filter sterilize, store at 4 °C in a sterile bottle 
 
TNE buffer (oligo annealing) 
 10 mM Tris (pH 8.0) 
 100 mM NaCl 
 1 mM EDTA 
 
TXN 
 0.7 % NaCal 
 0.04 % TritonX-100 
  in dH2O 
 
Wash buffer for RNA probe quantification 
 0.1 M NaCl 
 0.05 M MgCl2 
 0.1 M Tris pH 9.5 
 0.1 % Tween-20 
 
Wash buffer for whole mount in-situ hybridisation 
 50 % Formamide 
 2 x SSC 
 0.1 % Tween-20 
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